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ABSTRACT 
DISEASE SELF-MANAGEMENT CAPACITY, PATIENT BURDEN, AND 
MEDICATION ADHERENCE IN AFRICAN AMERICAN ADULTS WITH TYPE 2 
DIABETES AND HYPERTENSION 
by 
Michelle R. Gaddis 
African American (AA) adults are disproportionately affected by type 2 
diabetes (T2D) and hypertension, with greater prevalence and disease-related 
complications. Disease complications may be prevented or delayed with 
adequate disease self-management (DSM). The literature indicates greater 
patient activation and health literacy and lower treatment burden and illness 
burden are associated with improved DSM, but AAs with comorbidities were 
underrepresented in these studies. The purpose of this study was to examine 
associations among patient activation, health literacy, treatment burden, illness 
burden, medication workloads, and medication adherence for AA adults wi th T2D 
and hypertension. This study also explored the perceived impact of COVID-19 on 
medication management.  
A non-experimental, predictive, correlational design was used. 
Participants were recruited using social media and flyers distributed via email. 
Data were collected via surveys administered through Qualtrics® and 
telephone/online interviews. Spearman’s correlations and hierarchical regression 
analyses were conducted to examine relationships among the study variables.  
vii 
 
Participants (N = 91) ranged in age from 25 to 73 years (M = 39.6), were 
mostly male (66%), college-educated (71%), and earning incomes of $30,000 or 
more (66%). Most were diagnosed with T2D and hypertension for less than five 
years (respectively, 64% and 75%) and averaged four (±1.3) prescribed 
medications.  
On average, participants had high patient activation scores, low health 
literacy scores, and moderate levels of treatment and illness burden. Overall, 
medication adherence scores (M = 2.4) indicated the presence of non-
adherence; 66% were classified as non-adherent. The model, including all 
predictor variables, was significant in predicting medication adherence, 
accounting for 19% of the variance. However, patient activation was the only 
significant contributor; for each one-point increase in patient activation, 
medication adherence improved by .03.The perceived impact from the COVID-19 
pandemic on medication management was moderate, with participants feeling 
worried about leaving their homes (e.g., to get medications) and paying for 
medications.  
In this sample of mostly younger AA men with T2D and hypertension, 
medication adherence was inadequate, but was only partially explained by 
patient activation. Further research is needed on DSM in AAs with T2D and 
hypertension to identify additional factors that may promote or hinder their 
medication adherence. 
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CHAPTER I 
INTRODUCTION 
Diabetes is the 7th leading cause of mortality in the United States 
(Centers for Disease Control and Prevention [CDC], 2018a). The CDC (2017a) 
reports that greater than 30 million individuals in the United States have diabetes, 
with 95% having Type 2 Diabetes (T2D). The prevalence of diabetes continues to 
increase rapidly, with a projected rise in prevalence to more than 54 million 
individuals in the US by the year 2030 (Rowley et al., 2017). Adults with diabetes 
have an increased susceptibility to the development of comorbidities and 
associated health complications, along with a 50% greater risk of death from any 
cause as compared to adults without diabetes (Rowley et al., 2017).  
Most adults with diabetes have at least one coexisting chronic condition 
(Lin et al., 2015). One of the more prominent comorbidities for individuals with 
diabetes is hypertension (CDC, 2018c). According to national estimates, about 
68% of individuals with diabetes also have hypertension (CDC, 2018c). In a 
cross-sectional analysis including 161,174 adults (63% White, 20% Black, 2% 
“other”, and 13% unidentified) with T2D, 36% of the sample had one to two 
comorbidities, with 65% having hypertension (Lin et al., 2015). Five of the six 
most common multiple morbidity clusters observed in the study included 
hypertension.  
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Background 
Individually, Type 2 diabetes (T2D) and hypertension are associated with 
elevated risks for several vascular complications including coronary artery 
disease, myocardial infarction, congestive heart failure, peripheral artery disease, 
retinopathy, nephropathy, neuropathy, stroke and heart disease (CDC, 2018b; 
Long & Dagogo‐Jack, 2011; National Institute of Diabetes and Digestive and 
Kidney Diseases [NIDDK], 2017). When diabetes and hypertension coexist, the 
risks for associated vascular complications greatly increases (American Heart 
Association [AHA], 2015; CDC, 2018b; Long & Dagogo-Jack, 2011; NIDDK, 
2017; Petrie et al., 2018). Hypertension has been identified as a significant risk 
factor in the accelerated development of vascular complications and the 
progression of cardiovascular disease for individuals with diabetes (Petrie et al., 
2018). The AHA (2015) reports that the presence of comorbid diabetes and 
hypertension doubles the risk of developing cardiovascular disease compared to 
having only one of the diseases.  
T2D and hypertension are also associated with higher rates of unplanned 
healthcare utilization (e.g., emergency room visits) resulting from complications 
of these diseases (CDC, 2017b; Lynch et al., 2015). Reportedly, emergency 
room (ER) visits for individuals with chronic disease(s) have continued to rise 
over the last decade, particularly for individuals with diabetes and hypertension 
(McNaughton et al., 2015). The heightened use of unplanned healthcare services 
for individuals with T2D and hypertension coincides with the estimated national 
expenditure ($375 billion) for managing both diseases (ADA, 2018a; CDC, 
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2016a). Additionally, on average, more than half of the total medical costs related 
to diabetes management are attributed to hospital inpatient care and prescription 
medications (ADA, 2018a).  
Many of the disease-related complications for individuals with T2D and 
hypertension can be prevented or delayed with appropriate disease management 
(AHA 2016a; CDC, 2017c). Supplementary to the clinical aspect of disease 
management, managing T2D and hypertension involves a significant amount of 
self-management activities. Disease self-management (DSM) activities are 
recommended actions for patients to take, typically on a regular basis, and 
independent of their healthcare provider’s direct assistance. DSM activities that 
may be recommended to patients with T2D and hypertension include healthy 
eating, physical activity, monitoring blood glucose and blood pressure, taking 
prescribed medications, and solving problems relating to disease management 
(e.g., calculating insulin doses; Byers et al., 2016; Powers et al., 2015). DSM 
activities collectively form an individual’s DSM workload. Adhering to the 
recommended DSM activities within the DSM workload has been associated with 
increased glycemic and blood pressure control, reductions in T2D and 
cardiovascular complications, and fewer unplanned hospitalizations (Byers et al., 
2016; CDC, 2018b). The escalating number of hospitalizations for individuals 
with T2D and hypertension may be associated with deficiencies in their DSM 
abilities and potentially overwhelming burdens in performance of DSM activities 
(CDC, 2017b; Fingar et al., 2017; McNaughton et al., 2015).  
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One prominent DSM activity for adults with T2D and hypertension is the 
management of prescribed medications. It has been estimated that roughly 85% 
of people with T2D and 70% of people with hypertension are prescribed 
medications for management of their disease (CDC, 2016b; CDC, 2019), 
indicating a heavy medication workload for individuals with these diseases. 
Adhering to prescribed medications is essential in achieving improvements in 
patient care outcomes and reducing the potential of associated disease-related 
complications (e.g., heart failure, stroke, and mortality) for individuals with T2D 
and hypertension (Brown & Bussell, 2011; CDC, 2018b; NIDDK, 2017). Adhering 
to prescribed medication regimens can be a complex and burdensome DSM 
activity, as it requires time, resources, knowledge, skills, and motivation . Thus, 
this study aimed to examine factors that had the potential to impact medication 
adherence and the DSM workload associated with managing prescribed 
medications for AA adults with T2D and hypertension.  
Problem 
African American (AA) adults are disproportionately affected by T2D and 
hypertension with higher prevalence rates and complications that result from 
these diseases (ADA,2018b; CDC,2017a; Gebregziabher et al., 2018). Currently, 
there is a greater prevalence of T2D among AAs (11.7%) than non-Hispanic 
Whites (7.5%; CDC, 2020e). Additionally, AAs have a greater number of 
diabetes-related comorbidities than other racial and ethnic groups (Lin et al., 
2015). For example, Lynch et al. (2015) conducted a retrospective cohort study 
of 892,223 veterans to identify multiple morbidity patterns across ethnicities. The 
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sample included 12% AAs, 61% Whites, 13% Hispanics, and 12% identified as 
“other”.  There were 32% of AA participants with three or more comorbid 
conditions as compared to 27% of Whites, 26% of Hispanics, and 14% of the 
group labeled as “other”. Hypertension, a commonly associated comorbidity of 
T2D, further increases and accelerates the risks for clinical complications (e.g., 
stroke and heart disease), especially for AAs (AHA, 2016a; CDC, 2019b). Similar 
to T2D, the prevalence of hypertension is greater for AA adults (40.3%) than non-
Hispanic Whites (27.8%) (CDC, 2017d).  
AAs have also been frequently identified as having an increased risk and 
higher rates of associated complications from T2D, compared to other 
racial/ethnic groups (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Office of 
Minority Health [OMH], 2016). The age-adjusted death rate per 100,000 
attributed specifically to diabetes is higher among AA adults (38.7) as compared 
to non-Hispanic White adults (18.8) and all other race/ethnicity groups (21.5; 
CDC, 2019b). The CDC (2019b) also reports that the age-adjusted death rate per 
100,000 from hypertension for AA adults (17.1) is higher than for non -Hispanic 
White adults (8.0). Higher mortality rates for AAs with T2D and hypertension are 
potentially due to the disproportionate challenges in medication adherence, 
leading to uncontrolled blood glucose and blood pressure (CDC, 2017d; OMH, 
2016).  
Management of T2D and hypertension involves a multifaceted approach, 
with self-management activities having a large role. Managing both conditions is 
more challenging than managing either alone. For example, there may be more 
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medications prescribed, additional self-monitoring tasks to complete (e.g., blood 
glucose and blood pressure monitoring), and additional diet restrictions to follow. 
DSM in T2D and hypertension requires patients to have adequate DSM capacity:  
relevant knowledge, motivation, and skills (Beck, 2018; Powers, 2015). This 
claim is supported by previous studies that demonstrated patient activation (i.e., 
knowledge, motivation, and skills for managing health) and health literacy (i.e., 
the skill needed to obtain, process, and understand basic health information to 
make decisions) were associated with DSM performance (Beck, 2018; Bolen  
et al., 2014; Mayberry et al., 2010; Powers, 2015; Weld et al., 2008; Ylitalo et al., 
2018). People with T2D and hypertension who have limited DSM capacity (i.e., 
patient activation and health literacy) may perceive their DSM activities as too 
complex, leading to inadequate performance and lack of glycemic and blood 
pressure goal attainments (Egan et al., 2014).  
Additionally, DSM activities for T2D and hypertension, particularly 
managing prescribed medications, may become overly burdensome leading to 
poor adherence. The burden in performance of DSM may stem from the 
complexity of the prescribed treatment plan (i.e., treatment burden) or from the 
symptomology associated with the illnesses being treated (i.e., illness burden), 
collectively described as patient burden. The performance of DSM activities may 
be further complicated during a major crisis, such as what may occur during a 
global pandemic. Presently, there is a worldwide pandemic that could be 
impacting the performance of DSM activities for AAs with T2D and hypertension. 
The Coronavirus Disease 2019 (COVID-19) is a life-threatening public health 
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situation that is currently impacting individuals on a global scale. The incidence 
and mortality for COVID-19 continue to climb at alarming rates. Recent reports 
indicate that there have been more than one million cases of COVID-19 identified 
in the U.S., with 68,279 deaths reported (CDC, 2020a). The CDC (2020b) states 
that during a pandemic such as with COVID-19, individuals may experience large 
amounts of stress which may subsequently create difficulty in concentrating (e.g., 
carrying out DSM activities) and worsen chronic health problems. The CDC 
(2020c) also reports that individuals with diabetes may be at a higher risk of 
experiencing a greater severity of illness from COVID-19 and have greater 
difficulty in recovering from the illness. Furthermore, AAs may be 
disproportionately impacted by COVID-19, with recent reports indicating that 
COVID-19 related hospitalizations and death rates are higher for AAs as 
compared to other ethnicities (CDC, 2020d). Thus, it is important to explore 
individuals’ perceived impact of the COVID-19 pandemic on their abilities to 
manage their prescribed medications.  
Although literature describing the benefits of DSM exists, some individuals 
with diabetes and hypertension still demonstrate poorly executed DSM (e.g., 
poor medication adherence), even with already having experienced a 
cardiovascular event (Beck et al., 2018; Brown & Bussell, 2011; Fox et al., 2015; 
Powers et al., 2015; Shrivastava et al., 2013; Weller et al., 2017). Considering 
that AA adults have a higher prevalence of uncontrolled T2D and hypertension, 
this may potentially indicate that AAs have significant DSM capacity deficiencies 
and overwhelming burdens in DSM (ADA, 2018b; CDC, 2017d; OMH, 2016). 
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There are no known studies that examine the combined impact of DSM 
capacity and patient burden (i.e., treatment burden and illness burden) on the 
performance of any DSM activities for AA adults with T2D and hypertension. The 
heightened health risks associated with comorbid T2D and hypertension (e.g., 
stroke, heart disease) are further magnified in this vulnerable population when 
appropriate DSM behaviors are absent (CDC, 2018b). The apparent disparity in 
health outcomes for AA adults with T2D and hypertension suggests a need to 
investigate factors that may impact their performance of DSM. Additionally, as 
managing medications is a prominent DSM activity for individuals with T2D and 
hypertension, it is also important to examine the relationships of DSM capacity 
and patient burden within the context of medication adherence. Furthermore, as 
no known studies have examined any DSM activities for T2D and hypertension 
during a pandemic, valuable information was also gained from exploring 
individuals’ perceptions of the impact of COVID-19 on their ability to manage 
their prescribed medications.  
Significance of the Study for Healthcare Professionals 
This study is significant because it addressed existing gaps in the 
literature by investigating underexamined factors potentially associated with 
medication adherence for AA adults with T2D and hypertension. Healthcare 
professionals are essential in providing self-management support to patients with 
T2D and hypertension through the provision of education, encouragement, and 
empowerment strategies relating to the performance of DSM tasks, specifically 
adherence to prescribed medication regimens. This study provides a gateway to 
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clinical practice improvements, specifically in the provision of care for AA adults 
with T2D and hypertension. First, this study highlights factors that associate with 
medication adherence (i.e., DSM capacity and patient burden). Additionally, this 
study strengthens the validity and reliability for measures of DSM capacity (i.e., 
health literacy and patient activation) and patient burden (i.e., treatment burden 
and illness burden). By gaining a better understanding of factors that associate 
with medication adherence and having valid methods to assess those factors, 
healthcare professionals can be better equipped to identify individuals at risk for 
poor medication adherence and enhance the effectiveness of the treatment plans 
developed for AA patients with T2D and hypertension. Ultimately, discoveries 
from this study can facilitate the development of novel strategies in patient care 
delivery, resulting in improved patient outcomes and reduced health care costs.  
Purpose 
The purpose of this study was to examine associations among patient 
activation, health literacy, treatment burden, illness burden, medication workload, 
and medication adherence for AA adults with comorbid T2D and hypertension. 
This study also explored the perceived impact of COVID-19 on the management 
of prescribed medications. 
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Research Questions 
For AA adults 18 years of age or older with comorbid T2D and 
hypertension who have been prescribed medications for blood pressure and 
glycemic control:  
RQ1: Are higher levels of illness burden associated with lower levels of patient 
activation and health literacy?  
RQ2: Are higher levels of treatment burden associated with a higher number of 
prescribed medications and greater perceived difficulty in managing prescribed 
medications?   
RQ3: Do patient activation, health literacy, treatment burden, and illness burden 
significantly predict medication adherence? 
RQ4: Which aspects of medication management are the most challenging?  
RQ5: What is the perceived impact of the COVID-19 pandemic on medication 
management? 
Theoretical Framework 
The Cumulative Complexity Model (CCM), developed by Shippee et al., 
2012, was used to guide the selection and analysis of variables in this study (See 
Figure 1). The CCM provides a patient-centered framework for exploring the 
complexity of disease management by illustrating: (1) how treatment burden and 
illness burden impact the interaction between workload of demands and capacity, 
(2) the potential imbalances that occur between individuals’ workload of demands 
and their abilities to manage their workloads, and (3) how imbalances between 
workloads and capacities indirectly impact health-related outcomes (Shippee et 
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al., 2012). The CCM provides a mechanism for understanding the complexity of 
patient care by illustrating how clinical and social factors accrue and interact, 
complicating patients’ disease management experiences (Shippee et al., 2012).  
The CCM incorporates interrelating concepts with feedback loops to 
display disease management complexity and the ongoing consequences of 
workload-capacity imbalances (Shippee et al., 2012). There are four primary 
constructs within the model: workload, capacity, burden of treatment, and burden 
of illness (Shippee et al., 2012). Workload is described as a collective of all the 
demands (e.g., DSM, family obligations, work obligations) individuals have in 
their lives (Boehmer, Shippee, et al., 2016). Capacity is defined as the abilities 
and resources individuals have in meeting the demands of their workload 
(Boehmer, Shippee, et al., 2016). Burden of treatment is the level of perceived 
difficulty individuals have in meeting their workload demands (Rogers et al., 
2017). Lastly, burden of illness refers to the perceived level of disruption in 
aspects of day-to-day life that is attributed to a pre-existing disease process 
(Shippee et al., 2012). 
The CCM posits that when there is an imbalance between workload and 
capacity, specifically when capacity fails to meet the demands of the workload, 
individuals are more likely to have deficiencies in their disease management 
performance (Boehmer, Shippee, et al., 2016). Performance deficits (e.g., poor 
medication adherence) are associated with unfavorable health outcomes such as 
illness leading to unplanned hospitalization (Fox et al., 2015; Leppin et al., 2015; 
Shrivastava et al., 2013). Poor health outcomes may lead to greater treatment 
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and illness burdens (Bodde et al., 2013; Shippee et al., 2012;). The increased 
burdens subsequently increase the demands of the workload and decrease the 
capacity in meeting the increasingly demanding workload (Boehmer, Shippee, et 
al., 2016). 
Figure 1 
Cumulative Complexity Model
 
 
Applicability of the Cumulative Complexity Model 
The CCM can be applied to studies examining medication adherence for 
individuals with chronic diseases, as it provides a framework to categorize patient 
capacity and burden factors and examine how DSM capacities and burdens 
interact. The CCM also reflects how certain attributes of a medication workload 
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(i.e., number, difficulty, and route) can highlight the complexity that individuals 
encounter when attempting to meet the DSM workload demand of managing 
prescribed medications. The model has been used in previous studies involving 
individuals with chronic illness (e.g., stroke survivors, patients on dialysis) to 
explore DSM capacity (Boehmer, Shippee, et al., 2016; Gallacher et al., 2018). 
Gallacher et al. (2018) conducted a qualitative study to explore patient burden 
and patient capacity for stroke survivors. Findings from the study indicated a 
cyclical relationship among patient workload, patient capacity, and deficiencies in 
performance of DSM activities. Additionally, clinical practice implications from the 
study included the need for healthcare professionals to review clinical guidelines 
and healthcare delivery models, as these also have an impact on a patient’s 
capacity and burden. In a cross-sectional study of adults receiving dialysis 
treatments, Boehmer, Shippee, et al. (2016) sought to explore patients’ 
perceived burdens from dialysis and their individual capacities in coping with the 
associated burdens. Findings from the study indicated that deficits in physical, 
emotional, and financial capacities were the most significant factors associated 
with a disruption in disease management. The CCM has also been used as a 
framework for the development of a self-report tool which facilitated 
communication between patients and clinicians, highlighted patients’ conflicts in 
managing competing priorities in DSM, and in some cases, led to changes in 
treatment plans (Boehmer, Hargraves, et al., 2016). To date, the model has not 
been utilized in a study specifically for AA adults with T2D and hypertension nor 
as a framework for predicting medication adherence.   
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Overview of Concepts 
Workload 
An individual’s workload is the summation of all their competing, personal 
demands (Shippee et al., 2012). Examples of workload demands include 
maintaining or acquiring employment, completing disease self-management 
activities, and managing household duties (Shippee et al., 2012). Workloads can 
vary in several ways including in the following attributes: number of demands, 
difficulty of demands, and how well each of their demands fit into an individual’s 
life among their other demands (Shippee et al., 2012).  In this study, “workload” 
was adapted to “DSM workload” for AA adults with T2D and hypertension. DSM 
workload is defined as the DSM demands that individuals have in managing their 
illness(es). For T2D and hypertension, demands may include the activities 
involved in exercising, acquiring and consuming healthy foods, communicating 
with healthcare providers, and managing prescribed medications (Gallacher et 
al., 2018). One specific DSM workload demand of interest, managing prescribed 
medications, was examined in this study. The specific attributes of this DSM 
workload demand that were examined in this study are number (i.e., the number 
of medications prescribed), difficulty (i.e., the perceived difficulty in managing the 
workload demand), and route (i.e., the routes prescribed for medication 
administration). These attributes were collectively described as “medication 
workload” and were used to gain additional insight into the workload demand of 
managing prescribed medications for AA adults with T2D and hypertension.  
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Capacity 
Capacity refers to the abilities and resources individuals possess in order 
to manage their workload responsibilities. Capacity includes any physical, 
mental, social, financial, personal, and environmental resources, all of which may 
change over an individual’s lifespan (Leppin et al., 2014). In this study, “capacity” 
was adapted to “DSM capacity” and was defined and measured through two 
functions: patient activation and health literacy. Patient activation is an 
individual’s perceived knowledge, motivation, and DSM skills relating to 
managing healthcare activities (Bolen et al., 2014). Health literacy is defined as 
the ability to obtain, process, and understand health and healthcare service 
information (Weld et al., 2008).  
Treatment Burden 
Treatment burden refers to the amount of difficulty and effort individuals 
perceive is involved in meeting DSM workload demands (Boehmer, Shippee,  
et al., 2016). Treatment burden is impacted by the amount and complexity of the 
DSM workload demands an individual has been tasked with completing. 
Treatment burden can also be impacted (positively or negatively) by other clinical 
and social factors (e.g., healthcare access, presence of social support, financial 
resources, physical functioning). The concept of treatment burden emphasizes 
the need to consider the impact that prescribed DSM activities have on 
individuals’ functioning or well-being (Boehmer, Shippee, et al., 2016).  
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Illness Burden 
Illness burden refers to the perceived level of disruption in day-to-day life 
that is associated with an existing disease (Shippee et al., 2012). Illness burden 
may be impacted by symptoms (e.g., fatigue and pain), deterioration of functional 
status, and an assortment of other health impairments relating to an individual’s 
morbidity (Devins, 2010).  
Conceptual Outcomes 
DSM in T2D and hypertension can be very demanding for the individuals 
who have these diseases, requiring completion of numerous DSM activities, 
including the management of prescribed medications (Rogers et al., 2017). When 
individuals with comorbid T2D and hypertension do not have the level of capacity 
(e.g., adequate health literacy and patient activation) necessary to manage their 
DSM demands, this may result in poor execution of DSM (e.g., poor medication 
adherence). Individuals who demonstrate poor medication adherence are at risk 
of experiencing negative health outcomes and may be further impacted by 
diminished health and additional prescribed DSM workload demands, adding to 
burdens that are likely already overwhelming (Rogers et al., 2017).  
 In this study, the attributes of one specific DSM workload demand (i.e., 
managing prescribed medications) was examined (i.e., number of prescribed 
medications, perceived difficulty in managing prescribed medications, and the 
routes prescribed for medication administration).  Additionally, the relationships 
among DSM capacity (i.e., patient activation and health literacy), patient burden 
(i.e., treatment burden and illness burden), and medication adherence for AA 
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adults with T2D and hypertension was examined. Greater illness burden was 
expected to associate with lower DSM capacity. Greater treatment burden was 
expected to associate with higher number of prescribed medications and greater 
perceived difficulty in managing prescribed medications. The routes of 
medication administration (e.g., oral, injection, topical) were also examined in this 
study. An attribute of DSM workload demands is the “fit” of the workload 
demands in individuals’ day-to-day lives (Shippee et al., 2012). As the specific 
DSM workload demand in this study was the management of prescribed 
medications, examining the routes prescribed for medication administration 
provides insight into additional challenges in medication management. For the 
outcome of interest in this study (i.e., medication adherence), individuals with 
poorer medication adherence were expected to have higher patient burdens (i.e., 
treatment burden and illness burden) and/or lower levels of DSM capacity (i.e., 
patient activation and health literacy).  
An adapted CCM model was developed to highlight the relationships that 
were anticipated among the selected study variables (see Figure 2). Without 
appropriate interventions, individuals who do not have the DSM capacity to 
manage their DSM workload demands or have patient burdens too heavy to 
overcome, may demonstrate poor medication adherence and have greater risks 
of experiencing poor health outcomes. Poor health outcomes may create 
additional treatment burdens and illness burdens, subsequently having additional 
negative impacts on future health outcomes. As this study did not examine the 
impact of DSM performance (e.g., health status, hospitalizations), researchers 
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may benefit from exploring the cyclical nature of the original CCM by conducting 
longitudinal studies that include objective measures of health status (e.g., 
glucose levels, HbA1c, blood pressure readings) and DSM performance, how 
increased treatment burden impacts the DSM workloads, and how changes in 
illness burden effect DSM capacity.  
Figure 2 
Adapted Cumulative Complexity Model  
 
Note. This model was adapted for medication adherence among African 
American adults with type 2 diabetes and hypertension. Adapted from Shippee et 
al., 2012. 
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Assumptions 
The following are assumptions inherent in the Adapted Cumulative 
Complexity model: 
1. Managing prescribed medications is a prominent disease self-management 
workload demand for African American adults with Type 2 diabetes and 
hypertension.   
2. The number of prescribed medications, perceived difficulty in medication 
management, and the prescribed route(s) for administration of prescribed 
medications are attributes that define the disease self-management workload 
demand of managing prescribed medications.   
3. Patient activation and health literacy are essential aspects of disease self-
management capacity that quantify individuals’ abilities to meet the disease 
self-management workload demand of medication management.  
4. Treatment burden and illness burden are specific patient burdens that may   
complicate individuals’ abilities to meet the disease self-management 
workload demand of medication management.  
5. Treatment burden, illness burden, and disease self-management capacity  
      collectively impact an individual’s ability to manage their prescribed     
      medications and shape their medication adherence.   
Summary 
Although several national initiatives have been implemented to facilitate 
reductions in complications from T2D and hypertension, the complications from 
these diseases continue to threaten the well-being of individuals living with them, 
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particularly AA adults. This study used an innovative model to examine a DSM 
workload demand (i.e., managing prescribed medications), DSM capacities (i.e., 
patient activation and health literacy), patient burdens (i.e., treatment burden and 
illness burden), and medication adherence for AA adults with T2D and 
hypertension. Considering that managing prescribed medications is a prominent 
DSM workload demand for AA adults with T2D and hypertension, it is essential to 
examine underexplored factors that may have a great impact on patients’ abilities 
to meet this DSM workload demand.   
Examination of patient activation, health literacy, and patient burden 
factors provided insight into the challenges that AAs face in meeting their DSM 
workload demand of managing prescribed medications. As this entire study was 
conducted remotely, this study also provides support for the feasibility of using 
the respective measures as risk assessment tools in remote settings, such as 
during telemedicine visits. In addition, findings from this study could potentially be 
translated into enhanced clinical practice guidelines, with the goal being to 
improve patients’ DSM capacities, decrease patient burdens, and improve 
patients’ medication adherence. Ultimately, improvements in medication 
adherence for AA adults with T2D and hypertension may lead to improvements in 
overall minority health and a reduction in health disparities for a currently 
vulnerable population. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
This study aimed to examine the relationships among disease self-
management capacity, patient burden, and medication adherence for AA adults 
with comorbid T2D and hypertension. The perceived impact of COVID-19 on 
management of prescribed medications was also examined in this study. This 
chapter presents an overview of the literature relating to the concepts that were 
examined in this study. The first section of this chapter provides context for the 
disease self-management workload in Type 2 diabetes and hypertension, 
including the specific workload demand of managing prescribed medications. 
Disease Self-Management Workload in Type 2 Diabetes and Hypertension 
T2D and hypertension are chronic diseases that often require lifelong 
disease management (AHA, 2016; Powers et al., 2015). Disease management in 
both T2D and hypertension is largely conducted through performance of disease 
self-management (DSM) activities (AHA, 2016; Powers et al., 2015). DSM 
activities are the specific DSM workload demands an individual must meet in 
managing their chronic conditions and preventing disease-related complications 
(Beck et al., 2018). Previous reports indicate that adhering to recommended 
DSM activities (e.g., medication adherence) is essential in achieving favorable 
health outcomes and reducing risks for long term disease-related complications 
(Fox et al., 2015; Powers et al., 2015; Shrivastava et al., 2013). Although
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recommended DSM activities are tailored to meet individualized needs, general 
guidelines for DSM have been established and reported (Powers et al., 2015).    
A joint position statement from the American Diabetes Association (ADA), the 
American Association of Diabetes Educators (AADE), and the Academy of 
Nutrition and Dietetics (AND) indicates that healthy eating, physical activity, 
glucose monitoring, taking prescribed medications, problem-solving, and healthy 
coping are general recommended DSM activities for individuals with diabetes 
(Powers et al., 2015). Furthermore, the ADA affirms that the DSM aspect of 
diabetes care also encompasses management of comorbidities, namely 
hypertension (de Boer et al., 2017). ADA recommendations for inclusion of 
hypertension for individuals with diabetes highlights the importance of home 
blood pressure monitoring and medication adherence (de Boer et al., 2017).  
 Previous studies have highlighted the significance of DSM performance. 
Weller et al. (2017) conducted a mixed-methods study to determine if the DSM 
practices of adults with T2D were linked to glycemic control outcomes. A total of 
56 participant interviews (29% AA) were retained from the larger study to conduct 
a qualitative comparative analysis. The study revealed key themes relating to 
glycemic control. Participants were then divided into three groups: good glycemic 
control was indicated by HbA1c of <7.0%, fair control by a HbA1c from 7.0% to 
8.0%, and poor control by a HbA1c of >8.0%. Individuals with good glycemic 
control performed self-monitoring of blood glucose, rarely skipped or missed 
medication doses, and followed dietary recommendations. More specifically, 
individuals with good glycemic control, as compared to those with poor control, 
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were less likely to report skipping medications (5% vs. 33%) and more likely to 
monitor dietary sodium intake (53% vs. 6%).  
Schmitt et al. (2016) also found associations between diabetes self -
management behaviors and glycemic control. The researchers conducted a 
study to compare the efficacy of two self-report measures of diabetes self-
management in predicting variations in HbA1c levels. The self-report tool of 
primary interest, the Diabetes Self-Management Questionnaire (DSMQ), 
incorporated essential measures of disease self-management: dietary control, 
medication adherence, blood glucose monitoring, physical activity, and 
maintaining recommended physician contact. Using a sample of 430 patients 
with diabetes (T2D patients = 182), the researchers found that the DSMQ 
explained 28% of the variance in glycemic levels, with higher DSMQ scores (i.e., 
better DSM performance) associating with lower HbA1c levels (-0.46, p < .001). 
These results highlight the importance of DSM performance in chronic disease 
management. Essentially, better DSM performance lead to greater improvements 
in glycemic control.  
Medication Workload 
An important DSM workload demand for individuals with T2D and 
hypertension is managing prescribed medications. It has been estimated that 
roughly 81% of individuals with T2D and 70% of individuals with hypertension are 
prescribed medications for management of their disease (CDC, 2016b; CDC, 
2019b). In 2018, antidiabetic medications ranked sixth out of the top 20 
therapeutic classes of dispensed prescriptions, with 214 million prescriptions 
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(Aitken et al., 2019). In that same year, antihypertensives ranked first for 
dispensed prescription medications, with 674 million prescriptions (Aitken et al., 
2019). The combined costs for both therapeutic classes of medications 
accounted for greater than $67 billion in non-discounted U.S. spending during 
2018 (Aitken et al., 2019). Furthermore, while the percentage of oral or insulin 
therapy was consistent between AA and non-Hispanic White groups (respectively 
47% vs 50%), AAs with diabetes were reported to have an almost two-fold 
prevalence of dual pharmacologic therapy consisting of insulin and pills as 
compared to their non-Hispanic White counterparts (respectively 25% vs. 13%; 
CDC,2019). These data indicate a hefty DSM workload demand for managing 
prescribed medications exists for AAs with T2D and hypertension.  
Managing prescribed medications can be very complex, as it may require 
numerous skills (e.g., health literacy, problem-solving skills). This complexity may 
create challenges in meeting this DSM workload demand, leading to poor 
medication adherence (Brown & Bussell, 2011; Greene et al., 2015; Ylitalo et al., 
2018). Deficiencies in DSM capacities and overwhelming burdens may exist for 
individuals who demonstrate difficulty in performance of DSM. There is evidence 
that knowledge deficits, the complexity of T2D management, and managing 
comorbid conditions such as hypertension, create additional challenges in 
performance of daily DSM activities (Akohoue et al., 2015; Bockwoldt et al., 
2017; Utz et al., 2006). While a few studies were identified that examined DSM 
performance in AAs with diabetes (Al Sayah et al., 2015; Bains et al., 2011; 
Bockwoldt et al., 2017; Davis et al., 2006; Skolasky et al., 2011; Weller et al., 
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2017), only one study was found that examined DSM solely in the AA population 
(Bockwoldt et al., 2017) and no studies were found that examined DSM 
performance exclusively in AAs with diabetes and comorbid conditions (e.g., 
hypertension). This study aimed to examine factors that potentially impact the 
performance of DSM activities for AA adults with T2D and hypertension. 
Additionally, the individual medication workloads (i.e. number of prescribed 
medications, perceived difficulty in managing prescribed medications, prescribed 
routes for medication administration) for AA adults with T2D and hypertension 
were examined. By gaining a better understanding of how the capacity and 
burdens of AAs with comorbid T2D and hypertension relate to performance of a 
specific DSM activity (i.e., managing prescribed medications), it may be possible 
to develop strategies that could improve medication adherence, and potentially, 
improve health outcomes for this population.  
Disease Self-Management Capacity 
Individuals must have adequate DSM capacity to take the necessary 
actions in meeting the demands of their DSM workloads (CDC, 2018d; Powers et 
al., 2015). DSM capacity relates to the abilities and resources an individual has in 
meeting disease management workload demands (Boehmer, Shippee, et al., 
2016). Considering that DSM capacity encompasses physical, mental, social, 
financial, personal, and environmental resources, there are several factors 
potentially related to an individual’s capacity to perform DSM activities (Leppin et 
al., 2014). Multiple studies have reported on the influence of personal attributes, 
physical and cognitive abilities, support networks, socioeconomic status, and 
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culture on performance of DSM for individuals with chronic diseases (Akohoue et 
al., 2015; Byers et al., 2016; Gallacher et al., 2018; Osborn et al., 2013; Rovner 
et al., 2013). While other studies have found that even when facing substantial 
challenges relating to disease management (e.g., low socioeconomic status), 
some individuals maintained the capacity to remain engaged in DSM activities 
(Greene et al., 2015; Keene et al., 2018). These findings highlight the importance 
of exploring attributes of DSM capacity for individuals with T2D and hypertension 
to gain a better understanding of factors that possibly enhance patients’ 
performance of DSM activities.  
Patient activation and health literacy levels were used as measures of 
DSM capacity in this study. Patient activation and health literacy represent an 
individual’s capacity (i.e., knowledge, motivation, and skills) to manage health-
related activities, with both patient activation and health literacy being previously 
linked with the performance of DSM activities, including adhering to prescribed 
medication regimens (Greene et al., 2015; Skolasky et al., 2011; Ylitalo et al., 
2018). Both measures have been used frequently in studies exploring DSM 
performance for individuals with chronic diseases, and together, patient 
activation and health literacy encompass the various skills required of individuals 
with T2D and hypertension to perform prescribed DSM activities (Bolen et al., 
2014; Fowles et al., 2009; Greene et al., 2015; Hibbard at al., 2008; Lubetkin et 
al., 2010; Mayberry et al., 2010; Weld et al., 2008; Ylitalo et al., 2018).  
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Patient Activation 
Patient activation represents individuals’ perceptions of their knowledge, 
motivation, and skills in managing their health (Bolen et al., 2014). Patient 
activation has four levels, with higher levels indicating greater patient activation: 
Level 1 reflects individuals who have not realized the importance of their role in 
the management of their health, Level 2 indicates individuals who lack the 
knowledge and confidence to take action in managing their health, Level 3 
reflects individuals who are beginning to engage in recommended health DSM 
behaviors, and Level 4 reflects individuals who have a proactive approach to 
managing their health and are engaging in most, if not all, recommended DSM 
activities (Greene et al., 2015). High patient activation levels are associated with 
greater competency in carrying out appropriate prevention measures, adequately 
managing chronic conditions (e.g., adhering to prescribed medication regimens) 
and having the ability to make sound decisions regarding health and health 
services (Greene et al., 2015; Lubetkin et al., 2010; Skolasky et al., 2011). For 
example, Skolasky et al. (2011) found in their cross-sectional study of 855 
multimorbid participants (46% AA) that a 10-point increase in patient activation 
scores yielded a 13% increase in odds of having increased medication 
adherence (p = .025). The study used the number of missed doses to calculate 
medication adherence (self-reported). No data on the specific chronic diseases 
the participants had were reported.  
Several other important associations have been reported for patient 
activation. In a cross-sectional study, Mayberry et al. (2010) examined 48 adults 
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with T2D to determine the relationships among patient activation, self-reported 
DSM behavior (i.e., confidence in diabetes self-management and summary of 
diabetes self-care), and glycemic control. The races of participants were only 
stratified into two categories: White and non-White (14.6%). The 13-item Patient 
Activation Measure® (PAM®) was used, with higher scores indicating greater 
patient activation. The scores range from 0 to 100, signifying the degree of an 
individuals’ active role in managing their health. Self-management behavior was 
measured using a revised 13-item subscale based on the transtheoretical model 
of stages of readiness for behavioral change, with higher scores indicating 
greater self-management. Glycemic control was determined by the participants’ 
most recent HbA1c levels (i.e., HbA1c > 7% = uncontrolled diabetes; HbA1c ≤ 7% = 
controlled diabetes). The researchers found a significant positive association 
between DSM behavior and patient activation scores. However, this correlation 
was stronger for individuals whose glycemic levels were under control (r = 0.73, p 
= .01) than among patients with uncontrolled glycemia (r = 0.48, p < .001). 
Additionally, there was no significant association found between patient 
activation scores and glycemic control (OR 0.99; 95% CI: 0.94–1.03; p > .05). A 
potential explanation offered for the lack of association between glycemic control 
and patient activation was that some T2D patients potentially need to be at the 
highest stage of activation (stage 4) to achieve glycemic control. Stage four of 
patient activation indicates consistency in adequate DSM performance even 
when DSM becomes problematic. Additionally, the small sample size of the study 
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may have impacted the power to detect correlations between patient activation 
and glycemic levels. 
The effectiveness of patient activation in terventions for adults with T2D (N 
=33,124) was examined in a systematic review of 138 randomized control trials 
(Bolen et al., 2014). The systematic review focused on intermediate outcomes 
(i.e., HbA1c, low-density lipoprotein cholesterol, high-density lipoprotein 
cholesterol, triglycerides, systolic blood pressure, or bodyweight).              
Results indicated patients receiving the patient activation interventions 
experienced greater reductions in HbA1c (weighted mean differences [WMD] = 
−0.37; 95% CI: −0.45, −0.28; I 2 = 83 %), systolic blood pressure (WMD = −2.2; 
CI: −3.5, −1.0; I 2 = 72 %), body weight (WMD = −2.3; 95% CI: −3.2, −1.3; I 2 = 
64 %), and triglycerides (WMD = −8.5;95% CI: −15.0, −2.3; I 2 = 64 %) than 
patients randomized to the control groups. It is important to note that although 
the studies yielded moderate reductions in HbA1c, a reduction as small as 1% in 
HbA1c is associated with a 21% reduction in mortality for individuals with T2D 
(Bolen et al., 2014). Additionally, the studies that had higher baseline means in 
HbA1c, systolic blood pressure, and cholesterol levels had greater reductions in 
these outcomes as compared to lower baseline means. This finding emphasizes 
that individuals with the greatest need for improvements in glucose and blood 
pressure control may benefit substantially from the implementation of patient 
activation strategies.  
 Patient activation encompasses attributes considered essential to the 
performance of DSM (i.e., knowledge, motivation, skills). Therefore, widening the 
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breadth of knowledge on patient activation’s role in medication adherence for AA 
adults with T2D and hypertension is imperative. Patient activation has been 
previously described as a modifiable risk factor for poor health outcomes, 
particularly for individuals with chronic diseases (Mitchell et al., 2014). For 
patients with T2D and hypertension, an examination of patient activation can 
provide supplementary assessment data potentially used to facilitate 
improvements in patients’ DSM performance, and more specifically, in their 
medication adherence. Likewise, health literacy can be considered a modifiable 
risk factor for patients with chronic diseases and the DSM workload demand of 
managing prescribed medications. Many activities involved in DSM, including 
managing prescribed medications, require adequate health literacy to perform 
properly. Exploration of health literacy provides further insight into medication 
adherence for individuals with T2D and hypertension. Although much can be 
gained from assessing patient activation levels, measuring patient activation is 
currently highly subjective. The examination of health literacy provided the 
opportunity to use more objective measures in examining patients’ DSM 
capacities.  
Health Literacy 
Health literacy is the ability to obtain, process, and understand basic 
health and service information needed to make wise decisions about healthcare 
(Weld et al., 2008). Health literacy encompasses multiple skills including visual 
literacy (i.e., ability to understand visual information), information literacy (i.e., 
ability to obtain and apply relevant information), numeracy (i.e., ability to 
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calculate numbers), and oral language skills (i.e., ability to articulate health 
concerns, ask pertinent questions, and understand verbalized information and 
instructions; CDC, 2019c; Dastani & Sattari, 2016). Several DSM activities for 
individuals with T2D and hypertension necessitate adequate health literacy. For 
example, DSM for individuals with T2D and hypertension may involve reading 
and comprehending prescription instructions, interpreting blood pressure 
readings and glucose levels, and calculating medication doses.  
Previous studies have described associations between health literacy and 
DSM activities. In a cross-sectional study of 343 adults (83% AA), Al Sayah et al. 
(2015) sought to determine associations between health literacy, behavioral 
indicators (i.e., depressive symptoms, diabetes knowledge, diabetes self-
efficacy, diabetes self-care, and self-reported medication adherence), and 
cardiometabolic parameters (i.e., HbA1c, systolic blood pressure, and body mass 
index) in individuals with T2D. Health literacy was measured using three 
screening questions that assessed difficulty understanding written information, 
confidence in filling out medical forms, and frequency of needing assistance 
reading hospital materials. Medication adherence was assessed with Morisky 
Medication Adherence Scale (MMAS), a self-report medication adherence tool. 
Diabetes self-care was assessed with the Summary of Diabetes Self-Care 
Activities questionnaire, another self-report tool. The researchers found that 
summative health literacy scale only had significant associations with knowledge 
(r = -0.34, p ≤ .05) and self-efficacy (r = -0.16, p ≤ .05). One item within the 
health literacy scale, “difficulty understanding written information ”, was 
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significantly associated with lower diabetes knowledge (r = 0.26, p ≤ .05.), lower 
diabetes self-efficacy (r = 0.24, p ≤ .05), and worse medication adherence (r = -
0.14, p ≤ .05). However, there were no significant associations between any 
health literacy screening questions and any cardiometabolic parameters. The 
researchers discussed that this lack of association might have resulted from the 
health literacy measure used. The brief health literacy screening questions had 
high specificity but were not as effective as expected in identifying individuals 
with marginal health literacy due to the low sensitivity of the screening questions 
(area under the ROC curve 0.62; 95% CI: 0.53, 0.72; Chew et al., 2004).  
In another cross-sectional study, Bains et al. (2011) examined 
associations among health literacy, diabetes knowledge, frequency of diabetes 
self-care activities, medication adherence, and glycemic control. The sample 
consisted of 125 adult patients with diabetes (AA = 71.4%). No data on 
comorbidities was provided. The Revised Rapid Estimate of Adult Literacy in 
Medicine (REALM-R) was the health literacy measure used in the study. 
Diabetes knowledge was assessed with the Diabetes Knowledge Questionnaire 
(DKQ). The Summary of Diabetes Self-Care Activities scale was used to 
measure the frequency of diabetes self-care activities (i.e., diet, foot care, 
glucose testing, and exercise). Medication adherence was measured using the 
MMAS. HbA1c was the measure used to determine glycemic control. The 
researchers found that higher health literacy scores associated with better 
diabetes knowledge (r = 0.446, p < 0.001). Also, better diabetes knowledge was 
associated with glycemic control (β = 0.12; 95% CI [0.01, 0.23], p < 0.05).  
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However, no associations between health literacy and medication adherence, 
frequency of diabetes self-care activities, or glycemic control were found. There 
are several potential explanations for the lack of associations between health 
literacy and the disease management variables (i.e., diabetes self-care activities, 
medication adherence, and glycemic control). First, it is possible that other 
unexamined factors have a mediating role between health literacy and 
performance of DSM activities and glycemic control (e.g., patient burden). 
Secondly, the study used self-report measures for all variables except for 
glycemic control. Inclusion of objective measures for performance of DSM 
activities would possibly provide more data on associations with health literacy.  
Lastly, the study utilized the REALM-R, a health literacy measure that does not 
assess numeracy or reading comprehension. By using a health literacy tool 
measure that incorporates assessment of numeracy and document literacy (e.g., 
The Newest Vital Sign), more insight can be gained into the health literacy skills 
necessary in the performance of DSM activities for individuals with diabetes.   
Another study conducted found associations between health literacy and 
other DSM activities. Ylitalo et al. (2018) found that the number of missed 
medical office visits was significantly greater for patients with limited health 
literacy (M = 9.8, SD = 10.4) as compared with individuals with adequate health 
literacy (M = 5.0, SD = 5.7; p < .001). Additionally, the number of prescribed 
medications for patients with limited health literacy (M = 10.5, SD = 7.3) was 
significantly greater than for patients with adequate health literacy (M = 8.1, SD = 
5.6; p = .03). This finding potentially indicates that individuals with limited health 
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literacy had poorer DSM performance, requiring the need for additional 
medications to sufficiently manage their disease. This phenomenon of the 
accumulation of treatments for individuals who struggle with managing initial 
treatments is a principal feature of the CCM. Polypharmacy is particularly 
concerning for individuals with insufficient health literacy, as Davis et al. (2009) 
found that the risk for misinterpreting prescription instructions was greater for 
individuals with low literacy (adjusted risk ratio [RR] 2.70; 95% CI: 1.81,4.03; p < 
.001) than those with adequate literacy.  
While no studies were found that examined the role of health literacy in 
any DSM activities (e.g., managing prescribed medications) in an exclusive 
sample of African Americans with T2D and hypertension, previous studies have 
been conducted that explored the health literacy of AAs. Overall, AAs tend to 
have lower healthy literacy levels than other racial/ethnic groups (Gwynn et al., 
2016; Kutner et al., 2006; Osborn et al., 2011; Rothman et al., 2004; Shiyanbola 
et al., 2018).  Ylitalo et al. (2018) conducted a cross-sectional study of 406 
patients (39% had diabetes; 41% non-Hispanic Blacks) to assess health literacy 
in a low-income adult population. The researchers used the Newest Vital Sign 
(NVS) and a single-item screening question (i.e., “How confident are you filling 
out medical forms by yourself?”) to measure health literacy. The NVS is a 6-item 
assessment tool that incorporates a nutritional label and corresponding 
questions, with scores of four or higher indicating the likelihood of adequate 
health literacy. After adjusting for several covariates (i.e., age, sex, self-rated 
health, BMI, diabetes status, number of medications, healthcare utilization, and 
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confidence completing medical forms), findings indicated that non-Hispanic Black 
patients were more likely to have inadequate health literacy (NVS < 4) compared 
to non-Hispanic White patients (OR   7.32, 95% CI [2.41, 22.16], p  < .001). 
Additional studies have also reported similar findings supporting the disparity in 
health literacy for AAs with diabetes (Gwynn et al., 2016; Osborn et al., 2011; 
Rothman et al., 2004; Shiyanbola et al., 2018). Therefore, it is imperative to 
conduct further exploration of health literacy for AAs with T2D and hypertension 
and the potential impact on medication adherence.  
Concurrent Examination of Patient Activation and Health Literacy 
Individually, patient activation and health literacy are distinct, measurable 
components of DSM capacity that provide insight into medication adherence for 
individuals with T2D and hypertension. However, previous research suggests the 
enhanced knowledge to be gained from examining patient activation and health 
literacy simultaneously. For example, Gwynn et al. (2016) examined 225 adults 
(67% Black) using data from a randomized controlled trial to determine the 
relationships between race, health literacy, and patient activation. The 
researchers also tracked participants’ number of comorbidities, which ranged 
from none to more than two. No data were provided on the participants’ specific 
types of comorbidities. Health literacy was measured with the short version of the 
Test of Functional Health Literacy in Adults (S-TOFHLA). The S-TOFHLA is a 
validated health literacy test designed to evaluate an individual’s ability to read 
and understand health-related information, with higher scores indicating higher 
literacy levels (Housten et al., 2018). The 21-item PAM® was used to measure 
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patient activation. Health literacy was found to have a greater influence on 
patient activation levels for individuals with greater comorbidities (path coefficient 
= 0.420; p < .001) as compared with those with fewer comorbidities (path 
coefficient = 0.119; p = .18). The researchers also found that low health literacy 
was significantly higher among AA participants (54%) compared to non-Hispanic 
White participants (12%); p < .0001. Furthermore, health literacy was found to 
mediate the negative impact of race/ethnicity on patient activation (indirect effect 
−0.139, SE = 0.036; p < .001).  
Additional studies have yielded results that further support an association 
between patient activation and health literacy. Lubetkin et al. (2010) conducted a 
cross-sectional study to explore the relationship between patient activation and 
health literacy. The researchers used a convenience sample of 454 patients 
(34% Black) receiving care from one of three health centers. No data were 
gathered on chronic disease status for the patients. However, patients provided 
self-rated health status data (excellent: 7%; very good: 23%; good: 38%; fair: 
22%; poor: 9%). The 13-item PAM® was used to measure patient activation, and 
health literacy was measured with the S-TOFHLA. Lubetkin et al. (2010) found 
that patients with adequate health literacy were more likely to achieve the highest 
level of patient activation (i.e., Level 4; 44%) and had significantly higher patient 
activation scores (M = 64.8) compared to patients with borderline or inadequate 
health literacy (21%; M = 55.7 p < .01).  
Mitchell et al. (2014) obtained similar results in their secondary data 
analysis. Health literacy was measured by the Rapid Estimate of Adult Literacy 
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Measure (REALM). Significant associations were found between patient 
activation and health literacy. Specifically, patients in the lowest health literacy 
category (Grade 6 and below) were more likely to be at the lowest level of patient 
activation (level 1; 16%) as compared with patients at the highest patient 
activation level (level 4; 9%), p < .01.  Previous research has indicated that as 
little as a four-point difference in patient activation scores can create a 
meaningful impact on DSM behavior sustainability (Fowles et al., 2009; Hibbard 
at al., 2008).  
In a different study, Sheikh et al. (2016) reported on the association 
between patient activation and health literacy. The researchers conducted a 
cross-sectional pilot study with a sample of 108 adult patients (63% AA) to 
examine patient activation and health literacy during emergency room visits. The 
13-item PAM® and the REALM were used to measure patient activation and 
health literacy, respectively. Higher health literacy was significantly associated 
with higher levels of patient activation (rs = 0.30; p = .001).  
In summary, there is insufficient evidence of the associations among 
patient activation, health literacy, patient burden, and medication adherence. 
While three studies found higher patient activation was associated with higher 
health literacy (Gwynn et al., 2016; Lubetkin et al., 2010; Sheikh et al., 2016), 
none of the studies were conducted among patients with comorbid T2D and 
hypertension or focused on AAs, a group at great risk for low health literacy and 
poorer health outcomes from diabetes and hypertension . A single study found a 
positive relationship between patient activation and better DSM behaviors (i.e., 
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self-reported confidence in diabetes self-management and summary of diabetes 
self-care) but did not include measures of the actual performance of any DSM 
activities (Mayberry et al., 2010). A different cross-sectional study discovered 
positive associations between patient activation and medication adherence but 
did not specifically analyze the association in a sample of AA adults with 
comorbid T2D and hypertension (Skolasky et al., 2011). A systematic review of 
randomized controlled trials involving individuals with T2D resulted in the 
discovery of the association between patient activation interventions and 
improved health outcomes (i.e., < HbA1c, <systolic blood pressure). However, the 
researchers did not study medication adherence (Bolen, 2014).  
Four studies discussed associations between health literacy and DSM 
activities. One study including AA adults with diabetes examined associations 
between health literacy and attending healthcare appointments as scheduled. 
The researchers found that lower health literacy associated with greater 
frequency of missing medical appointments (Ylitalo et al., 2018). Another study 
found the risk for misinterpreting prescription instructions was greater among 
individuals with low literacy. The remaining two studies examined health literacy 
along with medication adherence, with both studies including samples of AAs 
with diabetes. One study examined health literacy, DSM indicators (i.e., diabetes 
knowledge, diabetes self-efficacy, and depressive symptoms), self-reported 
medication adherence, and health outcomes (i.e., HbA1c, systolic blood pressure, 
and body mass index). No relationship between health literacy and health 
outcomes were found, potentially due to the low sensitivity of the health literacy 
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measured used.  However, one item within the health literacy scale used, 
“difficulty understanding written information”, was significantly associated with 
lower diabetes knowledge and worse medication adherence (Al Sayah et al., 
2015). The other study examined associations among health literacy, diabetes 
knowledge, frequency of diabetes self-care activities, medication adherence, and 
glycemic control. No associations between health literacy and medication 
adherence, frequency of diabetes self-care activities, or glycemic control were 
found, potentially due to unexamined factors (e.g., patient burden) and exclusion 
of measures of numeracy and reading comprehension from the health literacy 
tool used in the study (Bains et al., 2011). Moreover, of the studies that examined 
health literacy, only one study used literacy measures that assessed the 
numeracy skills of the participants (Ylitalo et al., 2018) and no studies examined 
the patient burden of participants. Numeracy relates to an individual’s ability to 
process numeric information (Housten et al., 2018). For patients with T2D and 
hypertension, numeracy skills are essential. Additionally, patient burden provides 
insight into how some individuals with adequate health literacy or high patient 
activation do not demonstrate expected DSM performance (e.g., good 
medication adherence).  
Overall, there is limited literature that suggests a relationship between 
patient activation and health literacy, particularly for AAs with chronic conditions. 
Moreover, the literature that describes associations among patient activation, 
health literacy, and the management of prescribed medications, specifically for 
AA adults with T2D and hypertension, is non-existent.  Several reports indicate 
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lower health literacy levels for AA adults as compared to non -Hispanic White 
adults (Gwynn et al., 2016; Osborn et al., 2011; Rothman et al., 2004; 
Shiyanbola et al., 2018; Ylitalo et al., 2018). However, no studies reported the 
inclusion of patients with comorbid T2D and hypertension . Higher levels of 
patient activation and health literacy were found to associate with improved DSM 
abilities: self-efficacy in diabetes care, interpreting prescription instructions, 
attending scheduled medical appointments (Al Sayah et al., 2015; Davis et al., 
2009; Mayberry et al., 2010; Ylitalo et al., 2018)  ), but the limited research 
conducted to examine the role of patient activation and health literacy in the 
actual performance of DSM activities (e.g., managing prescribed medications) is 
conflicting (Al Sayah et al., 2015; Bains et al., 2011; Skolasky et al., 2011) . 
Therefore, more research is needed. This study addressed the gaps in literature 
by investigating patient activation, health literacy, and medication adherence for 
AA adults with T2D and hypertension. The patient burden (i.e., treatment burden 
and illness burden) reported by AA adults with comorbid T2D and hypertension 
was also examined. The following section describes the potential role of patient 
burden (i.e., treatment burden and illness burden) in DSM.   
Patient Burden 
Individually, T2D diabetes and hypertension are burdensome chronic 
diseases (AHA, 2016; Powers et al., 2015; Rowley et al., 2017). When these 
diseases co-exist, the patient burden is further compounded (CDC, 2018b; 
NIDDK, 2017). Individuals with chronic diseases often experience illness and 
treatment burden. These burdens stem from the physiological impact of the 
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diseases and the complexity of treatment regimens prescribed for disease 
management (Brod et al., 2009; Eton et al., 2012; Gupta et al., 2016). Individuals 
with comorbidities, namely T2D and hypertension, may have DSM workloads that 
include completion of daily activities (i.e., taking medications), creating daily 
treatment burdens for patients to overcome (Eton et al., 2012). Considering the 
typical DSM workload that patients with comorbid T2D and hypertension 
encounter, it is very probable that many of these patients experience treatment 
burden. As treatment burden potentially impacts DSM productivity, such as what 
is needed for medication adherence, it is essential to examine this burden for 
patients with T2D and hypertension (Rogers et al., 2017). The following sections 
describe the specific aspects of patient burden of interest in this study, treatment 
burden and illness burden.  
Treatment Burden 
The burden of treatment has been defined as an individual’s DSM 
workload and the impact that the workload has on well-being (Eton et al., 2012). 
A DSM workload consists of prescribed therapies and individualized DSM 
demands, which are essential activities in the effective management of T2D and 
hypertension (Byers et al., 2016; CDC, 2018b; Shippee et al., 2012). Although 
the benefits of proper management of T2D and hypertension are well known 
(e.g., decreased risks of heart disease and stroke), the prescribed DSM activities 
to manage these comorbidities can be burdensome for patients (AHA, 2016; 
Brod et al., 2009; CDC, 2017c). The ADA recommends that healthcare 
professionals consider patients’ overall treatment burden when engaging in 
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shared decision-making with patients to establish glycemic and blood pressure 
control targets (de Boer et al., 2017). The integration of minimally disruptive 
medicine into patient care is an attempt to address the concerns regarding 
treatment burden for patients (Eton et al., 2012). Minimally disruptive medicine 
refers to the development of treatment plans and the provision of services that 
are designed to facilitate patients’ healthcare goal attainments while limiting the 
healthcare burden patients experience. A key aspect of effectively implementing 
minimally disruptive medicine is to establish patients current and potential 
treatment burdens. 
Few studies have specifically explored the treatment burdens experienced 
by individuals with chronic disease. Findings from two qualitative studies 
described how managing prescribed medications along with other factors may 
lead to increased treatment burden (Eton et al., 2012; Gallacher et al., 2018). 
Gallacher et al. (2018) conducted a qualitative study to explore patient burden 
and patient capacity for stroke survivors (N = 29). Findings from the study 
indicated that treatment burden arose from the participants’ healthcare workloads 
or the occurrences of care deficiencies. Within participants’ healthcare 
workloads, several factors that added to chronic disease management treatment 
burdens were reported as: (1) understanding symptoms and treatments, (2) 
problem-solving, (3) goal setting and prioritizing, (4) routine appointments, and 
(5) managing medications. Additionally, specific care deficiencies that added to 
treatment burdens were: (1) difficulty with understanding provided information, 
(2) poorly timed information, (3) information not tailored to the individual, (4) 
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complicated medication regimes, and (5) poor long-term follow-up from health 
care providers. In a similar study, Eton et al. (2012) conducted semi-structured 
interviews of thirty-two adults who had at least one chronic condition and were 
tasked with DSM activities (i.e., taking multiple medications and monitoring their 
health, diet, and exercise), to understand the perspectives of patients regarding 
their treatment burden. Twelve of the participants were previously diagnosed with 
diabetes and fourteen were diagnosed with hypertension. Findings revealed 
several themes for treatment burden, similar to the Gallacher et al. study, 
including medication adherence challenges, financial challenges, and confusion 
about medical information.  
In a secondary analysis of a quantitative cross-sectional study, Rogers et 
al. (2017) examined 120 adults (AA = 22) with diabetes and at least one other 
comorbid condition (hypertension =85% of the sample) to examine the 
associations between treatment burden and disease-related outcomes. Of the 
associations examined in the study, the associations between treatment burden 
and two outcome measures: chronic condition distress and perceived 
competence in managing health conditions are of primary interest. Treatment 
burden was measured with the 48-item Patient Experience with Treatment and 
Self-Management (PETS) questionnaire, with higher scores on each subscale 
indicating greater perceived treatment burden in the corresponding domain. 
Chronic condition distress was positively associated with multiple treatment 
burden subscales: medical information burden (rs = 0.56), medication burden (rs = 
0.53), monitoring health burden (rs = 0.50), health care expenses burden (rs = 
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0.48), medical appointments burden (rs = 0.44), and bothersome medication side 
effects (rs = 0.39); p < .001 for all associations. These findings imply that 
individuals who felt more overwhelmed with their health conditions (i.e., 
experienced greater illness burden) also experienced greater treatment burdens 
related to managing their chronic conditions. Additionally, perceived competence 
in disease self-management was negatively associated with several treatment 
burden subscales: monitoring health burden (rs = -0.50; p < .001), physical and 
mental health exhaustion (rs = -0.47), medical information burden (rs = -0.46), 
healthcare expenses burden (rs = -0.39), medication burden (rs = -0.33); all with  
p < .001. Based on these findings, it appears that individuals who had lower 
perceived competence (e.g., lower DSM capacity) in completion of DSM activities 
also experienced greater treatment burdens. Therefore, by exploring factors 
associated with patients’ DSM capacity (e.g., patient activation and health 
literacy) in addition to treatment burden, strategies can be developed that could 
enhance patients’ DSM capacities and reduce their treatment burdens, 
subsequently improving their chances of meeting the demands of their DSM 
workloads. 
In addition to the factors previously described in regard to treatment 
burden, some of the burden patients experience stems from changes to patients’ 
treatment regimens. For example, according to clinical practice guidelines, 
diabetic patients who have elevated HbA1c during a hospital admission are 
prescribed a more intense outpatient treatment regimen, as compared to the 
regimen received during hospitalization (Umpierrez et al., 2012). Thus, 
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individuals who have poorly controlled diabetes are likely to have even greater 
treatment burdens following a hospitalization. Griffith et al. (2012) conducted a 
retrospective cohort study to examine how pre-hospital admission medication 
prescriptions for 1,359 Veteran Affairs patients (AA = 19%) differed from the 
prescribed outpatient regimen following hospital discharge. Of the 2,2025 
admissions that occurred during the study period (indicating that there were 
repeat admissions for some patients), 22% (n = 454) of the encounters involved 
a change to the post-discharge treatment regimen. The most frequent changes in 
treatments included initiating a new insulin medication (44%), initiating a non -
insulin medication (17%), change from one insulin medication to another (12%), 
and increasing medication dosages (34%).  
Individuals who are overly burdened with their treatment regimen may 
struggle with completing DSM activities (i.e., managing prescribed medications), 
leading to partial or complete nonadherence to prescribed DSM activities (Eton  
et al., 2012; Lin et al., 2015; Shippee et al., 2012). For example, greater 
treatment burden has been found to associate with poorer medication adherence 
(Rogers et al., 2017). As nonadherence to prescribed DSM activities places 
patients at a greater risk for negative health outcomes, healthcare providers may 
respond with the implementation of additional treatments, further increasing the 
complexity of patients’ disease management and intensifying treatment burdens 
(Eton et al., 2012; Rogers et al., 2017). 
Along with treatment burdens, patients with T2D and hypertension may 
also experience illness burdens. Even with adequate disease management, 
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individuals with T2D and hypertension may still experience daily illness burdens 
as a result of associated disease symptomatology. As such, an examination of 
potential illness burdens alongside treatment burdens is necessary to achieve a 
greater understanding of patient burden.  
Illness Burden  
Comparable to treatment burden, illness burden reportedly has negative 
associations with the performance of DSM activities. Illness burden refers to the 
perceived disruption in a person’s life attributed to symptoms (e.g., pain) and 
functional limitations (e.g., amputation) that occur as a result of disease 
(Adriaanse et al., 2016; Boehmer, Shippee, et al., 2016). The presence of more 
than one chronic condition is associated with poorer health, decline in functional 
status, lower quality of life, and higher mortality (Adriaanse et al., 2016; 
Boehmer, Shippee, et al., 2016; Payne et al., 2013; Rogers et al., 2017). People 
with chronic diseases, such as T2D and hypertension, may suffer from numerous 
disease-related symptoms and/or functional challenges, ultimately leading to 
considerable illness burdens. Rogers et al. (2017) also found that chronic illness 
distress was significantly associated with greater medication burden (0.53, p < 
.001).  
In a cross-sectional study, researchers evaluated the illness burden for 
255 patients (AA = 19%) with diabetes who also had diabetic peripheral 
neuropathy (Gore et al., 2006). Neuropathy is one of the most common diabetes 
complications that causes pain, numbness, and potentially leads to permanent 
disabilities (CDC, 2017c). Most of the sample had T2D (86%) and 52% reported 
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taking at least two prescription medications specifically for managemen t of 
neuropathic symptoms (Gore et al., 2006). Many participants reported declines in 
home productivity (59%) and diminished ability to perform activities of daily living 
(86%) due to the pain experienced from diabetic neuropathy. For participants 
who worked at least part-time (n = 73), 64% reported missing work (M = 13 
days), leaving work early, and decreased work productivity as a result of diabetic 
neuropathy pain.  
Examples of illness burden were also found among people with kidney 
disease, a major complication that can result from poorly managed diabetes 
and/or hypertension. Boehmer, Shippee, et al. (2016) conducted a cross-
sectional study of 137 adult dialysis patients to discover associations between 
domains of patient capacity and disruptive of illness (i.e., illness burden). The 
Illness Intrusiveness Scale was used to measure illness burden. The results 
indicated that illness intrusiveness (i.e., perceived impact of illness burden on 
daily life) had significant negative associations with capacity measures: self-
efficacy (-0.4, p < .001), mental capacity (-0.6, p < .001), and financial capacity  
(-0.5, p < .001). They also found that specific illness burden factors had 
significant positive associations with overall illness intrusiveness scores: pain 
(0.5, p < .001) and fatigue (0.6, p < .001).  
In a retrospective population-based cohort study of 530,771 adults with 
chronic kidney disease (CKD), it was found that participants with one concordant 
comorbid condition (e.g., diabetes and hypertension) had a greater occurrence of 
acute myocardial infarctions (HR 1.2; 95% CI: 1.13, 1.19; p < .05) and mortality 
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(HR 1.8; 95% CI: 1.73, 1.93; p < .05 ) than participants without a concordant 
comorbidity (Tonelli et al., 2015). Diabetes and hypertension were listed as 
concordant comorbidities in the study, as they have been indicated as having a 
similar pathophysiological profile as CKD, similar care management strategies, 
and in many cases, are major contributing factors in the development of CKD 
(Aga et al., 2019; Tonelli et al., 2015).  
The burden of illness for individuals with diabetes and hypertension also 
includes indirect costs stemming from the inability to acquire or maintain 
employment due to disease-related disabilities and increased absenteeism from 
work due to disease-related symptoms and/or hospitalizations (ADA, 2018a). 
AAs with T2D and hypertension reportedly have greater costs associated with 
hospital inpatient visits and higher rates of disease-related mortality as compared 
with non-Hispanic White patients, indicating a greater burden of illness in this 
population (ADA, 2018a; CDC, 2019a; CDC, 2019b). The disparity in illness 
burden for AAs may be explained by the higher rates of chronic disease noted in 
this population. Gebregziabher et al. (2018) analyzed differences in 
multimorbidity magnitude and patterns among a national sample of more than 
three million Veterans (n = 1,263,906 for participants with diabetes, 13% AA). 
They found that urban non-Hispanic Blacks had an elevated risk of multimorbidity 
when compared to urban non-Hispanic Whites (RR 1.05; 95% CI: 1.05, 1.05;  
p < .001). Other reports have also supported the higher prevalence of diabetes-
related comorbidities and disease-related complications for AAs as compared to 
other racial and ethnic groups (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Lynch 
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et al., 2015; Mathur et al., 2011; OMH, 2016), further highlighting the illness 
burden for the AA population.  
In summary, multiple studies have reported on the illness and treatment 
burden experienced by individuals with chronic disease (Brod et al., 2009; Eton 
et al., 2012; Gallacher et al., 2018; Griffith et al., 2012; Gupta et al., 2016; 
Rogers et al., 2017; Rowley et al., 2017; Shippee et al., 2012; Umpierrez et al., 
2012) and others have highlighted the added burden that occurs in the AA 
population (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Lynch et al., 2015; 
Mathur et al., 2011; OMH, 2016) and with the presence of more than one chronic 
disease  (Adriaanse et al., 2016; Aga et al., 2019; Boehmer, Shippee, et al., 
2016; Gebregziabher et al., 2018; Lin et al., 2015; Payne et al., 2013; Tonelli  
et al., 2015). Few associations among treatment burden, illness burden, and 
performance of DSM activities have been reported (Gore et al., 2006; Rogers  
et al., 2017). Only one study was found that discovered associations between 
illness burden and DSM capacity measures, with greater illness burden 
associating with lower self-efficacy and mental capacity (Boehmer, Shippee,  
et al., 2016). However, no studies were found that examined associations among 
patient burden, patient activation, health literacy, and medication adherence, 
specifically for AA adults with T2D and hypertension.   
Considering that multimorbidity has been associated with poor health 
outcomes and greater risks of mortality, it can be reasonably inferred that the AA 
population with multimorbid conditions (i.e., T2D and hypertension) potentially 
experience elevated burdens as compared to other ethnic groups 
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(Gebregziabher et al., 2018; Tonelli et al., 2015). Therefore, the examination of 
illness burdens and treatment burdens for AA adults with T2D and hypertension 
reveals important factors involved in DSM for this population, ultimately providing 
a foundation for the development of methods to address the notable disparities in 
patient burden.  
Another potential factor that has a role in individuals’ inabilities to meet 
their DSM workload demands relates to managing DSM activities in the presence 
of catastrophic global public health challenges, such as the current COVID-19 
pandemic. This study explored the perceived impact of the COVID-19 pandemic 
on DSM performance, including the management of medications for AA adults 
with T2D and hypertension. The following section describes DSM performance in 
the context of the COVID-19 pandemic.  
Potential Impact of the Coronavirus Disease 2019 Pandemic 
The Coronavirus Disease 2019 (COVID-19) is a life-threatening infectious 
disease with no specific vaccines or treatments (World Health Organization 
[WHO], 2020). Although many individuals who become infected with COVID-19 
may experience only mild symptoms, certain individuals (e.g., individuals with 
underlying cardiovascular disorders or diabetes) are more likely to develop more 
serious illnesses from COVID-19 and have greater challenges in recovery (AHA, 
2020a; CDC, 2020c; WHO, 2020). Additionally, AAs are disproportionately 
impacted by COVID-19, as the hospitalizations and death rates related to 
COVID-19 are higher for AAs as compared to other ethnic groups (CDC, 2020d).  
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The COVID-19 pandemic has presented many potential challenges in 
performance of DSM activities. During a pandemic such as with COVID-19, 
individuals may have increased levels of stress. This increased stress may 
reduce their ability to concentrate on routine activities, including performance of 
DSM. Additionally, since the declaration of pandemic status for COVID-19, the 
U.S. has experienced a drastic rise in unemployment rates, with rates increasing 
from 3.6% in January 2020 to 14.7% in April 2020 (U.S. Bureau of Labor 
Statistics, 2020). This surge in unemployment is likely a consequence of COVID-
19 related business closures, massive layoffs, and furloughs. Potential 
challenges are also presented from changes in patient access to routine 
healthcare visits, as many organizations were driven to either postpone non-
urgent care visits or transition to telemedicine services, per public health 
recommendations (AHA, 2020b). Moreover, the developing nature of COVID-19 
has led to uncertainty relating to performance of DSM activities (e.g., managing 
medications). For example, Schroeder (2020) discussed erroneous speculations 
that the use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II 
receptor blockers (ARBs), both of which are medications used to treat high blood 
pressure, increase the risk of illness from COVID-19. Although there have been 
no studies that confirm associations between COVID-19 illness and these 
medications, the uncertainty of risks and fear of illness may lead individuals 
prescribed these medications to stop taking them.  
The potential financial strain, changes in access to non-urgent healthcare 
services (e.g. telemedicine), and the need to navigate a sea of new and 
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potentially conflicting information relating to COVID-19, may present additional 
challenges in managing medications for individuals with T2D and hypertension. 
There is limited information on how COVID-19 impacts DSM activities for 
individuals with chronic disease. Additionally, no studies were found that 
examined performance of DSM in the context of COVID-19. Therefore, 
exploration of the perceived impact that the COVID-19 pandemic has had on 
performance of DSM, namely managing prescribed medications, is of great 
importance.   
This study examined the associations among DSM capacity (i.e., patient 
activation and health literacy), patient burden (i.e., treatment and illness burden), 
and medication adherence for AA adults with T2D and hypertension. Additionally, 
the perceived impact of the COVID-19 pandemic on the management of 
prescribed medications was explored. The importance of DSM, the specific DSM 
activity of managing prescribed medications, and factors that influence DSM 
performance (i.e. capacity and burden) for individuals with comorbid T2D and 
hypertension have been described. The remaining review of literature describes 
the dependent variable of this study, medication adherence.  
Medication Adherence 
Medication adherence is defined as the extent to which an individual’s 
medication usage parallels with the prescribed medication regimen (World Health 
Organization [WHO], 2003). Medication adherence is a DSM activity that is of 
great importance for individuals with T2D and hypertension, as it has been 
reported as a vital factor in the prevention of health complications for individuals 
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with chronic conditions (Brown & Bussell, 2011). Adhering to medication 
prescribed specifically for management of T2D and hypertension has been 
associated with reduction in the risk of diabetes complications (e.g., kidney 
disease) and reductions in the risk of stroke and heart disease (CDC, 2018b). 
Inconsistent medication adherence in  the management of T2D and HTN is 
associated with failing to achieve glycemic and blood pressure control and 
increased risks of cardiovascular disease (CDC, 2018b; Dragomir et al., 2010). 
Poor medication adherence has also been found to associate with high  perceived 
treatment burden (Rogers et al., 2017). More specifically, medication adherence 
was poorer for individuals who reported feeling more overwhelmed by medical 
information (OR 0.94; 95% CI: 0.90 -0.99) and for individuals with greater 
perceived medication burden (OR 0.96: 95% CI: 0.92 -0.99), p < 0.001 (Rogers 
et al., 2017). Reportedly, from 2017-2018 approximately 13% of adults 
diagnosed with diabetes in the U.S. did not take diabetic medications as 
prescribed (Cohen & Cha, 2019). Other reports have indicated that nationwide 
measures of medication adherence have varied for individuals with hypertension 
and diabetes, from 50% in some states among Medicaid recipients to 85% for 
those covered by Medicare Part D (Aitken et al., 2019).   
Taking medication as prescribed for T2D and hypertension requires health 
literacy skills (e.g., numeracy and reading comprehension), which creates a level 
of complexity that may be difficult for some individuals to manage. This 
complexity may lead higher occurrences of poor medication adherence (Brown & 
Bussell, 2011; Greene et al., 2015; Ylitalo et al., 2018). For example, in a cross-
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sectional study of 395 adult primary care patients (AA = 47%), the abilities of the 
patients to understand and demonstrate instructions found on container labels of 
common prescription medications were explored (Davis et al., 2006). While 70% 
of patients with low literacy were able to verbalize the instructions, only 30% 
were able to accurately demonstrate the instructions, implying a lack of 
comprehension for some of the patients. Davis et al. (2006) also found that 
misunderstanding prescription instructions was more likely to occur for 
individuals taking three or four prescription medications (adjusted RR 3.22; 95% 
CI: 1.53–6.77; p < 0.001) and for individuals with low literacy (adjusted RR 2.32; 
95% CI: 1.26, 4.28; p < 0.001).  
Previous studies have explored factors that contributed to medication 
adherence, or lack thereof. Weller et al. (2017) found in a qualitative comparative 
analysis of 56 adults (AA = 29%) with T2D that there were specific medication-
taking behaviors participants identified that might have influenced glycemic 
control outcomes. Individuals with good glycemic control reported greater use of 
memory aids to assist with complexity of adherence (e.g., a pillbox organizer), 
indicating the use of problem-solving skills in managing the complexity of 
medication management. Forgetting to take medications, stopping prescribed 
medications to try alternative therapies, and not comprehending medication 
administration instructions contributed to poor medication adherence (Weller  
et al., 2017). Eton et al. (2012) also described several challenges individuals had 
with taking medications including experiencing side effects of medications, being 
confused about medication administration (e.g., not knowing the purpose and 
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timing of medication administration), managing multiple medications, and dealing 
with the interference in daily routines caused by managing medications. Similar 
to the Weller et al. study, participants also reported improving medication 
adherence by organizing and preparing medications with a pill box.  
In another qualitative study, Bockwoldt et al. (2017) explored the 
medication-related experiences of fifteen AA adults with T2D to identify factors 
that influenced their adaptation to medication adherence. Participants reported 
that acute physical changes (e.g., residual effects from a stroke), acquisition of 
new knowledge relating to DSM, and changes in life status (e.g., death of a 
family member) led to a greater sense of accountability and improved adherence 
to their medication regimen. Additionally, the study revealed health promoting 
and health impairing factors involved in medication adherence. Health promoting 
factors (i.e., factors that facilitated medication adherence) included self-
confidence in performance of DSM, belief in the value of medication adherence, 
assuming responsibility for their health, development of a routine for medication 
adherence, and maintaining positive relationships with the healthcare team. 
Some participants reported coordinating their medication administration with 
mealtimes and/or making lifestyle adjustments to improve adherence. Health 
impairing factors (i.e., factors that impeded medication adherence) included 
feelings of powerlessness, self-blame, and fear relating to taking medication. 
Some participants with inconsistent medication adherence reported not taking 
prescribed medications due to being fearful of the medication side-effects, while 
others reported taking medications only when physical symptoms were 
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experienced (Bockwoldt et al., 2017). Kennedy et al. (2008) reported similar 
findings from a quantitative study of 1.6 million Medicare beneficiaries. Results of 
the study indicated that greater than 4% of the total sample failed to fill or refill at 
least one prescription, with the most common reasons being not finding the 
medication necessary (18%) and fearing the medication side effects (12%).  
In summary, previous studies have reported findings that support the role 
of medication adherence in achieving improved disease management outcomes 
(Brown & Bussell, 2011; Dragomir et al., 2010; Weller et al., 2017). Individuals 
who adhere to prescribed medication regimens have lower risks in the 
development of disease-related complications such as neuropathy, kidney 
disease, stroke and heart disease (CDC, 2018b). Problem-solving skills and 
literacy have been identified as important aspects in adhering to prescribed 
medications (Bockwoldt et al., 2017; Brown & Bussell, 2011; Eton et al., 2012; 
Greene et al., 2015; Rogers et al., 2017; Weller et al., 2017; Ylitalo et al., 2018).   
A few studies were found that examined factors that facilitated and 
hindered medication adherence. Individuals who demonstrated poor medication 
adherence were found to experience greater perceived treatment burden, have 
poorer health literacy, have more difficulty in carrying out written instructions, fear 
the medication side effects , and feel more overwhelmed by medical information 
and managing their prescribed medications (Bockwoldt et al., 2017; Davis et al., 
2006; Kennedy et al., 2008; Rogers et al., 2017; Weller et al., 2017). Additionally, 
individuals with poor medication adherence reported difficulty in managing 
multiple medications, remembering to take their medications, understanding 
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medication administration instructions, and managing the disruption in daily 
routines caused by taking prescribed medications (Eton et al., 2012; Weller et al., 
2017). The use of memory aids, acquiring DSM knowledge, having greater 
confidence in performance of DSM, and developing a routine for medication 
management were found to increase individuals’ potentials for good medication 
adherence (Bockwoldt et al., 2017; Weller et al., 2017). However, no studies 
were found that examined medication adherence among in a sample of AA 
adults with T2D and hypertension. Additionally, none of the studies examined 
medication adherence during a global public health crisis.  
Taking medications as prescribed can be complex process, thus it is 
imperative to examine factors that potentially impact individuals’ abilities to 
manage this DSM activity. In this study, medication adherence was examined 
along with DSM capacity (i.e., patient activation and health literacy), patient 
burden (i.e., illness burden and treatment burden), and the potential impact of 
COVID-19 on medication management. Considering the complexity of adhering 
to a prescribed medication regimen and the high prevalence of prescribed 
medications for individuals with T2D and hypertension, this study provides 
valuable medication adherence associations. These associations may be key in 
the development of strategies to improve health outcomes for AAs with comorbid 
T2D and hypertension. 
Summary 
In this chapter, multiple studies were presented that reinforced the need 
for further exploration of DSM capacity and patient burden for AA adult patients 
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with T2D and hypertension. The existing literature supports the role of DSM 
performance in disease management and prevention of disease-related 
complications (Beck, 2018; Powers, 2015; Weller et al., 2017). However, the 
literature examining medication workloads, DSM capacity, patient burden, and 
medication adherence for AAs with T2D and hypertension is fragmented and, in 
some cases, non-existent.  
This study addressed several gaps in the literature. First, existing literature 
describing the role of DSM capacity in DSM performance (Al Sayah et al., 2015; 
Bolen et al., 2014; Davis et al., 2009; Greene et al., 2015; Gwynn et al., 2016; 
Lubetkin et al., 2010; Mayberry et al., 2010; Ylitalo et al., 2018), provide limited 
evidence on associations among patient activation, health literacy, and 
medication adherence, particularly for adult AAs with both T2D and hypertension. 
Secondly, research on patient burden (Adriaanse et al., 2016; Boehmer, 
Shippee, et al., 2016; Eton et al., 2012; Gallacher et al., 2018; Gebregziabher  
et al., 2018; Gore et al., 2006; Griffith et al., 2012; Payne et al., 2013; Rogers  
et al., 2017; Ylitalo et al., 2018), has provided limited information on associations 
with patient activation and health literacy. Furthermore, the studies that were 
found on patient burden did not compare associations of illness and treatment 
burden with medication workloads, DSM capacity, and medication adherence, for 
patients with comorbidities. Treatment and illness burdens have both been 
described by participants in previous studies as being barriers to performance of 
DSM activities (Eton et al., 2012; Gore et al., 2006).  
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Third, the literature on medication adherence for patients with chronic 
disease provides some insight on associations among health outcomes, health 
literacy, and treatment burden (Aitken et al., 2019; Davis et al., 2006; Dragomir  
et al., 2010; Rogers et al., 2017; Weller et al., 2017). However, only one study 
was found that examined the associations between an aspect of treatment 
burden (i.e. medication burden) and illness distress (Rogers et al., 2017). A few 
studies reported on factors that promote and hinder medication adherence has 
been described (Bockwoldt et al., 2017; Davis et al., 2006; Eton et al., 2012; 
Kennedy et al., 2008; Rogers et al., 2017; Weller et al., 2017). However, little is 
still known on how medication adherence associates with patient activation, 
medication workload, or illness burden within the target population.   
Lastly, no studies were found that explored medication adherence in the 
context of the COVID-19 pandemic. This study extends the current knowledge of 
DSM by examining patient activation, health literacy, treatment burden, illness 
burden, and medication adherence. The perceived impact of the COVID-19 
pandemic on the performance of DSM was also explored.  
Managing prescribed medications is an important DSM workload demand 
for individuals with T2D and hypertension. Guided by the Cumulative Complexity 
Model, the study adds to the body of knowledge for underexamined and 
potentially significant factors associated with medication adherence in T2D and 
hypertension, specifically for AA adults. By developing a more thorough 
understanding of specific DSM capacity factors and the patient burdens from 
prescribed treatments and disease symptomatology, additional insight was 
60 
 
 
 
gleaned on the identification of risks for poor medication adherence and 
strategies to improve medication adherence for vulnerable populations.  
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CHAPTER III 
METHODOLOGY  
This chapter describes the methodology that was used for this study. The 
sections included in this chapter are organized as follows: study design, setting, 
sample, recruitment, measures and instruments, data collection procedures, data 
management, data analysis procedures, potential challenges, and the protection 
of human subjects. 
Study Design 
A non-experimental, predictive, correlational design was used to examine 
relationships among disease self-management capacity measures (i.e., patient 
activation and health literacy), patient burden measures (i.e., treatment burden 
and illness burden) and medication adherence for AA adults with T2D and 
hypertension. This study also explored the workload and perceived impact of 
COVID-19 in the context of managing prescribed medications.  
Setting and Sample 
All aspects of this research study were conducted remotely. A non-random 
sample of 91 AA adults who met the inclusion criteria were recruited for this 
study. Inclusion criteria for this study were: (1) self-identify as African 
American/Black, (2) adult aged 18 years or older, (3) diagnosis of T2D and 
hypertension for at least one year, (4) ability to read, 
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understand, and speak English and provide informed consent, (5) prescribed at 
least one medication for diabetes and one for hypertension treatment, (6) ability 
to access the study surveys online or receive the surveys via a physical mailing 
address, and (7) ability to participate in a scheduled online or telephone session 
with the student Principal Investigator (student PI) following completion of online 
or mailed surveys. The exclusion criterion for this study was inability to 
independently carry out two or more activities of daily living (i.e., eating, bathing, 
getting dressed, and toileting). As the ability to perform mental and physical tasks 
were examined in this study, participants needed to meet minimum mental and 
physical capacity levels, limiting the potential impact of covariates.   
Sample Size Calculation 
Using an online sample size calculator by Soper (2020), a priori 
statistical power analysis for hierarchical multiple regression was 
conducted to determine an adequate sample size for this study. The 
results indicated that a sample size of 69 participants was needed for a 
medium effect size of 0.15, an alpha level of 0.05, a statistical power of 
0.80, with two primary predictor variables (set A) and two secondary 
predictor variables (set B) (Soper, 2020). Because no similar studies that 
provided effect sizes could be identified, the student PI used the ranges 
and SD reported previously by similar studies (Boehmer, Shippee, et al., 
2016; Huang et al., 2018; Sheikh et al., 2016; Weiss et al., 2005) to 
provide an estimate of the variability and an estimate of the potential effect 
size for this current study (Schmidt & Hollestein, 2018). The SDs were all 
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approximately one-third of their respective ranges, therefore, a medium effect 
size appears to be an appropriate selection for this study. An additional sample 
size calculation was performed to ensure an adequate sample size for the 
analyses that was conducted to detect correlations for variables not included in 
the hierarchical regression model. Using the G*Power calculator 3.1.9.2 to 
determine an a priori sample size for bivariate correlation analyses, a sample 
size of 84 participants was needed to have 80% power in detecting a moderate 
association, with an alpha level of .05. A moderate association was anticipated 
based on findings from two studies (Eton et al., 2012; Gallacher et al., 2018) that 
found the management of medications, and specifically the management of 
multiple medications, were key factors in the treatment burden participants 
reported. Based on these findings, the larger target sample size calculation of 84 
was used for this study.  
A survey completion rate of 85% was anticipated based on the lowest 
response rate observed in a review of previous studies with a similar target 
population and variables (Al Sayah et al., 2015; Ylitalo et al., 2018). Therefore, 
oversampling to the amount of 99 participants was determined to yield the 
needed sample size for this study (N=84 complete survey sets). 
Recruitment 
Upon receipt of study approval from Georgia State University’s 
Institutional Review Board (IRB), participants were recruited remotely from online 
settings via a digital recruitment flyer (See the Recruitment Flyer in Appendix A). 
Flyers were posted to social media outlets (i.e., Facebook, Instagram, LinkedIn, 
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and Pinterest) and disseminated via email and text messaging to 
individuals within the student PI’s networks of healthcare professionals 
(See email/text messaging script in Appendix B). The Flesch-Kincaid 
grade level for the email/text messaging script was 7.3. The student PI 
created profiles on each of the identified social media outlets for the 
specific purpose of providing study information and facilitating recruitment 
(e.g. posting the recruitment flyer). The recruitment flyer included a 
description of the study, criteria for inclusion eligibility, honorarium 
information, directions for accessing the study information online, how to 
receive printed versions of the study surveys if preferred, and the contact 
information for the student PI. The Flesch-Kincaid grade level for the 
recruitment flyer was 7.4. Participants were recruited and enrolled until the 
sample size of 84 with complete surveys was acquired. 
Measures and Instruments 
Data collected via online surveys included demographic data, 
contact information for participants, and participants’ responses to 
measures of medication workload, patient activation, treatment burden, 
illness burden, medication adherence, and perceived impact of COVID-19 
on medication management. Data collected via scheduled telephone calls 
(n = 22) or online sessions via Zoom Video Conferencing (n = 69) were 
participants’ responses to the health literacy measure. The Flesch -Kincaid 
grade level for all survey instruments used in this study was 8th grade or 
below, with the exceptions of two surveys (i.e. health literacy and 
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treatment burden measures). The total estimated time of completion for all the 
surveys that were used in this study was 35 minutes. Descriptions of the survey 
instruments that were used in this study are provided in this section .  
Demographic Variables 
Using a demographic survey developed by the student PI, fifteen items 
were assessed: age, sex, race/ethnicity, level of education, employment status, 
household income, marital/relationship status, length of time since diagnosis of 
diabetes and hypertension, most recent HbA1c value, most recent blood 
pressure, list of any additional comorbidities, insurance status, primary care 
provider status, presence of social support, and activities of daily living status 
(See Appendix C). The Flesch-Kincaid grade level for the demographic survey 
was 5.9. The estimated time of completion for this survey was three minutes.  
Independent Variables 
Measures of medication workload, DSM capacity, patient burden , and 
perceived impact of COVID-19 on management of medication were independent 
variables in this study. A description of each variable and how each variable was 
measured is provided below. 
Medication Workload  
The attributes of individuals’ medication management (i.e. number, 
difficulty, route) were examined with the Medication Workload Survey (See 
Appendix D). The survey consists of 10 questions that assessed the following: 
(1) the number of medications taken for diabetes, hypertension, and other health 
issues (e.g. cholesterol), (2) if medications must be taken at separate times each 
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day, (3) the difficulty in managing medications at separate times, (4) the 
routes prescribed for medication administration (i.e., oral, topical, and or 
injection), (5) the difficulty in administering medications via the prescribed 
routes, (6) if medication dose(s) had to be adjusted based on glucose or 
blood pressure levels taken at home and their perceived difficulty in 
performing the necessary assessments and dosage adjustments, (7) if 
their healthcare provider made any changes to their medications in the 
last 90 days and their perceived difficulty in managing the changes that 
were made, and (8) the difficulty they had with eight situations relating to 
medication management (i.e., remembering to take their medications, 
paying for medications, opening medication containers, getting refills on 
time, reading the instructions on medication containers, taking 
medications at inconvenient times, understanding what their medications 
are for, and dealing with the side effects from their medications). The 
Flesch-Kincaid grade level for the Medication Workload Survey was 6.9. 
The estimated time of completion for this survey was five minutes.  
 For the items that assessed level of difficulty, participants selected 
a response option from a 3-point Likert scale that corresponded to their 
perceived difficulty in dealing with the respective situation. The 3-point 
Likert scale consisted of the following options: not hard, a little hard, and 
very hard. Responses were scored from 0-2, with higher scores indicating 
greater perceived difficulty in the respective situation. Total workload 
difficulty scores were calculated by summing the individual scores of all 
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items that assessed perceived difficulty in specific aspects of medication 
management (total of 13 items). Scores range from 0-26, with higher scores 
indicating a greater perceived difficulty in medication workload management. The 
questions within this survey were developed by the student PI using th e 
Cumulative Complexity Model and the Brief Medication Questionnaire as a 
framework (Shippee et al., 2012; Svarstad et al., 1999). The Medication 
Workload Survey was reviewed prior to implementation in this study by 
healthcare professionals and educators with healthcare backgrounds and 
demonstrated good face validity. However, the Medication Workload Survey had 
not been administered prior to this study. Therefore, the initial internal 
consistency reliability for this measure was assessed during the data analysis 
portion of this study.  
Disease Self-Management Capacity 
 Two measures (i.e., patient activation and health literacy) were used in 
this study to assess participants’ capacities to complete disease self-
management activities. The Patient Activation Measure® (See Appendix E) and 
the Newest Vital Sign (See Appendix F) were the specific instruments used to 
measure patients’ activation and health literacy, respectively. 
Patient Activation. The Patient Activation Measure® (PAM®) is a 13-item 
questionnaire that assessed participants’ beliefs, motivation, knowledge, and 
skills in managing their diseases and preventing disease-related complications 
(Hibbard et al., 2004). The PAM® is a Guttman-like scale, with each question 
having one of the following response options: disagree, strongly disagree, agree, 
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strongly agree, or not applicable (N/A). The measure incorporates a 0-100 
scoring method, with higher scores indicating greater patient activation. 
Insignia Health has rights to the PAM® and does not share the specific 
methods used to score individual patient activation items. To obtain PAM® 
scores for this study, licensing was purchased to use the PAM® scoring 
spreadsheet. Participants’ responses were keyed into the spreadsheet. 
The spreadsheet has built-in formulas that analyze participants responses 
and yield a corresponding activation score. PAM® scores indicate if 
individuals: (1) believe that the patient role is important, (2) have the 
confidence and knowledge necessary to take necessary action, (3) take 
steps to maintain and improve personal health, and (4) stay adherent to 
disease self-management even under stressful circumstances. Scores are 
categorized into one of four patient activation levels. Level one (scores = 
0-47) is the lowest level of patient activation and indicates that individuals 
possibly lack the belief that they have an important role to play in their 
health and lack basic knowledge about their condition and their care. 
Patients at level two (scores = 47.1 - 55.1) of patient activation have the 
knowledge and confidence necessary to manage their health. Level three 
(scores = 55.2 - 72.4) patient activation indicates that patients are not only 
knowledgeable and confident, but also take the initiative to perform health 
promotion and illness prevention activities. Level four (scores = 72.5 - 
100), the highest level of patient activation, involves maintaining 
performance of DSM activities even under stressful circumstances 
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(Greene et al., 2015; Hibbard et al., 2004). The Flesch-Kincaid grade level for 
this document was 4.0. The estimated time of completion for this questionnaire 
was five minutes. 
The instrument has been used to measure self-management abilities 
across differing levels of health status, age groups, racial groups (including AAs), 
and different chronic illnesses including T2D (Bolen et al., 2014; Greene and 
Hibbard, 2012; Lubetkin et al., 2010; Mayberry et al., 2010; Mitchell et al., 2014; 
Skolasky et al., 2011). Previous literature has indicated that individuals with 
higher levels of patient activation had significantly lower rates of emergency room 
visits and days of hospitalization, supporting criterion validity of the PAM® 
(Greene et al., 2015; Mitchell et al., 2014).  A Cronbach’s alpha range of 0.81 - 
0.87 has also been reported from studies that included samples of AA adults, 
individuals with varying health statuses (including chronic illness), and adequate 
and low health literacy levels (Lubetkin et al., 2010; Prey et al., 2016). Thus, the 
PAM® has demonstrated very good internal consistency reliability. 
Health Literacy. The Newest Vital Sign (NVS) is a 6-item questionnaire 
that evaluated participants’ health literacy by: (1) assessing their understanding 
of words and numbers and (2) examining their ability to apply reading and 
numeracy skills (Weiss et al., 2005). The instrument involved each participant 
reviewing a nutritional facts label and answering six corresponding questions. 
The NVS was administered by the student PI over the phone or via a Zoom 
meeting. For phone administration, participants were emailed the nutritional 
label. For Zoom meetings, the student PI shared the screen to display the 
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nutritional label. Participants were then asked questions about the 
nutritional label and participants responded verbally with their answers. 
The NVS has not yet been tested as a self-administered tool. Scores were 
calculated on a 0 to 6 scale, with the lowest scores (i.e., 0 to 1) suggesting 
a high likelihood (50% or more) of limited literacy, middle scores (i.e., 2 to 
3) indicating the possibility of limited literacy, and higher scores (i.e., 
scores of 4 or  more) high likelihood of adequate literacy (Weiss et al., 
2005). The Flesch-Kincaid grade level for the nutritional label participants 
were expected to read and comprehend is 10.5. The target grade reading 
level of this study’s population was eighth grade. Although the reading 
level for this instrument was above the 8th grade level, the nutritional label 
reflects real life occurrences that potentially require higher levels of 
literacy skills to manage. The estimated time of completion for this 
questionnaire was three minutes. 
The NVS has been previously used to assess health literacy in the 
AA population, including AA patients with diabetes (Ylitalo et al., 2018). 
The NVS has also been compared to other validated instruments 
considered as gold standards for health literacy measurement (Ylitalo et 
al., 2018). The NVS demonstrated good criterion validity when compared 
with the Test of Functional Health Literacy for Adults (TOFHLA; r = 0.59, p 
< .001). The TOFHLA is an instrument used to measure health literacy 
and has been used often in healthcare research. However, the TOFHLA 
requires a longer administration time (18-22 minutes) as compared to the 
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NVS (three minutes), making the NVS a more appealing health literacy 
assessment tool for the inpatient setting (Weiss et al., 2005). Another study 
examining a sample of 170 patients with T2D (no report of participant’s 
races/ethnicities), indicated that the NVS was useful in predicting risks for 
complications from diabetes (e.g., neuropathy; OR 2.3, 95% CI [1.05,5.2], p = 
0.037), based on comparisons of individuals with varying health literacy levels 
(Mann et al., 2019). Cronbach’s alpha coefficients have been adequate ranging 
from 0.76 – 0.91 in samples of AAs, individuals with T2D, and individuals who 
were prescribed medications for diabetes management (Huang et al., 2018; 
Miser et al., 2013; Weiss et al., 2005). Therefore, the NVS has demonstrated 
good internal consistency and was an appropriate variable to include in this study 
as a potential predictor of medication adherence. 
Patient Burden 
 In this study, measures of treatment burden and illness burden were used 
to assess patient burden. The Multimorbidity Treatment Burden Questionnaire 
(See Appendix G) and the Illness Intrusiveness Ratings Scale (See Appendix H) 
were the specific instruments used to measure treatment burden and illness 
burden, respectively.  
Treatment Burden. The Multimorbidity Treatment Burden Questionnaire 
(MTBQ) was used to measure treatment burden in this study. The MTBQ is a 13-
item questionnaire that measures patients’ perceived effort in self-management 
of their medical conditions (e.g., managing medication adherence) and the 
impact that effort has on their daily well-being (Duncan et al., 2018). Each 
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question involves scaled response choices relating to level of difficulty: 
extremely difficult, very difficult, quite difficult, a little difficult, not difficult, 
or does not apply. The scores range from 0-100, with higher scores 
indicating greater perceived treatment burden. In a study of 143 adults 
with multimorbidity (predominantly White with no report of AA participants; 
44% had diabetes), the instrument had good content validity and construct 
validity demonstrating a negative association between MTBQ and quality 
of life (r −0.36, p<0.0001) and self-rated health (r −0.36, p<0.0001)  
(Duncan et al., 2018). The Cronbach’s alpha reported for the MTBQ was 
0.83 demonstrating internal consistency reliability (Duncan et al., 2018). 
The Flesch-Kincaid grade level for this document was 10.7. The estimated 
time of completion for this questionnaire was five minutes. 
Illness Burden. The Illness Intrusiveness Ratings Scale (IIRS) was 
used to measure illness burden in this study. The IIRS has been 
previously used to assess illness burden among AAs and individuals with 
varying chronic diseases including diabetes (Boehmer, Shippee, et al., 
2016; Devins, 2010; Molzon et al., 2013). The IIRS is a 13-item measure 
that assessed participants’ perception of the degree of interference in 
his/her life attributed to disease (Devins, 2010). The lIRS measured 
intrusiveness in the following life domains: health, diet, work, active 
recreation, passive recreation, financial situation, relationship with partner, 
sex life, family relations, other social relations, self-improvement/self-
expression, religious expression, and community and civic involvements. 
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Participants rated the intrusiveness of their illness from one to seven, with one 
symbolizing not very much and seven symbolizing very much. Scores range from 
13 to 91, with higher scores indicating greater perceived illness intrusiveness 
(i.e., illness burden). Good convergent validity has been reported for the IIRS, as 
predicted differences in scores were observed for individuals with differing 
observable burdens (Devins, 2010). The Cronbach’s alpha coefficients previously 
reported for the IIRS were obtained from samples of individuals with diabetes 
(0.88) and for AAs with chronic disease (0.93) support reliability of the IIRS and 
its usefulness in examining illness burden in a sample of AA patients with chronic 
disease (Devins, 2010; Molzon et al., 2013). The Flesch-Kincaid grade level for 
this document was 7.2. The estimated time of completion for this questionnaire 
was four minutes. 
Dependent Variable 
 The specific outcome measured in this study was medication adherence. 
A description of how this dependent variable was measured is provided below.  
Medication Adherence 
Medication adherence was assessed using the Extent of Adherence 
Survey (See Appendix I). This survey consists of two scales totaling fourteen 
items. The first scale includes six items that assess self-reported medication 
adherence over the prior 30 days. Participants responded with their level of 
agreement to medication adherence statements (e.g., “I missed or skipped at 
least one dose of my diabetes medications”), with strongly disagree, disagree, 
neutral, agree, and strongly agree as response options. Possible scores for each 
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item range from one (strongly disagree) to five (strongly agree), with items 
numbered one and two being reverse scored. To be considered adherent 
to their medication regimens, participants needed to respond with the 
highest level of agreement to adherence behaviors and highest level of 
disagreement to non-adherence behaviors. For example, participants 
needed to respond with strongly agree to “I took all doses of my diabetes 
medications” and strongly disagree to “I missed or skipped at least one 
dose of my diabetes medications.“ Participants were considered 
nonadherent if they received a score of ≥ two on any item. A total score 
reflecting adherence was calculated by averaging responses to the six 
items. While higher scores indicated greater levels of nonadherence, 
lower scores indicated greater levels of adherence (Voils et al., 2012).  
The second scale in the survey assessed reasons for non-
adherence. The eight questions of the reasons for non-adherence scale 
presented situations that potentially led to missing or skipping doses of 
medications (Voils et al., 2012). Participants responded to each situation 
using a Likert-scale with the following options: not at all, a little, or a lot. 
Scores for each situation ranged from zero through two, with higher 
scores indicating that the situation was perceived to contribute more 
greatly to non-adherence. Participants were also presented with an 
opportunity to report additional reasons that were not already listed for 
their non-adherence. In a study of 202 veterans with hypertension (50% 
Black), the Extent of Adherence Survey had good internal consistency 
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reliability, Cronbach’s alpha = 0.84 (95% CI: 0.80, 0.87). Concurrent validity was 
also demonstrated by correlations between the extent measure, systolic (r=0.27, 
p<.0001) and diastolic (r=0.27, p<.0001) blood pressure (Voils et al., 2012). The 
Flesch-Kincaid grade level for this document was 7.8. The estimated time of 
completion for this survey was five minutes.  
Exploratory Variable 
COVID-19 Impact on Medication Management 
The perceived impact of the COVID-19 pandemic on the management of 
medications was measured with the COVID-19 Impact Survey. The 10-item 
survey assessed participants’ beliefs on how much the COVID-19 pandemic has 
changed situations relating to their medication management. Using a Likert-
scale, participants responded with one of the following options: strongly disagree, 
disagree, neither agree nor disagree, agree, or strongly agree to the survey 
questions. Response item scores range from one through five, with higher scores 
indicating a greater belief that the presence of the COVID-19 pandemic has 
negatively impacted that specific aspect of their medication management. Total 
scores range from 10-50, calculated by summing the individual scores, indicating 
the overall perceived impact of COVID-19 on their medication management. 
Participants were also provided with the option of reporting additional details on 
how COVID-19 has affected their medication management (See Appendix J).  
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The questions within this survey were developed by the student PI 
using the Extent of Adherence and previous COVID-19 related literature 
(AHA, 2020b; Schroeder, 2020; Voils et al., 2012). The COVID-19 Impact 
Survey was reviewed by healthcare professionals and educators with 
healthcare backgrounds and demonstrated good face validity. However, 
the COVID-19 Impact Survey was not administered prior to this study, 
therefore, reliability measurements were not available. Internal 
consistency reliability for this measure was assessed in the data analysis 
portion of this study. The Flesch-Kincaid grade level for this document was 
7.6. The estimated time of completion for this survey was five minutes.  
Data Collection Procedures 
Upon IRB approval from Georgia State University, the student PI 
began posting, emailing, and text messaging digital recruitment flyers. 
Potential participants were directed to the Qualtrics survey page 
developed by the student PI to determine their eligibility for the study. If a 
participant met inclusion criteria and did not have any exclusion criteria, 
they moved on to the informed consent process. The informed consent 
process was conducted via the Qualtrics survey. Informed consent 
included: (1) an explanation of the purpose of the research study, (2) the 
duration of the research study, (3) a description of the procedures that 
were followed, (4) how data confidentiality was maintained, (5) any 
potential risks to the participants, (6) an explanation that participants 
would not receive any direct benefits from the research findings, (7) whom 
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participants would contact if they had questions regarding the research study, (8) 
circumstances that required the participant’s termination from the study, (9) how 
the data from the study would be used, (10) incentive details, and (11) a 
statement that participation in the study was voluntary and participants had the 
choice to withdraw from the study at any point they decided to do so. The Flesch-
Kincaid grade level for the informed consent was 7.2.  
The informed consent process was conducted online. Consent information 
was provided in the Qualtrics survey. Eligible participants independently read the 
consent form. The student PIs contact information was provided on the Qualtrics 
survey if participants had questions about the consent information or the study. 
All eligible participants were informed that their participation was voluntary and 
could be terminated at any time if they chose to do so. Once the informed 
consent document was reviewed, eligible participants responded to the following 
question, “Do you have any questions about this form or this study?”. If “yes” was 
selected, eligible participants were directed to the contact information for the 
student PI and the survey ended. If “no” was selected, the eligible participants 
proceeded to a true or false question to assess their understanding of the 
information within the consent form. Individuals who did not respond correctly 
were redirected to the consent form along with a reminder that the student PI 
could be contacted with any questions. They also had the opportunity to respond 
to the question again. If answered incorrectly for a second time, eligible 
participants were directed to the student PI contact information to assist them 
with understanding the details of the study and the survey ended. Eligible 
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participants who responded correctly proceeded to selection of one of the 
following statements in the Qualtrics survey, “I consent, begin the study” 
or “I do not consent, I do not wish to  participate.”, with the first statement 
indicating their desire to proceed with the survey.  
The Qualtrics survey was set up to assign random identification 
numbers to all participants following their consent to the study. The 
identification numbers were used for data tracking purposes and 
protection of participants’ identities. There was no waiting period between 
participants providing consent and initiating their participation in the study. 
Once was provided, eligible participants proceeded to the survey portion 
of the study. For eligible participants who elected not to consent, the 
survey ended. A copy of the consent form was made available to each 
participant.  
For eligible participants who indicated interest in the study but 
lacked access to the online documents, a paper version of the consent 
was offered to be mailed to them along with an addressed and stamped 
envelope for them to return the document. By returning the surveys, 
participants would indicate that they were consenting to participate. 
Eligible participants who opted to receive a paper version of the study 
documents were also provided with the student PI’s contact information in 
the event they had any questions or concerns regarding the consent 
process or study.  
Once consent was provided, participants proceeded to the 
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demographic survey portion of the Qualtrics survey. The demographic 
information obtained from participants included age, sex, race/ethnicity, level of 
education, employment status, household income, marital/relationship status, 
length of time since diagnosis of diabetes and hypertension, list of any additional 
comorbidities, insurance status, primary care provider status, presence of social 
support, and activities of daily living status. The student PI also obtained 
participants’ contact information (i.e., telephone numbers, email addresses, and 
mailing  addresses) per participants’ preferences. The contact information 
collected from participants via the Qualtrics survey was used to conduct the 
scheduled telephone or online session of the study (i.e., administer the NVS 
survey) and as a method for disseminating incentives. For participants who 
elected to receive telephone communications, they were asked to provide their 
preferred time(s) for contact, the name the student PI should use to address the 
participant in telephone communications, and if it was acceptable to leave 
voicemail messages.  
Following the collection of demographic data and contact information, 
participants were asked to complete the Medication Workload Survey, PAM®, 
IIRS, MTBQ, Extent of Adherence Survey, and COVID-19 Impact Survey. While 
participants had the option to pause the survey and come back to complete at a 
later time, participants were encouraged to complete their surveys with in 48 
hours of initiating the survey process. Upon completion of the online surveys, 
participants were notified via a message in Qualtrics that they would be 
contacted within 72 hours, via their preferred contact method, to schedule 
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completion of the final survey (i.e., NVS). The completion of the NVS for 
each participant took place within one week of them completing the online 
surveys. During the scheduled session for completion of the NVS survey, 
the student PI reassessed participants for inclusion/exclusion criteria. 
Each participant was asked to confirm that they were (1) an AA adult with 
T2D and hypertension, (2) diagnosed with T2D and hypertension for at 
least one year, (3) prescribed at least one medication for T2D and at least 
one medication for hypertension, and (4) able to perform activities of daily 
living independently. Additionally, participants were asked to provide any 
responses missing from the online survey. Participants were also asked 
how they found out about the study for recruitment analysis purposes. 
Although the intent was to conduct this study primarily online, alternative 
methods of data collection were used when necessary. However, each 
participant needed to have access to at least a telephone to complete the 
NVS survey. Upon completion of the NVS survey, each participant was 
sent a digital gift card of $25. Upon acquiring the required sample of 84 
participants with complete survey sets, the Qualtrics survey was closed to 
new participants. Participants who started the survey process but had not 
completed their surveys and had not had any survey activity for 48 hours 
prior to acquiring the sample of 84 completed survey sets, were informed 
of the study closure and thanked for their time. Participants that had 
activity within the prior 48 hours were notified of the time they had 
remaining to complete their study surveys. An additional seven 
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participants completed their survey sets and scheduled interviews, resulting in a 
total sample size of 91. Participants were advised if they did not complete all 
aspects of the study upon study closure they would not receive an incentive.  
Data Management  
The student PI collected data using self-report measures and one survey 
that was administered via a scheduled online or telephone session (i.e., NVS). 
Prior to data collection, the student PI developed a code book for the study 
variables and two tracking sheets. The code book was created in Microsoft Word 
and contained no identifying participant information. The code book was used to 
maintain the scoring methods for each of the variables used in this study. 
Microsoft excel was used to develop a spreadsheet to track each participant’s 
responses on surveys. The student PI maintained a separate spreadsheet which 
consisted of participants’ identification numbers, participants’ contact information, 
a log of the dates and number of times participants were contacted, the 
scheduled dates for the administration of the NVS, a log of how the participants 
found out about the study, and the record for distribution of incentives. This list 
was also maintained on a password protected excel spreadsheet. 
All surveys were administered in one of two ways: (1) via an online 
Qualtrics survey or (2) through scheduled online or telephone sessions based on 
participant preference and instructions from the developers of the instruments 
being used in the study. Each survey used in this study was labeled with a 
unique identification number in lieu of using participants’ names. Survey 
responses were primarily collected online via Qualtrics. The Qualtrics data were 
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password protected. Upon obtaining the completed surveys and contact 
information from participants, the student PI transferred the data from the 
surveys into a password protected Microsoft excel sheet on a duo 
password protected tablet equipped with a 15-minute inactivity timeout, 
data storage encryption, automatic data wiping after 10 consecutive failed 
login attempts, and ability to remotely wipe the device.  
The NVS survey was administered via a scheduled session, per 
instructions from the NVS developers. For participants who chose to 
complete the NVS via telephone, the nutritional label was emailed or 
texted to them. For online sessions, the nutritional label was displayed via 
a screen share for them to view. The online platform used included 
microphone capability so that the student PI and participant could 
communicate verbally. The student PI transcribed participants’ responses 
on an electronic copy of the document, labeled with the participant’s study 
identification number, and stored on the password protected tablet. 
Upon completion of all surveys, the student PI assessed them for 
missing responses and followed up with participants as appropriate. All 
identifiable information was removed from the study data before reporting 
the study results. As this study had exempt status, signatures were not 
required on informed consent forms and therefore, did not need to be 
retained for three years, in accordance with regulations (U.S. Department 
of Health & Human Services [HHS], 2017). The data collected from 
participants via the Qualtrics survey were password protected and only 
83 
 
 
 
accessible by the PI (i.e., Dr. Dawn Aycock) and student PI (i.e., Michelle 
Gaddis). No study documents were distributed or collected via mail, therefore, no 
hard copies needed to be stored in this study. Any data shared via the student 
PI’s dissertation defense, research conferences, or publications was deidentified 
prior to disseminating.  
Data Analysis  
IBM SPSS Version 25 software was used to conduct the statistical 
analyses for this study. Prior to inputting data into the SPSS database, the data 
were assessed to identify errors and missing values. Upon transferring data into 
SPSS, the data were rechecked for errors, missing values, and normality. Errors 
were corrected and missing values were handled by following up with the 
participants to acquire the missing information. Normality was assessed by using 
descriptive statistics then assessing for kurtosis or skewness. Outlier values were 
identified by using frequencies, minimum, and maximum. For data that deviated 
from a normal distribution, appropriate transformations were conducted. For 
variables that did not achieve normality, non-parametric tests were used. The 
data were also examined to ensure assumptions to perform the inferential data 
analysis were met (i.e., linearity, independent errors, homoscedasticity, and 
multicollinearity). Internal consistency reliability was assessed for each of the 
scales within the Medication Workload Survey, PAM®, NVS, MTBQ, IIRS, the 
Extent of Adherence Survey, and COVID-19 Impact Survey using Cronbach 
alpha test. Descriptive statistics (i.e., frequencies, percentages, measures of 
central tendency and variability) were used to summarize the demographic 
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characteristics of the sample, independent variables, outcome variable, 
and the exploratory variable. The data were also analyzed for potential 
covariate variables. As potential covariates were identified during data 
analysis, the appropriate steps were taken to control for their effects. The 
literature indicated that the following demographic variables were potential 
covariates for the concepts in this study: age, sex, and socioeconomic 
status (Akohoue et al., 2015; Boehmer, Shippee, 2016; Byers et al., 2016; 
Gallacher et al., 2018; Osborn et al., 2013; Rovner et al., 2013). In this 
study, income and level of education were the measures used to assess 
socioeconomic status. The data analyses for addressing the research 
questions are described next.  
Data Analysis for Research Questions 
The research questions were analyzed as follows:  
For AA adults 18 years of age or older with comorbid T2D and hypertension who 
have been prescribed medications for blood pressure and glycemic control:  
RQ1: Are higher levels of illness burden associated with lower levels of patient 
activation and health literacy?  
RQ2: Are higher levels of treatment burden associated with a higher number of 
prescribed medications and greater perceived difficulty in managing prescribed 
medications?   
The plan for answering the first and second research questions was to use 
Pearson’s correlation test if the assumptions were met (e.g., normality) and if not, 
a non-parametric alternative (e.g., Spearman’s rank-order correlation) would be 
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used. As the variables did not achieve normal distribution upon multiple 
transformation attempts, the non-parametric alternative was used to answer 
questions one and two. The correlation matrix provided an indication of the 
direction of relationships (i.e., either positive or negative correlations), the 
strength of the relationships among the variables, and if any of the correlations 
were significant.  
RQ3: Do patient activation, health literacy, treatment burden, and illness burden 
significantly predict medication adherence? 
To answer the third research question, a linear regression analysis was 
performed. Multiple linear regression analysis uses a model composed of 
multiple independent variables (X) to explain or predict variance in one 
dependent variable (Y) at a time. Therefore, one linear regression analysis was 
performed to test the model consisting of patient activation, health literacy, 
treatment burden, and illness burden in predicting the variance in medication 
adherence. Hierarchical entry was the method used for the regression analysis, 
with potential covariates entered first (i.e., age, sex, income, and level of 
education), patient activation entered second, health literacy third, treatment 
burden fourth, and illness burden entered last. The decision for hierarchical entry 
and the order in which variables were entered was based on the amount of 
literature found to support each of the independent variables’ associations with 
the dependent variables. The level of significance used for the data analysis was 
α = 0.05. The model summary indicated whether the model that included patient 
activation, health literacy, treatment burden, and illness burden significantly 
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predicted variance in the dependent variables. The coefficients table displayed 
each independent variable’s contribution to predicting the variance in the 
dependent variables and the significance of those predictions.  
RQ4: Which aspects of medication management are the most challenging?  
The fourth research question was addressed by analyzing: (1) the 
frequencies of the responses to questions five, seven, eight, nine, and 10 of the 
Medication Workload Survey to identify the aspects of managing medications 
most frequently identified as being a challenge, and (2) the modes for the Likert-
scale responses to question #s five, seven, eight, nine, and 10 of the Medication 
Workload Survey to determine the extent of the challenge created by medication 
management activities. The same analysis was conducted for questions four and 
five of the Extent of Adherence Survey. For both analyses, items with higher 
frequencies in level 1 and level 2 scale responses (i.e., A little and A lot on the 
Medication Workload Survey; A little hard and Very hard on the Extent of 
Adherence Survey) indicated they were the more commonly identified 
challenges. Items that had modes of zero indicated the situations that were the 
least challenging, modes of one indicated situations that were perceived as a 
little challenging, and modes of two indicated situations that were found to be the 
most challenging in managing medications and medication adherence.   
RQ5: What is the perceived impact of the COVID-19 pandemic on medication 
management? 
To answer the final research question, (1) the frequencies of the 
responses to questions from the COVID-19 Impact Survey were analyzed to 
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identify the aspects of managing medications most frequently identified as being 
impacted by COVID-19, and (2) the modes for the Likert-scale responses to 
questions one through 10 of the COVID-19 Impact Survey to determine the 
extent of the perceived impact of COVID-19 on medication management 
activities. Items with higher frequencies in level four and level five scale 
responses (i.e., Agree and Strongly agree) indicated they were the more 
commonly identified activities believed to have been impacted by COVID-19. 
Items that had modes of zero through three indicated situations that were not 
perceived to be impacted by COVID-19, items with modes of four indicated 
situations perceived to have been impacted by COVID-19, and modes of five 
indicated situations relating to medication management that were found to be the 
most impacted by the presence of COVID-19.   
Priori Identification of Study Challenges 
Prior to conducting the study, potential situations that could cause 
challenges in the study were identified. These potential challenges have been 
outlined below. Any additional situations that were not identified prior to the study 
were addressed as they arose during the study.  
Recruitment Challenges 
This study was conducted entirely remotely. Potential participants could 
have been uncertain in determining that this study’s recruitment efforts were 
legitimate, that it was safe to participate in the study, that they were not being 
spammed, and that they were not targets of fraudulent attempts to gain access to 
their information. To address these problems, the contact information for the 
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student PI was included on all recruitment materials (i.e., social media 
posts, recruitment flyer, emails, text messages). The recruitment flyer that 
was disseminated also included a picture of the student PI. Potential 
participants who contacted the student PI were provided with the study 
details along with the informed consent form to review. The consent form 
included contact information for the PI, student PI, and GSU IRB. The 
student PI allowed adequate time for them to review the consent form and 
answered any questions they had for making their decision to participate. 
Participants were informed of the privacy protection and data security 
measures that were in place. At any point that a potential or active 
participant indicated that they no longer desired to be contacted, the 
student PI terminated all future contact with that individual. The student PI 
conducted weekly analyses to evaluate the recruitment flow and detect 
any additional unanticipated challenges with recruitment.  
Completion of Study Surveys Questionnaires 
There was a total of eight surveys (i.e., Demographic survey, 
COVID-19 Impact Survey, Medication Workload Survey, PAM®, NVS, 
MTBQ, and IIRS) that participants were asked to complete during this 
study. The estimated completion time for all surveys in this study was 35 
minutes. For participants who unintentionally skipped questions or left out 
information, the student PI evaluated the participants’ responses to the 
surveys at least every 72 hours to determine if the participants 
demonstrated having difficulty in providing their responses. The student PI 
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assisted participants in the completion of their questionnaires during each 
scheduled 1:1 session as needed, while ensuring any actions to assist 
participants did not conflict with the administration guidelines provided for the 
study instruments. As indicated in the informed consent, participants had the 
right to skip questions at any time of their choosing. If any participants 
intentionally skipped questions for reasons that could not be resolved, the 
student PI honored the participant’s choice to not respond.   
Additionally, as most of the questionnaires relied on self-reported data, 
there was potential for response bias from the participants. To address this issue, 
participants were informed of the importance of providing honest responses to 
the surveys. Participants were also reminded that the information they provided 
in the study would be de-identified prior to sharing any results.  
This study involved a small incentive for participants. As such, some 
participants possibly attempted to complete the study more than once. To 
address this potential issue, the Qualtrics survey was equipped with a “prevent 
ballot stuffing” feature, which deterred individuals from joining the study more 
than once. Additionally, as this study involved a scheduled telephone or online 
session prior to receiving incentives, the student PI also monitored for repeated 
attempts to participate in the study.  
Retention of Study Participants 
As this study involved a scheduled session (i.e., administration of the NVS 
survey), for which scheduling took place within 72 hours after completion of the 
online surveys, potential problems with retention of participants were anticipated. 
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To address potential retention issues, the student PI included information 
about the required scheduled session in the informed consent. The 
student PI also provided participants with reminders for the session. 
Additionally, the student PI planned for oversampling to the amount of 99 
to increase the potential of acquiring the completed set of surveys for 84 
participants.  
Protection of Human Subjects 
Prior to initiating this study, IRB approval was obtained from 
Georgia State University, in accordance with Human Research Protection 
regulations. This study posed no more risks than participants would 
experience in a normal day. However, as this study involved participation 
of human subjects, the student PI acknowledged potential ethical 
concerns. In addition to the activities described in the data management 
section regarding protection of participant data (e.g., password protection 
of surveys, assignment of Participant ID numbers, locked file cabinet for 
hard copy documents), the following human subjects’ protection activities 
were performed. The student PI completed required research training 
provided by the Collaborative Institutional Training Initiative (CITI) program 
for studies involving human subjects. The student PI obtained informed 
consent from all study participants. Participants were informed that their 
participation was voluntary, and they had the option to withdraw from the 
study at any time, even if consent to participate in the research study was 
already provided. The student PI ensured that the approved study 
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procedures were followed, including assigning participant identification numbers 
in lieu of using names on study documents, to maintain participants’ privacy and 
confidentiality of the information study participants provided.  
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CHAPTER IV 
RESULTS 
The results of this non-experimental, predictive, correlational study of 
disease self-management capacity, patient burden, and medication adherence in 
African American adults with type 2 diabetes and hypertension are outlined in 
this chapter. More specifically, this chapter contains a description of the 
recruitment and retention outcomes, demographic characteristics of the sample, 
and the reliability of the scales used to quantify the study variables. The 
descriptive statistics for all study variables and the results of the analyses of five 
research questions are also presented.    
Recruitment and Survey Completion Results 
 A total of 498 Qualtrics survey entries were received from July 4, 2020 to 
August 1, 2020 (See Figure 3). Of the 498 entries, 62 (12%) potential participants 
did not proceed past the informed consent. Fifty-six (11%) potential participants 
indicated they had questions following the review of the consent but did not call 
or email the student PI as instructed nor did they provide their contact 
information. Two did not pass the assessment for understanding the elements of 
the study following the informed consent and were directed via Qualtrics to 
contact the student PI for assistance. Neither contacted the student PI to discuss 
options for reentry into the study and therefore were not included. Lastly, four 
potential participants declined to participate in the study.
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Although 436 consents were received, 319 were found to be duplicate 
survey entries and were removed. Duplications were identified by examining the 
individual survey responses and by examining the re-captcha and relevant ID 
duplicate scores provided by Qualtrics. Of the remaining 117 participants who 
provided informed consent, 12 did not complete their online surveys and did not 
provide contact information for follow up. Three participants did not complete 
their online surveys, and although contact in formation was provided, they did not 
respond to the student PI’s attempts to reach them. Seven participants upon 
reassessment of eligibility criteria, were found to not meet the criteria and 
therefore were excluded; five participants indicated on the question that asked 
how many medications do they take for T2D and hypertension that they were not 
prescribed medications for both T2D and hypertension and two participants 
indicated that they were not able to independently carry out activities of daily 
living (i.e., eating, bathing, getting dressed, and toileting). Of the remaining 95 
participants who completed the online surveys and proceeded to the scheduling 
of session two (i.e., telephone/Zoom interview), four were excluded for not 
returning emails or calls to schedule the session.  
The final sample consisted of 91 African American adults with T2D and 
hypertension who completed both data collection sessions, meeting the required 
sample size indicated by the priori statistical power analysis (n = 84). The 
retention rate for this study, excluding the duplicate responses and potential 
participants who consented but did not qualify for the study, was 83% (91/110). 
More than half of the sample (51%) were recruited via a social media platform 
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(i.e., Facebook). The remainder of the sample were recruited via referrals from 
friends, relatives, and co-workers of the participants as indicated by the results of 
the survey question that assessed how participants found out about the study. 
Figure 3 
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Withdrawal (n = 341) 
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*Did not meet inclusion (n = 7) 
             (5: meds; 2: ADLs) 
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Session 1 data) 
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Withdrawal (n = 4) 
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attempts to schedule) 
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Data Cleaning 
 Upon acquiring completed survey sets from 91 participants, the data from 
the completed surveys were transferred from Qualtrics to SPSS and checked for 
accuracy.  All study variables were analyzed for errors and missing values. 
Outlier values were assessed using frequencies, minimum, and maximum. 
Normality was also assessed by examining the variables for kurtosis or 
skewness.  
The data were free from errors and excluding “do not apply” items, there 
were 13 missing responses. Specifically, nine responses were missing for HbA1c. 
The remaining four responses were missing from two participants who did not 
provide a recent SBP and DBP. During their health literacy interviews, the 13 
participants were asked to provide responses for the missing data (i.e., SBP, 
DBP, and/or HbA1c), however, the participants were unable to recall their levels.  
Therefore, pairwise deletion was the method used for managing the missing data 
for HbA1c, SBP, and DBP. Pairwise deletion involves running the analyses on the 
data available for each case. The cases with missing data were not considered in 
the analyses for HbA1c, SBP, and DBP. As these variables were not considered 
major variables in any of the correlation or regression analyses, this was an 
appropriate method for managing these missing variables. All data sets needed 
to answer the research questions in this study were complete.  
All of the demographic and theoretical variables were skewed. Skewness 
was notable (i.e., skewness values greater than one or less than negative one) 
for age. The kurtosis measure for several variables (i.e., perceived difficulty in 
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managing medication workload, health literacy, medication adherence, and 
perceived difficulty in medication adherence) were also out of range. There was a 
total of 12 noteworthy outlier values for the major study variables. Outliers were 
identified by assessing the box plots for patient activation, health literacy, 
treatment burden, illness burden, medication adherence, total number of 
prescribed medications, total difficulty in managing medications, and COVID-19 
impact scores. While there were 4 outlier values ranging from 27 through 36 for 
treatment burden, only one outlier (i.e., 36) was not within one standard deviation 
of the mean treatment burden score. Another four outliers ranging from 77 
through 88 were found within the illness burden scores, all of which were outside 
of one standard deviation of the mean illness burden score. The remaining four 
outliers (i.e., four scores of 10) were from the COVID-19 impact scores, with the 
scores being more than two standard deviations below the mean COVID-19 
impact scores. Shapiro-Wilk tests were conducted on the major study variables 
to determine whether the distributions of the variables were significantly different 
from a normal distribution. The results indicated that all of the variables 
significantly differed from normality based on an alpha of 0.05. Logarithmic, 
square root, and reciprocal transformations were conducted on these variables, 
but normal distribution was only achieved for illness burden (W = 0.97, p = .066). 
Therefore, non-parametric alternatives were used for the analyses, as 
appropriate.   
Descriptive statistics (i.e., frequencies, percentages, measures of central 
tendency and variability) were used to summarize the demographic 
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characteristics of the sample, independent variables (i.e., patient activation, 
health literacy, treatment burden, and illness burden), outcome variable (i.e., 
medication adherence), and the exploratory variable (i.e., perceived impact of 
COVID-19 on medication management). The next section describes the 
characteristics of the study sample.   
Description of the Sample 
 For the 91 African American adults with T2D and hypertension who 
participated in this study, ages ranged from 25 to 73 years (M = 39.6; SD = 11.9). 
The majority of the sample were male (n = 60; 66%), had a college degree 
(71%), were employed part-time (53%), had an income of $30,000 or more 
(66%), and were married (64%). Additionally, 89% of the sample reported having 
some form of health insurance, with the most prevalent being employer-
sponsored (37%) and Medicare/Medicaid (33%). Most participants also reported 
having a primary health care provider (78%) and social support (80%).  
For clinical characteristics of the sample, most reported having T2D and 
HTN for less than five years (respectively, 64% and 75%) and denied having 
additional health issues (79%). Most participants (> 91%) were able to self-report 
their most recent HbA1c, SBP, and DBP levels. The mean HbA1c value was 
slightly above 7.0 % (7.4 %; SD = 1.8), indicating the potential for elevated risk of 
vascular complications among participants (American Diabetes Association 
[ADA], 2020). Though the mean reported SBP (139; SD = 18.7) and DBP (82;  
SD = 10.4)  were below the general blood pressure target of 140/90 
recommended by the ADA for individuals with T2D and low risk for 
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cardiovascular disease, the mean blood pressure in this study was above 130/80 
which has been indicated as the BP target for individuals at higher risk for 
cardiovascular disease, such as AAs, who may require more intensive blood 
pressure control (ADA, 2019; Passarella et al., 2018; Saab et al., 2015; Whelton 
et al., 2018). See Table 1 for the full demographic characteristics of the sample.  
Table 1 
Characteristics of the Sample (N = 91)  
Variables M (SD) Minimum Maximum 
Age (years) 39.6 (11.9) 25 73 
Time Since Diabetes Dx (years) 4.3 (3.2) 1 18 
Time Since Hypertension Dx (years) 4.4 (5.7) 1 47 
HbA1c (%) a 7.4 (1.8) 5.0 14.7 
SBP (mmHg) b 139 (18.7) 100 187 
DBP (mmHg) c 82 (10.4) 50 98 
Variables n (%)   
Sex 
     Female 
     Male 
 
31 (34.1) 
60 (65.9) 
  
Level of Education  
     High school graduate 
     Trade school graduate 
     College: Undergraduate degree 
     College: Graduate degree 
 
15 (16.5) 
11 (12.1) 
30 (33.0) 
35 (38.5) 
  
Employment Status 
     Full-time 
     Part-time 
     Unemployed 
     Retired 
 
32 (35.2) 
48 (52.7) 
5 (5.5) 
6 (6.6) 
  
Household Income 
      < $30,000       
      ≥ $30,000 
 
31 (34.1) 
60 (65.9) 
  
Marital Status 
     Single 
     Married 
     Separated 
     Divorced 
     Widowed 
     Domestic Partnership 
 
17 (18.7) 
58 (63.7) 
10 (11.0) 
4 (4.4) 
1 (1.1) 
        1 (1.1) 
  
a n = 82; b n = 89; c n = 89.  
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Table 1 
Characteristics of the Sample Cont’d (N = 91) 
Variables           n (%)                                 
Other Health Issues  
     Obesity 
     High cholesterol 
     Arthritis 
     Anxiety 
     Depression 
     Pain 
     Heart disease 
     Kidney disease 
     Gout 
     Allergies 
     Ulcers 
 
5 (5.5) 
4 (4.4) 
4 (4.4) 
3 (3.3) 
3 (3.3) 
2 (2.2) 
2 (2.2) 
1 (1.1) 
1 (1.1) 
1 (1.1) 
1 (1.1) 
  
Insurance status 
     None 
     Private 
     Employer-sponsored 
     Medicare/Medicaid 
     Other (not described) 
 
10 (11.0) 
16 (17.6) 
34 (37.4) 
30 (33.0) 
1 (1.1) 
  
Primary healthcare provider  
     Yes 
     No 
 
71 (78.0) 
20 (22.0) 
  
Presence of social support  
     Yes 
     No 
 
73 (80.2) 
18 (19.8) 
  
 
Descriptive Statistics of Study Variables 
The descriptive statistics for the major study variables (i.e., patient 
activation, health literacy, treatment burden, illness burden, medication 
adherence, total difficulty in managing medications, total number of prescribed 
medications, and perceived impact of COVID-19) are reported in Table 2. The 
Cronbach’s alpha coefficients are also provided, as appropriate. The NVS was 
scored based on correct or incorrect responses, thus, Kuder-Richardson (KR) 20 
is the recommended method for reliability testing for this measure. In SPSS, the 
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Cronbach’s alpha is reported as providing the same result as the KR 20 value.  
All coefficient alphas were above .75, indicating adequate internal consistency 
reliability of all scales.  
Table 2 
 
Descriptive Statistics for Major Study Variables (N = 91)  
Variables M (SD) Observed  
Min - Max 
Possible 
Min - Max 
α 
 
Patient activation 
 
78 (13.3) 
 
54 - 100 
 
0 – 100 
 
.87 
 
Health literacy 
 
2.6 (2.0) 
 
0 - 6 
 
0 - 6 
 
.81 
 
Treatment burden 
 
20.6 (14.7) 
 
0 - 69 
 
0 - 100 
 
.87 
 
Illness burden 
 
46 (15.8) 
 
13 - 88 
 
13 - 91 
 
.91 
 
Total # of prescribed medications 
 
4 (1.3) 
 
2 - 8 
 
≥ 2 
 
- 
 
Medication adherence (overall) 
 
2.4 (0.9) 
 
1 - 4 
 
1 - 5 
 
.78 
 
Total perceived difficulty in 
managing medications  
 
10.5 (6.8) 
 
0 - 29 
 
0 - 42 
 
.92 
 
Perceived COVID-19 impact 
 
30 (8.8) 
 
10 - 44 
 
10 - 50 
 
.89 
 
Patient Activation 
The Patient Activation Measure ® has a possible score range of 0 - 100 
and the mean score was 78 (SD = 13.3),  indicating a high level of patient 
activation within the sample. Of the four patient activation levels, most 
participants’ (63%) were categorized at level four, the highest level of patient 
activation (scores of 72.5 – 100), indicating they perceived themselves as being 
more proactive and engaged in recommended health behaviors. Table 3 reflects 
the distribution of patient activation levels in the sample.  
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Table 3 
Participants Categorized by Patient Activation Levels (N = 91)  
Patient activation levels N % 
PA Level 1: Disengaged and overwhelmed  
(scores = 0 – 47)                                              
0 0 
PA Level 2: Becoming aware but still struggling  
(scores = 47.1 – 55.1) 
2 2 
PA Level 3: Taking control and gaining control  
 (scores = 55.2 – 72.4) 
 
32 35 
PA Level 4: Maintaining behaviors and pushing further  
(scores = 72.5 – 100) 
57 63 
 
As reflected in Table 4, for the individual item responses, strongly agree 
was the most frequently observed response, supporting the high patient 
activation mean score. The items with the highest prevalence of disagree and 
strongly disagree responses were patient activation items number eight (i.e., I 
understand my health problems and what causes them; 19%), number 12 (i.e., I 
can figure out solutions when new health problems arise; 18%), and number nine 
(i.e., I know what treatments are available for my health problems; 13%). 
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Table 4 
Distribution of Patient Activation Measure® Responses (N = 91)  
PAM® Questions Level of Agreement 
 Strongly 
agree 
n(%) 
Agree 
 
n(%) 
Disagree 
 
n(%) 
Strongly 
disagree 
n(%) 
Not 
applicable  
n(%) 
1. I am responsible for my 
health. 
 
 
53(58) 
 
38(42) 
- - - 
2. Taking an active role is the 
most important thing that 
affects my health.  
 
 
 
57(63) 
 
 
31(34) 
 
 
3(3) 
 
 
- 
 
 
- 
3. I can help prevent/reduce 
my health problems.  
 
 
49(54) 
 
38(42) 
 
4(4) 
 
- 
 
- 
4. I know what my prescribed 
medications do.  
 
 
43(47) 
 
40(44) 
 
5(6) 
 
3(3) 
 
- 
5. I know what I can handle 
and when I need to see the 
doctor.  
 
 
 
44(48) 
 
 
41(45) 
 
 
6(7) 
 
 
- 
 
 
- 
6. I can tell a doctor about my 
concerns without being 
prompted.  
 
 
 
45(49) 
 
 
40(44) 
 
 
5(6) 
 
 
1(1) 
 
 
- 
7. I can follow through on 
medical treatments at 
home.  
 
 
44(48) 
 
 
42(46) 
 
 
5(6) 
 
 
- 
 
 
- 
8. I understand my health 
problems and what causes 
them.  
 
 
30(33) 
 
 
44(48) 
 
 
15(17) 
 
 
2(2) 
 
 
- 
9. I know what treatments are 
available for my health 
problems.  
 
 
26(29) 
 
 
53(58) 
 
 
11(12) 
 
 
1(1) 
 
 
- 
10. I have maintained positive 
lifestyle changes.  
 
34(37) 
 
48(53) 
 
8(9) 
 
1(1) 
 
- 
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Table 4 
Distribution of Patient Activation Measure® Responses Cont’d (N = 91)  
PAM® Questions Level of Agreement 
 Strongly 
agree 
n(%) 
Agree 
 
n(%) 
Disagree 
 
n(%) 
Strongly 
disagree 
n(%) 
Not 
applicable  
n(%) 
11. I know how to prevent 
health problems.  
 
30(33) 
 
53(58) 
 
7(8) 
 
1(1) 
 
- 
12. I can figure out 
solutions when new 
health problems arise.  
 
 
24(26) 
 
 
51(56) 
 
 
15(17) 
 
 
1(1) 
 
 
- 
13. I can maintain positive 
lifestyle changes even 
during stressful times.  
 
 
42(46) 
 
 
40(44) 
 
 
8(9) 
 
 
1(1) 
 
 
- 
 
Health Literacy 
 On average, participants completed the NVS measure by phone or web-
based interview within the anticipated time frame of six minutes (M = 5.53 
minutes, SD = 2.2). The possible score range for the NVS health literacy 
measure is 0 - 6.The mean score for health literacy was 2.6 (SD = 2.0), indicating 
low health literacy within the sample. Participants were grouped by literacy 
scores as level one (score = 0 - 1), level two (score = 2 - 3), or level three (score 
≥ 4), with higher scores indicating higher levels of health literacy. Health literacy 
levels varied, but the most frequently observed level was a high likelihood of poor 
health literacy (40%), followed by a high likelihood of adequate health literacy 
(32%), then possibility of limited literacy (29%). Most participants answered 
questions one through four incorrectly, indicating low numeracy and document 
literacy. Conversely, most participants provided the correct answers to questions 
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five and six, indicating high prose literacy. Table 5 displays the frequencies and 
percentages of correct vs. incorrect responses for each of the six health literacy 
questions.  
Table 5 
Distribution of Newest Vital Sign (NVS) Responses (N = 91) 
 
Health Literacy Questions Correct  
n (%) 
1. If you eat the entire container, how many 
calories will you eat? 
 
18 (19.8%) 
2. If you are allowed to eat 60 grams of 
carbohydrates as a snack, how much ice cream 
could you have? 
 
42 (46.2%) 
3. Your doctor advises you to reduce the 
amount of saturated fat in your diet. You usually 
have 42 g of saturated fat each day, which 
includes one serving of ice cream. If you stop 
eating ice cream, how many grams of saturated 
fat would you be consuming each day? 
 
34 (37.4%) 
 
4. If you usually eat 2,500 calories in a day, 
what percentage of your daily value of calories 
will you be eating if you eat one serving? 
 
29 (31.9%) 
 
Pretend that you are allergic to the following 
substances: penicillin, peanuts, latex gloves, 
and bee stings. 
 
 
 
5. Is it safe for you to eat this ice cream?  
 
65 (71.4%) 
 
6. Why not?  
 
47 (51.7%) 
 Note: Items one through four assess document literacy and numeracy. Items five 
and six assess document literacy and prose literacy.  
105 
 
 
 
Treatment Burden 
 The Multimorbidity Treatment Burden Questionnaire has a possible score 
range of 0 – 100. The mean score for participants’ treatment burden (M = 20.6, 
SD = 14.7) indicated a moderate level of perceived burden from treatment for this 
sample. Based on treatment burden scores, nine participants (10%) were found 
to have no burden (score = 0), 12 (13%) had low burden (score <10), 34 (37%) 
had medium burden (score 10 – 22), and 36 (40%) had high burden (score > 22). 
Most participants reported no or little difficulty in several aspects of their 
treatment. For example, monitoring medical conditions (n = 83, 91%), getting 
clear and up-to-date information about their condition (n = 82, 90%), collecting 
prescription medications (n =81, 89%), making recommended lifestyle changes 
(n = 73, 80%), and getting healthcare in the evenings or weekends (n = 71, 
78%). Conversely, there were some activities that a number of participants found 
quite difficult, very difficult, or extremely difficult.  For example, taking lots of 
medications (n = 46, 51%) and seeing lots of healthcare providers (n = 29, 32%), 
indicating a potentially heavy perceived medication burden for half of the 
participants and a provider burden for one-third of the participants. Frequencies 
and percentages of participants’ responses to the treatment burden questions 
are presented in Table 6. 
 
 
 
 
106 
 
 
 
Table 6 
Distribution of Multimorbidity Treatment Burden Questionnaire (MTBQ) 
Responses (N = 91) 
Variable Level of Difficulty 
 Extremely 
difficult 
n(%) 
Very 
difficult 
n(%) 
Quite 
difficult 
n(%) 
A little 
difficult 
n(%) 
Not 
difficult/ 
Does not 
apply 
n(%) 
 
1. Taking lots of meds 9(10.0) 10(11.0) 27(29.6) 23(25.0) 22(24.0) 
2. Remember to take 
meds 
 
- 4(4.4) 16(17.6) 29(31.9) 42(46.2) 
3. Paying for meds - 8(8.8) 14(15.4) 29(31.9) 40(44.0) 
4. Collecting meds - - 10(11.0) 32(35.0) 49(53.8) 
5. Monitoring medical 
conditions 
 
1 (1.1) 2(2.2) 5(5.5) 29(31.9) 54(59.3) 
6. Arranging appointments 
 
- 1(1.1) 10(11.0) 38(41.8) 42(46.2) 
7. Seeing lots of 
healthcare providers 
5(5.5) 7(7.7) 17(18.7) 26(28.6) 36(39.6) 
8. Attending appointments 
 
1(1.1) 5(5.5) 14(15.4) 29(31.9) 42(46.2) 
9. Getting healthcare in 
evenings/weekends 
2(2.2) 4(4.4) 14(15.4) 23(25.3) 48(52.7) 
10. Getting help from 
community services 
2(2.2) 5(5.5) 11(12.0) 29(31.9) 44(48.4) 
11. Getting clear/up-to-date 
info about condition 
 
- 1(1.1) 8(8.8) 35(38.5) 47(51.6) 
12. Making recommended 
lifestyle changes 
3(3.3) 2(2.2) 13(14.3) 25(27.5) 48(52.7) 
13. Having to rely on help 
from family and friends 
1(1.1) 2(2.2) 15(16.5) 29(31.9) 44(48.4) 
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Illness Burden 
Score on the Illness Intrusiveness Ratings Scale may range from 13 – 91. 
On average, total illness burden scores for this sample were moderate (M = 46, 
SD = 15.8), suggesting the existence of illness burden for participants, but not 
excessively high levels of burden (See Table 7). Participants reported the highest 
scores of illness intrusiveness (i.e., illness burden) in health (M = 5.2, SD = 1.6), 
diet (M = 4.7, SD = 1.6), and financial situation (M = 4.5, SD =1.9). The factors 
that were the least impacted by participants’ illnesses were religious expression 
(M = 2.6, SD = 1.7) and social relationships (M = 2.9, SD = 1.6).  
Table 7 
Mean Scores for Illness Intrusiveness Ratings Scale (IIRS) Responses (N = 91) 
Variables M SD 
Observed 
Min - Max 
Possible 
Min-Max 
Perceived interference in:     
Health 5.23 1.59 1-7 1-7 
Diet 4.69 1.60 1-7 1-7 
Work 3.73 1.67 1-7 1-7 
Active recreation 3.69 1.64 1-7 1-7 
Passive recreation 3.29 1.78 1-7 1-7 
Financial situation 4.47 1.86 1-7 1-7 
Relationship w/ sig. other 2.98 1.83 1-7 1-7 
Sex life 3.23 2.21 1-7 1-7 
Family relationships 2.92 1.80 1-7 1-7 
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Table 7  
Mean Scores for Illness Intrusiveness Ratings Scale (IIRS) Responses Cont’d  
(N = 91) 
Variables M SD 
Observed 
Min - Max 
Possible 
Min-Max 
Social relationships 2.88 1.64 1-7 1-7 
Self-improvement 2.93 1.88 1-7 1-7 
Religious expression 2.57 1.68 1-7 1-7 
Community involvement 3.38 1.65 1-7 1-7 
Total illness burden 45.99 15.84 13-88 13-91 
 
Number of Prescribed Medications  
 As shown in Table 8, the total number of prescribed medications in this 
sample ranged from 2 - 8 (M = 4, SD = 1.3). The number of prescribed 
medications for diabetes and blood pressure ranged from 1-3 per medication 
type. Most participants reported taking two medications for diabetes (n = 53, 
58%) and two medications for blood pressure (n = 48, 53%). Thirty-three (36%) 
participants reported taking medications for health issues other than diabetes or 
blood pressure, with one additional medication being the most frequently 
observed response.  
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Table 8 
 
Distribution of Prescribed Medications (N = 91) 
 
# of 
prescribed 
medications 
 
Diabetes 
n(%) 
Blood 
pressure 
n(%) 
Other 
medications 
n(%) 
 
Total 
n(%) 
0 - - 58(63.7) - 
1 27(29.7) 39(42.9) 16(17.6) - 
2 53(58.2) 48(52.7) 13(14.3) 13(14.3) 
3 11(12.1) 4(4.4) 2(2.2) 19(20.9) 
4 - - 1(1.1) 28(30.8) 
5 - - - 18(19.8) 
6 - - 1(1.1) 9(9.9) 
7 
8 
- 
- 
- 
- 
- 
- 
3(3.3) 
1(1.1) 
 
Medication Adherence  
The mean medication adherence score was 2.4 (SD = 0.9), indicating the 
potential for a lack of adherence within the sample. The possible range of scores 
was 1 – 5, with actual medication adherence average scores ranging from 1 – 4. 
Participants were grouped by average medication adherence scores as adherent 
(scores < 2) or non-adherent (scores ≥ 2). The majority of the sample (66%) were 
classified as non-adherent. For this measure, any participants who do not 
indicate the highest level of agreement (i.e., strongly agree) for questions one 
and two and the lowest level of agreement (i.e., strongly disagree) to the 
remaining four questions, are considered non-adherent.  
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Most participants agreed or strongly agreed to taking all of their diabetic  
(n = 64, 70%) and blood pressure (n = 68, 75%) medications over the prior 30 
days. These responses aligned with the low level of agreement to questions 
which assessed whether they were “unable” to take all of their diabetes and 
hypertension medications. However, responses to whether they missed or 
skipped a dose, somewhat conflicted with the level of adherence questions. For 
example, 42 (46%) participants disagreed or strongly disagreed to missing or 
skipping any of their diabetic medications and only 46 (51%) participants 
disagreed or strongly disagreed to missing or skipping any of their blood 
pressure medications. This was a difference of 22 conflicting responses for both 
diabetes and blood pressure medication adherence. Table 9 displays the 
frequencies and percentages of responses to each of the six medication 
adherence questions.  
 
 
 
 
 
 
 
 
 
 
111 
 
 
 
Table 9 
Distribution of Extent of Adherence Responses (N = 91) 
 
 
Perceived Difficulty in Managing Prescribed Medications  
 Total difficulty in managing medication scores were determined by 
aggregating the difficulty scores from participants’ responses on the Medication 
Workload Survey (i.e., difficulty in attributes of the medication workload) and the 
Reasons for Non-adherence Scale within the Extent of Adherence Survey (i.e., 
barriers in medication adherence).  The measure has a possible score range of  
0 – 42. As reflected in Table 10, total scores for level of difficulty in managing 
medications ranged from 0 to 29, with a mean score of 10.4 (SD = 6.9). This 
Medication Adherence 
Questions 
Level of Agreement 
 
Over the past 30 days: 
 
Strongly 
agree 
n(%) 
Agree 
n(%) 
Neutral 
n(%) 
Disagree 
n(%) 
Strongly 
disagree  
n(%) 
1. I took all of my diabetes 
medications. 
 
 
19(20.9) 
 
45(49.5) 
 
15(16.5) 
 
12(13.2) 
 
- 
2. I took all of my blood 
pressure medications. 
 
 
24(26.4) 
 
44(48.4) 
  
 8(8.8) 
 
14(15.4) 
 
1(1.1) 
3. I missed or skipped a 
dose of my diabetes 
medications.  
 
 
 
2(2.2) 
 
 
31(34.1) 
 
 
16(17.6) 
 
 
20(22.0) 
 
 
22(24.2) 
4. I missed or skipped a 
dose of my blood 
pressure medications. 
 
 
 
2(2.2) 
 
 
22(24.2) 
 
 
21(23.1) 
 
 
21(23.1) 
 
 
25(27.5) 
5. I was unable to take all of 
my diabetes medications. 
 
 
3(3.3) 
 
20(22.0) 
 
11(12.1) 
 
34(37.4) 
 
23(25.3) 
6. I was unable to take all of 
my blood pressure 
medications. 
 
 
3(3.3) 
 
 
21(23.1) 
 
 
11(12.1) 
 
 
32(35.2) 
 
 
24(26.4) 
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finding indicates that participants experienced some difficulty in overall 
medication management and further supports the presence of medication burden 
indicated by the treatment burden measure. Both instruments measured difficulty 
in different aspects of medication management on a three-point scale, with a 
maximum difficulty score of 2 for each of the 21 items. Additionally, as some of 
the medication difficulty questions from the workload survey did not apply to 
some participants, there are fewer responses noted for those questions.   
Table 10 
Mean Scores for Perceived Difficulty in Managing Prescribed Medications Scales  
(N = 91) 
Variables M SD 
Observed 
Min-Max 
Possible 
Min - Max 
Perceived difficulty in:     
 
Medication workload 
 
5.8 
 
4.2 
 
0-22 
 
0-26 
 
Medication adherence 
 
4.6 
 
3.4 
 
0-12 
 
0-16 
 
Managing medications (Total) 
 
10.4 
 
6.9 
 
0-29 
 
0-42 
 
Medication Workload Difficulty 
The mean medication workload difficulty score was 5.8 (SD = 4.2), 
indicating a low perceived difficulty in managing aspects of the medication 
workload (e.g., routes of administration, timing of medications, changes to 
medication regimen, etc.) among participants. Although overall workload difficulty 
was low, 83 participants (91%) reported some level of difficulty in managing 
certain aspects of their medication workload. As indicated by frequencies of not 
hard, the easiest aspects of participants’ medication workloads, were opening 
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medication containers (n = 77, 85%), reading medication labels (n = 72, 79%), 
and understanding what prescribed medications are for (n = 72, 79%). The most 
difficult aspects of the medication workload, as indicated by higher frequencies of 
very hard, were paying for medications (n = 19, 21%), dealing with side effects  
(n = 12, 13%), and getting refills on time (n = 7, 8%). The sample responded 
equally with not hard and a little hard on how difficult it was to manage taking 
medications at inconvenient times (n = 43, 47%). Participants reported taking 
medications orally (n = 91,100%), topically (n = 5, 6%), via self-injection (n = 47, 
52%), pump (n = 11,12%), and through other routes (n = 1,1%). Thirty-six 
participants (40%) reported some level of difficulty with administering their 
medications via the prescribed routes.  
Sixty-two (68%) participants reported having to alter their blood pressure 
or diabetes medications based on blood pressure and glucose readings they 
obtain at home. Of these participants, about half indicated they experienced  
difficulty in checking their blood pressure and glucose levels at home and in 
figuring out how to adjust their dose based on the blood pressure and glucose 
readings. Of the 48 participants who indicated their healthcare provider made 
changes within the last 90 days to their medication  regimens, 40% (n = 19) 
reported having difficulty with managing those medication changes. The 
distribution of responses to the questions that assessed difficulty in medication 
workload are displayed in Table 11.  
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Table 11 
Distribution of Difficulty in Medication Workload Responses (N = 91) 
Medication Workload Difficulty Questions Levels of Difficulty 
 Not hard 
n(%) 
A little hard 
n(%) 
Very hard 
n(%) 
1. Taking meds at different times a 30(46) 31(48) 4(6) 
2. Administering meds via prescribed 
route(s)   
 
55(60) 
 
31(34) 
 
5(6) 
3. Checking blood pressure/glucose levels b 29(47) 31(50) 2(3) 
4. Figuring out med doses c 30(48) 28(45) 4(7) 
5. Managing med changes d 29 (60) 19(40) - 
6. Remembering to take meds 57(63) 31(34) 3(3) 
7. Paying for meds 31(34) 41(45) 19(21) 
8. Opening med containers 77(85) 13(14) 1(1) 
9. Reading med containers 72(79) 17(19) 2(2) 
10.  Getting refills on time 35(38) 49(54) 7(8) 
11.  Taking meds at inconvenient times 43(47) 43(47) 5(6) 
12.  Understanding purpose of meds  72(79) 16(18) 3(3) 
13.  Dealing with side effects from meds 33(36) 46(51) 12(13) 
a n = 65; b n = 62; c n = 62; d n = 48.  
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Difficulty in Medication Adherence 
Overall, the sample reported relatively low perceived difficulty in managing 
barriers to medication adherence, with a mean difficulty score of 4.6 (SD = 3.4). 
However, the majority had some level of non-adherence attributed to the 
medication adherence barriers on the scale (n = 75, 82%). As displayed in Table 
12, the most prevalent contributors to non-adherence were being busy (n = 52, 
57%), cost (n = 51, 56%), and taking medications more than once a day (n = 48, 
53%). Most participants reported that adherence to their medication regimens 
was not impacted by feeling too ill to take their medications (n = 60, 66%), feeling 
that they did not need their medications (n = 57, 63%), running out of 
medications (n = 54, 59%), or having a blood glucose or blood pressure that was 
too low to take their medications (n = 52, 57%) . Although 64% of participants 
reported some level of difficulty with side effects on the workload survey, for 
medication adherence, only 48% reported that side effects impacted their 
adherence.  
A total of six participants shared comments on additional reasons for non-
adherence. One participant reported they “ran out of money” and could not pay 
for their prescriptions. Another participant commented they were “too tired” to get 
up from bed once they realized they had forgotten to take their medications. Two 
participants indicated they overslept and were not able to take their medications 
at the scheduled times. Lastly, two participants reported that their travel plan 
conflicted with them taking their medications as scheduled. One of  the two 
116 
 
 
 
participants reported forgetting to pack their medications in their luggage before 
departing.  
Table 12 
Distribution of Reasons for Medication Non-Adherence Responses (N = 91) 
Reasons for Non-Adherence Levels of Contribution 
In the past 7 days, how much did each 
situation contribute to you missing a dose 
of your diabetes or blood pressure 
medication? 
 
 
Not at all 
n(%) 
 
 
A little 
n(%) 
 
 
A lot 
n(%) 
1. I was busy 39(43) 42(46) 10(11) 
2. They caused some side effects 47(52) 34(37) 10(11) 
3. They cost a lot of money 40(44) 35(38) 16(18) 
4. I felt I did not need them 57(63) 28(31) 6(6) 
5. I had to take them > once a day 43(47) 30(33) 18(20) 
6. I ran out of medication 54(59) 28(31) 9(10) 
7. My blood pressure/glucose was too low 52(57) 31(34) 8(9) 
8. I was feeling too ill to take them 60(66) 23(25) 8(9) 
 
Impact of Coronavirus Disease 2019 on Medication Management  
Participants were asked how much they believed the Coronavirus disease 
2019 (COVID-19) impacted 10 aspects of their medication management. 
Participants’ COVID-19 impact scores ranged from 10 – 44, with a mean score of 
30 (+8.8), indicating that COVID-19 was perceived to have had a moderate 
impact on medication management activities. The items with the most prevalent 
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responses of strongly agree and agree to COVID-19’s impact on medication 
management were worrying about leaving their homes to get medications, get 
supplies, or see their healthcare providers (n = 62, 68%), getting prescription refill 
orders from healthcare providers (n = 58, 64%), paying for medications (n =57, 
63%), and getting help from others (n = 53, 58%). In contrast, the items with the 
least prevalent responses of strongly agree and agree to COVID-19’s impact on 
medication management were checking their blood pressure and glucose levels 
(n = 22, 24%), remembering to take their medications (n = 23, 25%), and feelings 
of uncertainty regarding which medications they should or should not take  
(n = 23, 25%). See Table 13 for the frequencies of responses on the COVID-19 
Impact survey. 
Table 13 
Distribution of COVID-19 Impact Survey Responses (N = 91) 
COVID-19 Impact Scale Level of Agreement 
 Strongly 
agree 
n(%) 
Agree 
n(%) 
Neither 
agree 
nor 
disagree 
n(%) 
Disagree 
n(%) 
Strongly 
disagree 
n(%) 
1. Remembering meds 3(3) 20(22) 8(9) 35(38) 25(28) 
2. Paying for meds 16(18) 41(45) 8(9) 15(16) 11(12) 
3. Getting prescription 
orders 
 
 
13(14) 
 
45(50) 
 
10(11) 
 
11(12) 
 
12(13) 
4. Getting refills 7(8) 44(48) 10(11) 18(20) 12(13) 
5. Talking with 
healthcare provider  
 
 
8(9) 
 
38(42) 
 
11(12) 
 
22(24) 
 
12(13) 
6. Getting help from 
others 
 
 
9(10) 
 
44(49) 
 
11(12) 
 
13(14) 
 
14(15) 
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Table 13 
Distribution of COVID-19 Impact Survey Responses (N = 91) 
COVID-19 Impact Scale            Level of Agreement 
 Strongly 
agree 
n(%) 
Agree 
n(%) 
Neither 
agree 
nor 
disagree 
n(%) 
Disagree 
n(%) 
Strongly 
disagree 
n(%) 
7. Getting supplies 
 
7(8) 45(50) 10(11) 15(16) 14(15) 
8. Checking blood 
pressure and 
glucose levels 
 
 
 
1(1) 
 
 
21(23) 
 
 
8(9) 
 
 
28(31) 
 
 
33(36) 
9. Uncertainty about 
which meds I should 
take 
 
 
 
1(1) 
 
 
22(24) 
 
 
14(15) 
 
 
30(33) 
 
 
24(27) 
10. Worry about leaving 
the house  
 
20(22) 
 
42(46) 
 
9(10) 
 
10(11) 
 
10(11) 
 
Relationships among Major Study Variables 
Bivariate correlations between select demographic characteristics (i.e., 
age and level of education) and major study variables (i.e., patient activation, 
health literacy, treatment burden, illness burden, medication adherence, total 
number of prescribed medications, total difficulty in managing prescribed 
medications, and perceived COVID-19 impact on medication management) were 
examined. Due to the lack of normality among the study variables, a non -
parametric correlation analysis was performed (i.e. Spearman’s rho correlation). 
The variables met all assumptions for conducting Spearman’s rho correlation 
analyses (i.e. levels of measurement, paired observations, and monotonic 
relationships).   
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Table 14 displays the Spearman’s rho correlation coefficients. Both 
increasing age and higher level of education were associated with greater 
treatment burden and more difficulty with managing medications. Increasing age 
was also associated with lower levels of patient activation and taking more 
prescribed medications. Due to the assumptions for Spearman’s rho correlation, 
age and education were the only demographic variables appropriate for inclusion 
in the correlation analyses.  
As an exploratory measure, independent t-tests were performed to 
examine the major study variables for significant differences by participants ’ sex. 
Men reported significantly higher levels of illness burden (M = 48, SD = 15.3) 
than women (M = 41, SD =15.9; t(89) = 2.056, p = .04). Men also had 
significantly higher COVID-19 Impact scores t(84) = 2.601, p = .01, (M = 31, SD 
= 9.5) than women (M = 27, SD = 6.3; t(84) = 2.601, p = .01). There were no 
significant differences found between men and women for patient activation, 
health literacy, treatment burden, number of prescribed medications, total 
medication difficulty, or medication adherence. 
The correlation analyses also revealed a significant, negative correlation 
between patient activation and health literacy. Patient activation was also 
negatively correlated with treatment burden and total difficulty in managing 
medications. The negative correlation between patient activation and medication 
adherence indicates that as patient activation goes up, the scores on the 
medication adherence measure decrease. Lower scores on the medication 
adherence measure indicates better medication adherence. The variables 
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significantly associated with medication adherence were treatment burden, 
patient activation, total difficulty in managing medications, and COVID-19 impact. 
Table 14 
Spearman’s rho Correlation Coefficients among Study Variables (N = 91) 
Variables 1 2 3 4 5 6 7 8 9 10 
1. Age 
 
-          
2. Education  -.07 -         
3. Patient 
Activation 
 
-.33** -.01 -        
4. Health 
Literacy 
 
.09 .02 -.22* -       
5. Treatment 
Burden 
 
.24* .22* -.31** .08 -      
6. Illness 
Burden 
 
-.17 .17 .07 -.29** .18 -     
7. Medication 
Adherence 
 
.03 -.05 -.39** .21 .24* -.10 -    
8. Total # of 
prescribed 
medications 
 
.22* -.04 .07 -.04 .14 .25* -.02 -   
9. Total 
difficulty in 
managing 
medications 
 
.24* .21* -.48** .09 .69** .20 .35** .29** -  
10. COVID-19 
Impact 
-.12 .15 -.16 .12 .45** .01 .22* .16 .56** - 
Note. *p < .05. **p < .01. 
Data Analyses for Research Questions 
Research Question 1: Are higher levels of illness burden associated with 
lower levels of patient activation and health literacy?  
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 To answer research question one, results from the Spearman’s correlation 
analyses (Table 14) were examined to determine the correlations between       
(1) illness burden and patient activation and (2) illness burden and health literacy. 
Cohen's standard was used to evaluate the strength of the relationships, where 
coefficients between .10 and .29 represent a small effect size, coefficients 
between .30 and .49 represent a moderate effect size, and coefficients above .50 
indicate a large effect size. A significant negative correlation was observed 
between illness burden and health literacy (rs = -0.29, p = .005), indicating that as 
illness burden increases, health literacy decreases. No significant correlation was 
found between illness burden and patient activation. 
Research Question 2: Are higher levels of treatment burden associated 
with a higher number of prescribed medications and greater perceived 
difficulty in managing prescribed medications?   
 To answer research question two, Spearman’s rho correlation coefficients 
(Table 14) were examined to determine the associations between treatment 
burden and (1) number of prescribed medications and (2) total perceived 
difficulty in managing prescribed medications scores. A significant positive 
correlation was observed between treatment burden and perceived difficulty in 
managing medications (rs = 0.69, p = .000) indicating as treatment burden 
increases, perceived difficulty in managing medications also increases. The 
correlation coefficient of 0.69 indicated a large effect size. No significant 
correlation was found between treatment burden and number of prescribed 
medications.  
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Research Question 3: Do patient activation, health literacy, treatment 
burden, and illness burden significantly predict medication adherence? 
 To answer research question three, a hierarchical regression analysis was 
conducted to test the model consisting of patient activation, health literacy, 
treatment burden, and illness burden in predicting the variance in medication 
adherence. The order of entry for the variables was based on existing literature 
on the concepts. Several assumptions for this statistical analysis were confirmed. 
All predictor variables and the dependent variable were measured at the interval 
level. The demographic variables included in the model as covariates were age, 
sex, income, and education. Although age and education were the only 
demographic variables appropriate for inclusion in the correlation analyses, sex 
and income were  identified in previous literature as potential confounding 
influencers on the major study variables. As such, the regression analyses 
conducted in this study adjusted for these potential covariates as well. Age was 
measured as a continuous variable. Sex and income were categorical variables 
with each having two categories (i.e., $30,000 or ≥ $30,000, male or female). 
Each category for the two variables were designated scores of 0 and 1, 
respectively. Education was measured as an ordinal variable. As such, dummy 
coding was used for each of the education levels assessed, excluding the 
reference category (i.e., high school or lower). A sample size of 91 was 
determined to be adequate based on the priori analysis performed.  Adequate 
variance of the predictor variables was determined by examining the descriptive 
statics. There were no predictor variables that had the same values for all 
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participants. All Variance Inflation Factor values were < 10 and all Tolerance 
statistics were > .2, indicating that none of the predictor variables were 
excessively correlated with each other and that the assumption of 
multicollinearity was met. Examination of residual and scatter plots indicated the 
assumptions of normally distributed errors, linearity, and homoscedasticity were 
satisfied. Results of the Durbin-Watson test indicated that the assumption of 
independent errors was met, as the value of 1.5 is an acceptable value for 
indicating non-autocorrelation. Lastly, Cook’s distances were examined. All 
values were found to be less than one, indicating that none of the observations 
for the predictor variables appeared to have excessive influence on the 
regression line.  
A five-step hierarchical linear regression was conducted with medication 
adherence as the dependent variable. For step one, age, income, education, and 
sex were entered as predictor variables into the null model. This was done to 
control for their potential confounding impact. Patient activation was added as the 
first predictor variable in the model at step two. Health literacy was added into the 
model at step three, treatment burden was added at step four, and illness burden 
at step five.  
As reflected in Table 15, the results of the hierarchical regression analysis 
indicated that the full model (i.e., Model 5) that included all of the independent 
variables was significant in predicting medication adherence [F ( 10, 90) = 3.11,  
p = .002)], accounting for 19% of the variance. Although model 4 explained more 
variance in medication adherence (19.6%) than model 5 (19%), model 5 is being 
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highlighted because this study sought out to follow the cumulative complexity 
model and determine if the model with all four predictor variables would 
significantly predict medication adherence. However, of the four predictors, only 
patient activation was a significant individual contributor in predicting medication 
adherence as indicated by a t-statistic of -3.73 ( p = .000). Additionally, 
interpretation of the unstandardized beta coefficient indicated that for each one-
point increase in patient activation, medication non-adherence decreases by .03 
(SE = .008; 95% CI: -.047, .014). These results indicate that while patient 
activation is a significant predictor of medication adherence, adding the other 
variables (i.e., health literacy, treatment burden, and illness burden) to the model 
only provided a minimal change (i.e., highest amount of change in adjusted R2 
after model 2 was <.023) in helping to explain the variance in medication 
adherence. Additionally, the demographic variables (i.e., age, income, education, 
and sex), did not have a significant contribution in explaining medication 
adherence.  
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Table 15  
Results of Hierarchical Regression Analysis Predicting Medication Adherence in 
African American adults with T2D and Hypertension (N = 91) 
 B SE 
B 
β T R2 Adj. 
R2 
R2 Δ F 
Model 1 
  Sex  
  Income 
  Age 
  Grad  
  Undergrad 
 
-.344 
.011 
-.003 
-.084 
-.082 
 
.245 
.226 
.010 
.315 
.321 
 
-.168 
.005 
-.039 
-.042 
-.039 
 
-1.404 
.048 
-.334 
-.266 
-.254 
.027 -.042 .027 .392 
 
 
 
 
  Trade -.028 .401 -.009 -.069     
 
Model 2  
  Sex  
  Income 
  Age 
  Grad  
  Undergrad  
  Trade 
  Patient Activation  
 
 
-.315 
.211 
-.015 
-.288 
-.408 
-.317 
-.037 
 
 
.219 
.206 
.009 
.284 
.294 
.363 
.008 
 
 
-.153 
.103 
-.177 
-.144 
-.197 
-.106 
-.495 
 
 
-1.440 
1.023 
-1.637 
-1.014 
-1.389 
-.874 
-4.764*** 
 
.236 
 
.172 
 
.209 
 
3.665** 
 
 
 
 
 
 
Model 3  
  Sex  
  Income 
  Age 
  Grad  
  Undergrad  
  Trade 
  Patient Activation 
  Health Literacy 
 
 
-.286 
.261 
-.014 
-.284 
-.439 
-.272 
-.035 
.068 
 
 
.218 
.208 
.009 
.282 
.293 
.362 
.008 
.049 
 
 
-.139 
.127 
-.175 
-.142 
-.212 
-.091 
-.470 
.140 
 
 
-1.310 
1.255 
-1.621 
-1.006 
-1.498 
-.751 
-4.479*** 
1.383 
 
.254 
 
.181 
 
.017 
 
3.481** 
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Table 15  
Results of Hierarchical Regression Analysis Predicting Medication Adherence in 
African American adults with T2D and Hypertension Cont’d (N = 91) 
 B SE 
B 
β T R2 Adj. 
R2 
R2 Δ F 
 
Model 4  
  Sex  
  Income 
  Age 
  Grad  
  Undergrad  
  Trade 
  Patient Activation 
  Health Literacy 
  Treatment Burden 
 
 
-.258 
.321 
-.015 
-.368 
-.500 
-.236 
-.032 
.077 
.011 
 
 
.217 
.209 
.009 
.285 
.293 
.360 
.008 
.049 
.007 
 
 
-.126 
.156 
-.185 
-.184 
-.241 
-.079 
-.429 
.159 
.166 
 
 
-1.188 
1.532 
-1.731 
-1.292 
-1.707 
-.656 
-4.008*** 
1.582 
1.597 
 
.276 
 
.196 
 
.023 
 
3.436** 
 
 
 
 
 
 
 
 
Model 5 
  Sex  
  Income 
  Age 
  Grad  
  Undergrad  
  Trade 
  Patient Activation 
  Health Literacy 
  Treatment Burden 
  Illness Burden 
 
 
-.249 
.306 
-.017 
-.345 
-.478 
-.177 
-.031 
.068 
.012 
-.005 
 
 
.218 
.211 
.009 
.288 
.296 
.373 
.008 
.051 
.007 
.007 
 
 
-.121 
.149 
-.202 
-.173 
-.231 
-.059 
-.413 
.141 
.185 
-.074 
 
 
-1.139 
1.449 
-1.827 
-1.200 
-1.615 
-.474 
-3.736*** 
1.335 
1.705 
-.642 
 
.280 
 
.190 
 
 
.004 
 
3.111** 
Note. **p < .01.  ***p  < .001. 
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Research Question 4: Which aspects of medication management are the 
most challenging?  
 To answer research question four, the responses from the Medication 
Workload Survey and the Reasons for Non-Adherence Scale from the Extent of 
Adherence Survey were examined. The five most challenging aspects of 
medication management, listed in order of most challenging to least challenging 
were (1) paying for medications, (2) dealing with side effects, (3) getting refills on 
time, (4) managing medication schedules (i.e., preventing a busy schedule from 
interfering with medication adherence, taking medications at different and/or 
inconvenient times), and (5) managing medication dosing (i.e., taking a 
prescribed medication more than once a day and figuring out medication doses).   
Research Question 5: What is the perceived impact of the COVID-19 
pandemic on medication management? 
To answer research question five, responses to the COVID-19 Impact 
Survey were examined. From greatest to least perceived impact, participants 
reported the following impact of COVID-19 on medication management: (1) 
worrying about leaving their homes (68%), (2) getting refill orders from their 
healthcare providers (64%), (3) paying for medications (63%), (4) getting help 
from others (59%), (5) getting supplies (58%), (6) getting refills from the 
pharmacy (56%), (7) talking with their healthcare provider about their 
medications (51%), (8) being uncertain about what medications they should or 
should not take (25%), (9) remembering to take their medications (25%), and 
(10) checking their blood pressure or blood glucose levels (24%).  
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Eight participants shared additional details about how COVID-19 impacted 
situations relating to their diabetes and hypertension. Four participants described 
how COVID-19 impacted their income sources, making it more difficult to pay for 
medications and supplies. One participant also described how they had to rely 
more on the financial support from family and friends. Two participants described 
how COVID-19 impacted their daily routines. One described how working from 
home, due to COVID-19 public health concerns, created additional difficulty in 
remembering to take medications as scheduled. The participant described how 
physically going into work created a daily structure for them, helping them with 
remembering to take their medications. The other reported that the restrictions 
relating to COVID-19 public health concerns impacted their ability to continue 
with their normal exercise routine at the gym. Another participant described how 
they are consistently worried about their potential for becoming ill from COVID-
19. Lastly, a participant described how they had recently suffered from a stroke 
and during their hospital admission discovered that they were positive for 
COVID-19. During their admission, their healthcare provider prescribed a 
medication for management of their diabetes. The medication was one that the 
participant had previously taken and one that created unpleasant side effects. 
The participant reported that they decided to take the medication, however, they 
reduced the daily dosage of the medication in hopes that it would reduce the side 
effects from the medication.  
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Summary 
 In this study of young to older African American adults with Type 2 
diabetes and hypertension, most were male, college graduates, employed part-
time, and had health insurance and a primary care provider. The time since 
diagnosis of diabetes and hypertension averaged four years each and most were 
able to provide their recent HbA1c, SBP, and DBP levels. All of the scales used to 
measure the major study variables in this study demonstrated adequate internal 
consistency reliability, with Cronbach’s alpha coefficients of >.70.  
On average, participants had high levels of patient activation. Their health 
literacy scores were somewhat split over the three health literacy categories, but 
the highest prevalence indicated a high likelihood of poor health literacy. The 
mean number of medications taken by participants was four, with a range of two 
to seven prescribed medications. The overall treatment burden was low; 
however, the medication burden aspect of the treatment burden scale was high 
for about one-third of the sample. Illness burden was moderate, with the highest 
impacts reported for health, diet, and financial status. The majority of the sample 
was found to be non-adherent to their medication regimen based on adherence 
scores ≥ 2, although the majority responded with some level of agreeance to 
taking all of their diabetic and blood pressure medications over the prior 30 days.  
The major demographic variable of interest was participant age, and 
increasing age was significantly associated with lower patient activation and 
greater treatment burden, greater number of prescribed medications, and 
increased difficulty in managing medications.  
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Five research questions were answered in this study. Illness burden was 
significantly associated with health literacy but not with patient activation, while 
treatment burden was significantly associated with perceived difficulty in 
managing medications but not with the number of medications prescribed. The 
results of the hierarchical regression analysis revealed that the model explained 
19% of the variance with patient activation being the only predictor variable 
significantly explaining the variance in medication adherence. The participants’ 
total perceived difficulty in managing prescribed medications on average was 
low. The aspects of medication management that participants found the most 
challenging were paying for medications, dealing with side effects, getting refills 
on time, managing medication schedules, and managing medication dosing. The 
mean COVID-19 impact score indicated a moderate perceived impact among 
participants. Most participants reported that paying for medications, getting refill 
orders, getting medications from the pharmacy, and getting supplies were harder 
to do than they were prior to the rise of the COVID-19 pandemic in March 2020. 
Additionally, participants shared how the changes from the COVID-19 pandemic 
created disruptions in their routines, making it more difficult to remember to take 
their medications.   
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
The purpose of this non-experimental, predictive correlational study was to 
examine relationships among disease self-management capacity, patient burden, 
and medication adherence in African American adults with T2D and 
hypertension. This study also explored the perceived impact of the COVID-19 
pandemic on the management of medications. This chapter provides a 
discussion of the study findings, study limitations, and strengths. The implications 
for practice and recommendations for future research are also described followed 
by the conclusion. 
Recruitment and Characteristics of the Sample 
Targeted advertising facilitated recruitment efforts for this study. 
Approximately half of the participants (n = 46) were recruited from a social media 
platform (i.e., Facebook). Potentially more people being at home due to the 
COVID-19 pandemic and greater accessibility and use of computers and cell 
phones may have also contributed to the successful online recruitment rates. In 
general, this sample was composed of mostly college-educated, males. Social 
media may also explain why the sample was composed of more college-
educated and younger participants than anticipated. 
Based on the employment-to-population ratio for males aged 25 – 54 
(81.5%) in comparison to females in the same age group (68.7%), the U.S. 
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workforce has a greater representation of males (U.S. Department of Labor., 
2020). Thus, the greater number of male participants in this study may be due to 
a greater prevalence of increased availability during the pandemic (e.g., COVID-
19 related employment challenges). Furthermore, the use of social media vs. 
traditional recruitment settings (e.g., clinics or doctor’s offices) may have 
provided greater opportunity to recruit AA males in this study, as AA males have 
been found to be less likely than AA females to have a usual source of 
healthcare (Stewart et al., 2019).  
Most participants (>91%) were able to self-report their most recent HbA1c, 
SBP, and DBP levels, which may be explained by participants being mostly 
young and college educated. Average HbA1c readings (M = 7.4%) were above 
recommended levels (CDC, 2018e). Though the mean SBP (139; SD = 18.7) and 
DBP (82; SD = 10.4)  were below the general blood pressure target of 140/90 
recommended by the American Diabetes Association (ADA) for individuals with 
T2D and that have lower risks for cardiovascular disease, the mean blood 
pressure in this study was above 130/80 (ADA, 2020). A target BP goal of < 
130/80 has been suggested as a more favorable BP target for individuals at 
higher risk for cardiovascular disease, such as AAs, who may require more 
intensive blood pressure control (ADA, 2020; Passarella et al., 2018; Saab et al., 
2015; Whelton et al., 2018). These findings support the presence of blood 
pressure levels and T2D that may lead to an increased risk for cardiovascular 
and neurological complications among these participants (AHA, 2015; CDC, 
2018b; NIDDK, 2017; Petrie et al., 2018).  
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Few participants reported having additional health issues other than T2D 
and hypertension. This may be due to the sample’s low average for years since 
diagnosis of T2D (M = 4.3) and hypertension (M = 4.4) and low mean age (39.6). 
The mean age in this study is lower than what was found in similar studies that 
included AAs with T2D and/or hypertension (Rogers et al., 2017; Skolasky et al., 
2011; Ylitalo et al., 2018). This mean age supports the previous research 
indicating that AAs tend to develop these diseases at earlier ages than other 
racial or ethnic groups, and as a result experience cardiovascular diseases, 
stroke and other complications at earlier ages.  
Of the participants (n = 19) that reported additional health issues (n = 19), 
obesity (n = 5), high cholesterol (n = 4), and arthritis (n = 4) were the most 
frequently identified. These additional health issues are in line with previous 
studies, as Lin et. al (2015) found that obesity, hyperlipidemia, and arthritis were 
some of the most common components of the multiple morbidity clusters for 
individuals with T2D and hypertension. However, in a sample of adults with both 
T2D and hypertension, it was anticipated that there would be higher rates of 
obesity. The low rates of obesity in this sample may be related to underreporting. 
Participants may not be fully aware of their body mass index levels or perceive 
themselves to be “obese”, and as such, may not have reported this health issue. 
A previous study also found that participant report of obesity was low, as only 
22.2% of obese women and 6.7% of obese men were able to correctly classify 
themselves as obese (Truesdale & Stevens, 2008). Future studies should include 
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inquiries of waist circumference or waist-to-hip ratio to help with determining 
rates of obesity.  
Illness Burden, Heath Literacy, and Patient Activation  
Illness burden was significantly associated with health literacy but not with 
patient activation; the higher the illness burden, the lower the level of health 
literacy. As illness burden has been described as being a barrier to performance 
of DSM activities in previous studies, findings in this study suggest that 
challenges created by illness burdens may be offset by greater health literacy 
(Eton et al., 2012; Gore et al., 2006). Additionally, Boehmer, Shippee, et al. 
(2016) found that greater illness burden related to diminished mental capacity. 
This further supports the link between health literacy and illness burden and 
emphasizes the importance of providing additional health literacy support to AA 
with co-morbid T2D and hypertension.  
Previous studies also reported that increased illness burden related to 
diminished ability to perform activities of daily living, decreased productivity, and 
less self-efficacy (Boehmer, Shippee, et al., 2016; Gore et al., 2006). As these 
are functions similar to those measured in this study with patient activation, it was 
anticipated that higher illness burdens would be related to lower patient 
activation. This was not found and may indicate that individuals who have greater 
patient activation, but not adequate health literacy, may not have the same ability 
to overcome challenges from the illness burden they experience.  
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Treatment Burden and Medication Workload 
While increased treatment burden related to greater perceived difficulty in 
managing medications (rs = 0.69, p = .000), no association was found between 
treatment burden and number of prescribed medications. These findings 
indicated that while individuals perceived increases in their treatment burden and 
greater difficulty in managing medications, the number of medications they 
reported taking did not largely factor into their overall perceived treatment 
burden. Additionally, as a high level of patient activation was found in this study 
and patient activation was significantly associated with treatment burden, it is 
possible that greater activation eased the impact from taking a greater number of 
medications in overall treatment burden.  
Although no association was found between number of medications and 
treatment burden, taking more medications was associated with greater difficulty 
in managing medications. As a high level of medication burden was found for 
some participants in this study, the association between number of medications 
and difficulty in medication management implies that individuals taking multiple 
medications may need more guidance on managing their medication workload.   
Application of the Adapted Cumulative Complexity Model in Predicting  
Medication Adherence 
As proposed by the adapted CCM, the regression model that included all 
of the independent variables (i.e., patient activation, health literacy, treatment 
burden and illness burden) was significant in predicting medication adherence; 
explaining 19% of the variance. However, only patient activation provided a 
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significant individual contribution in predicting medication adherence. This finding 
suggests that individuals who perceived themselves as more capable in 
managing their DSM workloads (i.e., higher patient activation) also perceived that 
they were more adherent to their prescribed medication regimens (i.e., had lower 
scores on the Extent of Adherence Survey). Skolasky et al. (2011) also found in 
their cross-sectional study of 855 multimorbid participants (46% AA) that higher 
patient activation related to improved medication adherence.  
Based on the available literature, it was anticipated that health literacy 
would also provide a significant contribution in predicting medication adherence.  
Al Sayah et al. (2015) found that a health literacy item that measured difficulty 
understanding written information was significantly associated with worse 
medication adherence (Al Sayah et al., 2015). Additionally, Ylitalo et al. (2018) 
examined health literacy using the Newest Vital Sign (NVS) among 406 patients 
(39% had diabetes; 41% non-Hispanic Blacks) and found attending scheduled 
medical appointments was significantly lower for patients with limited health 
literacy as compared with individuals with adequate health literacy. Although 
attending office visit appointments is a different activity than adhering to 
medication, the study provided support that health literacy is linked with 
performance of disease management activities. A different study (Bains et al., 
2011) reported that they did not find associations between health literacy and 
medication adherence, however, the lack of association in that study was thought 
to be due to that study not using a tool such as the NVS that measures numeracy 
and reading comprehension.  
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 The lack of contribution from health literacy in the regression model may 
be related to response bias of participants. While health literacy examined actual 
ability to solve numerical problems and make decisions based on written 
information, the medication adherence tool captured participants perceived level 
of adherence. Essentially, participants may have overestimated their adherence 
to their medication regimens. Additionally, it is possible that by modifying the 
medication adherence tool to capture adherence over the prior 30 days, instead 
of the original 7 days, may have created challenges for participants to accurately 
recall their adherence.  
Patient burden (i.e. illness burden and treatment burden) also did not 
significantly contribute to explaining the variance in medication  adherence. This 
finding suggests that while individuals who demonstrate poor adherence may 
also be experiencing higher levels of treatment burden, other factors or 
relationships should be considered in explaining adherence to their medication 
regimen. Possibly, focusing more on the burden of their medication workloads 
rather than their entire disease-related burden may be beneficial.  
Additionally, although burden was not significant in the model, in bivariate 
correlation analysis, greater treatment burden was significantly associated with 
poorer medication adherence, but not illness burden. Individuals who believed 
their prescribed treatments were less burdensome (i.e., lower treatment burden 
scores) perceived themselves as being more adherent to their medication 
regimens. Rogers et al. (2017) also found significant associations between 
treatment burden and medication adherence. The negative bivariate correlation 
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observed between patient activation and treatment burden provides further 
support for the CCM, as it posits that patient burdens (e.g., treatment burden) 
work against capacity factors (e.g., patient activation) in an individual’s attempt to 
carrying out DSM activities. Therefore, by addressing an individual’s burden, 
increases in patient activation may be observed leading to greater medication 
adherence.   
Exploratory Findings 
Two concepts examined in this study but were not included in the model 
explaining medication adherence were difficulty in managing medications and the 
impact of COVID-19 on managing medications. Examination of how attributes of 
individual medication workloads (e.g., level of perceived difficulty) provided 
additional insight into the workload demand of managing prescribed medications 
for AA adults with T2D and hypertension and highlighted situations that add to 
the complexity individuals encounter when attempting to meet the DSM workload 
demand of managing prescribed medications. Additionally, as this study 
considered factors that may create challenges in individual medication 
workloads, it was fitting to also incorporate an exploration of the potential impact 
of the COVID-19 pandemic on medication management.  
Perceived Difficulty in Managing Medications 
Overall, participants reported little perceived difficulty in their medication 
management (i.e., difficulty in managing prescribed medication workloads and 
overcoming potential barriers to medication adherence). However, 45% of 
participants had total perceived difficulty scores that exceeded the sample mean. 
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The challenges in medication management that participants generally perceived 
the most difficult related to managing medication costs, side effects, getting 
refills, taking medications at inconvenient times, and medication frequency (i.e., 
taking medications more than once a day). These findings are in line with 
previous studies that also found participants with T2D and/or hypertension had 
challenges in their medication management relating to the side effects they 
experienced, being confused about medication administration (e.g., timing of 
medication administration), managing multiple medications, and dealing with the 
interference in daily routines caused by managing medications (Bockwoldt et al., 
2017; Eton et al., 2012; Rogers et al., 2017; Weller et al., 2017). Additionally, 
studies have examined how feelings of powerlessness and fear can hinder 
individuals from taking their medications as prescribed (Bockwoldt et al., 2017; 
Kennedy et al., 2008). Considering that dealing with side effects was one of the 
more challenging aspects of medication management for participants, it is very 
possible that the fear from experiencing side effects lead to inconsistencies in 
their medication management.  
Managing prescribed medications require various skills. This complexity 
potentially created challenges for participants in meeting their medication 
workload demands (Brown & Bussell, 2011; Greene et al., 2015; Ylitalo et al., 
2018). Of the participants in this study who had to self-monitor their blood 
pressure and glucose at home, 53% reported having some difficulty in self-
monitoring their blood pressures and glucose levels (53%). Also, 52% of this 
same group reported difficulty in adjusting their medication dosing based on 
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those levels. In these situations, participants must use technical skills (i.e., 
operating blood pressure and glucose monitoring equipment, handling an  insulin 
syringe), health literacy skills (e.g., reading and interpreting medication 
instructions), and problem-solving skills (e.g., what to do if they run out of 
medications, supplies, etc.). Individuals who have deficiencies in the skills 
needed to manage these tasks (i.e., deficient DSM capacity) likely have greater 
challenges in carrying out their medication workload activities and achieving their 
blood pressure and glucose goals.  
Of the participants that had provider-initiated changes to their medication 
regimen, 40% of them reported difficulty in managing those changes. These 
findings indicate that participants also need skills in adapting to medication 
changes. Previous studies have found that diabetic patients who have elevated 
HbA1c during a hospital admission are typically prescribed a more intense 
outpatient medication regimen, as compared to what they receive during 
hospitalization (Umpierrez et al., 2012). Griffith et al. (2012) also found that the 
most frequent changes in patients medication regimens were initiating a new 
insulin medication (44%), initiating a non-insulin medication, change from one 
insulin medication to another, and increasing medication dosages. These 
findings highlight the importance of assessing individual abilities in managing 
medications, providing clear instructions on managing changes to their 
medication regimens, and providing them with resources for managing their 
medication management challenges. 
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Perceived Impact of the COVID-19 Pandemic 
The mean COVID-19 impact score indicated participants perceived a 
moderate impact on their medication management. Participants felt most strongly 
about COVID-19 impacting their abilities to get prescription refill orders from their 
healthcare providers, pay for medications, and receive help from others. Most 
participants also reported worrying more about leaving their homes to get 
medications and supplies and to see their healthcare providers. Considering that 
COVID-19 is life-threatening infectious disease, transmitted through contact with 
infected individuals, and has no specific vaccines or treatments, it is 
understandable that individuals would have concerns with performing activities 
that may increase their potential for contracting the illness (World Health 
Organization [WHO], 2020). In line with the impact on pay reported by 
participants, a review of U.S. unemployment reports indicated a dramatic rise, 
with rates increasing more than threefold from January 2020 to April 2020 (U.S. 
Bureau of Labor Statistics, 2020). The additional stress and concerns that come 
from the presence of the COVID-19 pandemic may have created additional 
challenges for individuals in performing their DSM activities (e.g., managing their 
medication workloads). The activities that the participants reported were least 
impacted by COVID-19 (i.e., monitoring blood pressure and glucose levels, 
remembering to take their medications, and having uncertainty regarding which 
medications they should or should not take), were activities that did not typically 
require them to leave their homes or interact with other individuals.  
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Furthermore, although only a small portion of the sample, 10% of 
participants indicated not believing they could maintain positive lifestyle changes 
during stressful times. Considering the current presence of the COVID-19 
pandemic, these participants may have great difficulty in carrying out the DSM 
activities necessary for their T2D and hypertension. This concept is further 
supported by the results of the correlation analysis performed in this study which 
indicated that greater perceived impact from COVID-19 associated with greater 
treatment burden and poorer medication adherence. Although the COVID-19 
impact was not included in the adapted CCM, this finding suggests the potential 
impact that the COVID-19 pandemic may have on the existing burden individuals 
with T2D and hypertension experience and on their abilities to carry out their 
DSM workload activities. Additionally, as the perceived COVID-19 impact as well 
as illness burden were found to be significantly greater for men as compared to 
women, this may indicate that men with T2D and hypertension may need greater 
support (e.g., emotional support, financial support) in managing their diseases 
including meeting their medication workload demands.  
The Cumulative Complexity Model 
The Cumulative Complexity Model (CCM) guided the selection of 
variables for examination of associations among DSM capacity (i.e., patient 
activation and health literacy), patient burden (i.e., treatment and illness burden), 
and a DSM outcome measure (i.e., perceived medication adherence) for AA 
adults with T2D and hypertension. The abilities individuals have in meeting the 
demands of their workload were examined with patient activation and health 
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literacy measures. The burdens that individuals experience in meeting their 
workload demands and the perceived level of disruption in aspects of day-to-day 
life attributed to their chronic diseases were measured with treatment burden and 
illness burden measures. Imbalances between medication workload and DSM 
capacity, specifically when capacity fails to meet the demands of the workload, 
individuals are more likely to have deficiencies in their disease management 
performance, such as poor medication adherence (Boehmer, Shippee, et al., 
2016). As poor medication adherence may lead to poor health outcomes, greater 
illness and more burden of treatment is likely to ensue (Bodde et al., 2013; 
Shippee et al., 2012;). An explanation of the findings from the application of the 
CCM in this study are described next. 
Disease Self-Management Capacity 
Disease self-management capacity is an individual’s ability to complete 
the activities involved in their individual disease workload (e.g., taking prescribed 
medications). Patient activation (i.e., an individual’s perceived knowledge, 
motivation, and DSM skills relating to managing healthcare activities) and health 
literacy (i.e., the ability to obtain, process, and understand health and healthcare 
service information) were measures used to examine the disease self-
management capacity of the participants in this study.  
Patient Activation  
Overall, mean patient activation (PA) scores were high (M = 78, SD = 
13,3), with the majority (63%) of the sample categorized in the highest level of 
patient activation (level 4). Level 4 patient activation indicates that individuals 
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proactively engage in recommended disease self-management (DSM) behaviors, 
such as medication adherence (Greene et al., 2015). The mean patient activation 
scores were similar to those found in previous studies examining patient 
activation, with mean scores ranging from 66 – 80 in diverse samples, some of 
which included AAs and individuals with T2D (Fowles et al., 2009; Hibbard et al., 
2008; Mayberry et al., 2010). The high level of patient activation reported in this 
study may be explained by the younger age of participants. This finding is 
supported by previous studies that found a correlation between lower patient 
activation scores and older age in diverse populations (Chubak et al., 2012; 
Gerber et al., 2011; Gleason et al., 2016; Hendricks & Rademakers, 2014). 
Essentially, participants may feel less confident in performing some of their DSM 
activities as they age.   
  Despite the high levels of PA, there were survey items for which 
participants generally reported lower levels of agreeance (e.g., understanding 
their health problems and what causes them, knowing what treatments were 
available for their health problems, figuring out solutions when new health 
problems arise). This suggests there are opportunities to enhance PA among 
AAs with T2D and hypertension. Several studies have reported differences in 
DSM behaviors and patient outcomes as PA scores change (Bolen et al., 2014; 
Fowles et al., 2009; Greene et al., 2015; Hibbard at al., 2008; Lubetkin et al., 
2010; Mayberry et al., 2010; Skolasky et al., 2011). For example, individuals who 
had increases in PA scores have been found to have greater reductions in 
systolic blood pressure, body weight, and cholesterol (Bolen et al., 2014).  
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Health Literacy 
In general, participants had low health literacy scores; 69% did not 
demonstrate a high likelihood of adequate health literacy (NVS scores <4). The 
mean NVS score of 2.6 was lower than scores in previous studies of AAs from 
diverse age groups, ranging from 3.2 to 3.7 (Huang et al., 2018; Miser et al., 
2013; Weiss et al., 2005). The lower health literacy scores found in this study 
may be related to the low mean years for time since diagnoses of T2D (M years = 
4.3) and hypertension (M years = 4.4). Although no studies could be found that 
examined associations between health literacy and the amount of time since 
diagnosis of any chronic disease, it is possible that the amount of time individuals 
have to adjust to DSM tasks plays a role in their development of health literacy 
skills.  
The majority of incorrect responses in  this study were for questions that 
assessed numeracy and document literacy. Numeracy and document literacy are 
essential components of the health literacy skills individuals with T2D and 
hypertension need to adequately carry out their DSM activities. For example, 
numeracy skills are needed when performing quantitative tasks (e.g., figuring out 
insulin dosage based on glucose levels or calculating carbohydrates) and 
document literacy skills are needed to search for and comprehend information 
presented in non-continuous text such as what may be found on medication or 
food labels (National Assessment of Adult Literacy [NAAL], n.d.). Although 71% 
(n = 65) of participants demonstrated prose literacy by correctly answering the 
prose-related question (i.e., Is it safe to eat the ice cream?), 48% (n = 44) were 
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not able to answer the corresponding question correctly (i.e., Why not?). This 
indicates that participants likely were unable to comprehend the information 
presented in the ingredients section (i.e., demonstrate document literacy skills) 
and instead, considered factors outside of the scenario (e.g., potential impact the 
ice cream may have on their glucose or blood pressure levels) to determine the 
appropriateness of consuming the food product. Although it is promising that the 
participants considered the impact of their choices on their health, failure to 
identify the rationale for their decisions leaves an opening for misinterpretation of 
instructions or lack of compliance in DSM activities. For example, a prescription 
may provide information on interactions with food or drug items and if participants 
are unable to comprehend this information, they may inadvertently create 
additional complications in their health. Individuals may also have instructions 
that direct them to take their medications with food. Inadequate interpretation of 
this information may lead individuals to decide that they should skip a medication 
dose because they did not eat, rather than eating so they can take their 
medications.  
Overall, the sample had insufficient disease self-management capacity in 
regard to patient activation and health literacy. Although patient activation scores 
were high, there was area for improvement, and average health literacy scores 
were less than adequate. Inadequate health literacy has been found to associate 
with less disease-related knowledge, greater risk of misinterpreting prescription 
instructions, and worse medication adherence (Al Sayah et al., 2015; Davis et al., 
2009). Interventions are needed to improve knowledge and critical thinking skills 
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for individuals with T2D and hypertension, particularly those with inadequate 
health literacy. Adequate health literacy and having a good understanding of 
health problems, prevention measures, and problem-solving are essential 
components to DSM. Interventions that enhance these components may further 
support efforts in reducing health complications associated with the presence of 
T2D and hypertension.  
This study also examined the relationship between patient activation 
levels and health literacy. As these variables were measures of DSM capacity, 
with higher scores indicating greater capacity, and based on previous research 
(Gwynn et al., 2016; Lubetkin et al., 2010; Mitchell et al., 2014; Sheikh et al., 
2016) it was anticipated that they would be positively associated. In contrast with 
previous studies, patient activation and health literacy had a negative correlation 
in this study. This unanticipated finding may be related to the use of a different 
health literacy measure in this study (i.e., NVS) than what was used in  the 
previous studies (i.e., Rapid Estimate of Adult Literacy in Medicine and the Short 
Test of Functional Health Literacy in Adults). The major difference between the 
NVS and the Rapid Estimate of Adult Literacy in Medicine (REALM) is that the 
latter does not incorporate measures of numeracy (Dumenci et al., 2013). While 
the Short Test of Functional Health Literacy in Adults (S-TOFLA) indicates that 
numeracy is examined, a previous study found that there were limitations in the 
S-TOFLA identifying individuals with poor numeracy as compared to other tools 
(Housten et al., 2018). This suggests that other measures of health literacy 
should be explored when examining DSM capacity in this population.  
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Patient Burden 
 Disease self-management capacity can be impacted by the burden that 
patients experience. In this study, burden was measured in respect to 
participants’ treatment burden and illness burden. Research has demonstrated 
that while having high levels of patient activation is beneficial, if high levels of 
burden are also present, individuals may have considerable challenges in 
managing their medication workloads (Boehmer, Shippee, et al., 2016). 
Treatment Burden  
There was a moderate level of perceived treatment burden among 
participants; 40% had scores above 22, indicating a high level of treatment 
burden. The item response with the highest burden score was “taking lots of 
medications”. This was similar to previous studies (Eton et al., 2012; Gallacher  
et al., 2018; Rogers et al., 2017), that found one of the most substantial aspects 
of greater treatment burden is taking multiple medications. The mean number of 
medications taken by participants in this study was 4 with a range from 2-8; half 
reported taking two medications for T2D and two for hypertension.  
The number of prescribed medications reported in this study was not 
associated with medication adherence. However, a previous study by Davis et al. 
(2006), found that misunderstanding prescription instructions was more likely to 
occur for individuals taking three or four prescription medications. As 
misinterpretation of prescriptions may lead to poorer adherence, individual’s 
perceived difficulty in managing their number of medications should be 
considered. Greater treatment burden was found to associate with greater 
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difficulty in medication management and worse medication adherence. These 
findings suggest that higher perceived treatment burden may impact DSM 
productivity (e.g. medication adherence), warranting the need to incorporate 
measures to reduce this burden when possible for patients (Rogers et al., 2017).  
Illness Burden  
Overall, the perceived illness burden in this sample was moderate and 
comparable with other studies that examined illness burden in  samples of 
primarily White individuals with chronic disease (Boehmer, Shippee, et al., 2016; 
Molzon et al., 2013). The highest levels of illness burden reported were for 
health, diet, and finances, indicating a greater perceived disruption in these 
aspects of the participants’ lives related to their diseases. This is not surprising 
as patients with two major chronic diseases, such as T2D and hypertension may 
perceive their overall health poorer than others and have dietary restrictions (e.g. 
reduced carbohydrate and sodium). Previous studies have reported that illness 
burden arises from the presence of more than one chronic disease and the 
symptoms that coincide with those comorbidities (Adriaanse et al., 2016; Aga  
et al., 2019; Boehmer, Shippee, et al., 2016; Gebregziabher et al., 2018; Lin  
et al., 2015; Payne et al., 2013; Tonelli et al., 2015). Illness burden was 
potentially intensified for some participants in this study, as 21% reported having 
a health issue other than T2D and hypertension.  
 Additionally, the higher reports for intrusiveness in finances were likely 
related to the associated costs of living with these diseases (e.g., paying for 
multiple medications). Furthermore, the ADA (2018b) described how individuals 
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with greater illness burden may be financially impacted, as they may have 
challenges in acquiring or maintaining employment due to their disease-related 
complications. The majority of participants in this study reported being employed 
part-time (n = 48; 53%); this underemployment further supports the presence of 
financial challenges for participants.  
Religious expression and social relationships were the least impacted 
factors in illness burden. Although no previous studies were found that examined 
the impact of these concepts on illness burden in AAs with chronic disease, 
these factors may serve as buffers to illness burden and warrant additional 
exploration.  
While illness burden did not associate with medication adherence, greater 
illness burden was found to associate with a higher number of prescribed 
medications. This is similar to the findings reported by Rogers et al. (2017) that 
greater illness burden associates with greater medication burden. Overall burden 
among participants in this study was moderate. Identifying strategies to reduce 
the burdens of living with co-morbid T2D and hypertension may improve DSM 
and patient outcomes.   
Disease Self-Management: Medication Adherence 
 The primary outcome for this study of disease self-management was 
medication adherence. On average, medication adherence scores were above 
two, indicating the presence of medication non-adherence among participants. 
Based on the medication adherence grouping, 66% of participants were 
classified as not adhering to their medication regimens. The level of non -
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adherence found in this study falls within the range of non -adherence (15% - 
85%) reported by previous studies that examined medication adherence among 
AAs with T2D (Al Sayah et al., 2015; Weller et al., 2017) and in diverse samples 
(Aitken et al., 2019; Brown & Bussell, 2011). Non-adherence to medication has 
been found to associate with not achieving glycemic and blood pressure control 
goals, increased risk for disease-related complications, and greater treatment 
burden (CDC, 2018b; Dragomir et al., 2010, Rogers et al., 2017). The mean 
Hba1c readings in this study were above recommended levels, potentially due to 
the lack of medication adherence among participants.  
Participants’ reporting on the Extent of Adherence tool indicated that 70% 
had taken all of their prescribed diabetic medications and 74% took all of their 
prescribed anti-hypertensive medications in the prior 30 days. However, when 
asked if they missed or skipped any of their prescribed medications, 53% 
indicated that they may have missed some of their diabetic medications and 49% 
said they potentially missed or skipped taking some of their anti-hypertensives. 
These percentages for missed or skipped medications were greater than what 
was anticipated based on the high reports of taking all medications. The higher 
percentages of missed or skipped medications in this sample suggests that while 
participants may have had a higher level of confidence in reporting that they were 
adhering to their medication regimens, they felt less certain about whether they 
may have missed or skipped a dose. The reports of missing or skipping 
medications may also be higher than anticipated due to participants including the 
medications they skipped in accordance with medication instructions (e.g., 
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medication instructions that advise not to take the medication if their glucose is 
below a certain level). The number of participants who missed or skipped 
medication doses based on their medication instructions was not tracked in this 
study. Future studies should delineate between participants who missed or 
skipped doses per medication instructions and those who did so for other 
reasons (i.e., side effects relating to sexual performance).  
Associations of Demographic Characteristics with Capacity, Burden and 
Medication Management 
Of the demographic characteristics assessed in this study, age correlated 
with the most study variables. Associations were found between age and one of 
the capacity variables (i.e., patient activation), one of the burden factors (i.e., 
treatment burden), and attributes of the DSM workload (i.e., number of 
prescribed medications and difficulty in managing medications). Associations 
were also found between level of education and two of the major study variables 
(i.e., treatment burden and total difficulty in managing medications). When 
examining differences by sex, males had significantly higher illness burden than 
females. Previous studies with diverse samples have found similar associations 
with age, socioeconomic status (e.g., income, level of education), and sex, 
identifying these demographic characteristics as confounding variables (Akohoue 
et al., 2015; Boehmer, Shippee, 2016; Byers et al., 2016; Gallacher et al., 2018; 
Neto et al., 2019; Osborn et al., 2013; Rovner et al., 2013). These findings 
suggest that age, sex, and level of education may impact the cumulative 
complexity of managing a DSM workload and should be taken into consideration 
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when developing treatment plans for individuals who are older and have lower 
education attainment.  
Limitations 
This study had limitations that affect generalizability and should be 
considered when interpreting the findings. The first limitation relates to the 
sample selection. Convenience sampling was the recruitment method used in 
this study, with a large number of participants being recruited from a social media 
platform. Participants also self-screened and self-identified as being AA, having 
T2D and hypertension, and taking prescribed medications for their T2D and 
hypertension. It is possible that some participants may have provided inaccurate 
information. To reduce the amount of false or inaccurate information, the student 
PI conducted daily quality checks on the data. Any information that appeared 
erroneous was reviewed with participants during their follow up call and revised 
as applicable. Prior to the conclusion of each participant’s interview session for 
administration of the NVS, the student PI verified eligibility of the participants by 
having them confirm their chronic disease status, age, the number of medications 
and the names of the medications they were taking.  
A second limitation is that, during the time of recruitment for this study, the 
effects of COVID-19 on employment and financial status were likely very present. 
The perceived impact of COVID-19 on medication management was explored in 
this study and found that there was an overall moderate perceived impact 
reported by participants. It is possible that participants who chose to volunteer for 
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this study may have been motivated more greatly by the small financial incentive 
as compared to times prior to the pandemic. 
A third limitation was that most of the instruments used in this study were 
self-report measures which created a space for recall and response bias. 
Potentially, participants may have intentionally, or unintentionally, provided 
inaccurate responses to some of the study questions (e.g., most recent blood 
pressure reading or whether they took all of their T2D and blood pressure 
medications). Incorporating more objective measures may have provided 
verification of the potential of recall and response bias and greater clarity into the 
accuracy of the reports provided by participants.  
Strengths of the Study 
While limitations of this study were observed, there were several strengths 
as well. This study adds to the limited body of literature describing disease-self 
management for AAs with comorbidities. This is the first known study that 
examined associations among patient activation, health literacy, treatment 
burden, illness burden, medication workload, and medication adherence for AA 
adults with comorbid T2D and hypertension. Also, the perceived impact of a 
pandemic on the management of prescribed medications was explored. The 
ability to recruit younger participants and male participants is also a major 
strength of this study. Furthermore, there was limited missing data and each 
instrument used in this study was found to have adequate internal consistency 
reliability.  
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 Implications for Nursing Practice 
Nurses have essential roles in supporting patients’ DSM efforts. The 
findings from this study suggest several implications for nursing practice in 
furthering the support provided by nurses to patients who have DSM 
responsibilities. First, this study highlighted factors that created burdens and also 
counteracted burdens in medication management for AA adults with T2D and 
hypertension. Lower patient activation was primarily associated with worse 
medication adherence, but treatment burden and difficulty in medication 
management may contribute to nonadherence directly or through patient 
activation.  
Assessing levels of patient activation may provide useful information for 
healthcare professionals, as patient activation was found to predict medication 
adherence. The patient activation tool used in this study provides an assessment 
measure and also a framework for implementing strategies to assist patients in 
achieving the highest level of activation. For example, a patient who is at the 
lowest level of patient activation (i.e., level one) would likely benefit most from 
receiving basic knowledge about their condition and their treatment plan and 
establishing with them the role they have in improving their health (Greene et al., 
2015; Hibbard et al., 2004).  
Without a basic understanding of their condition and their treatment plan, 
the patient may make choices that they believe will have positive outcomes, but 
not have an adequate understanding of how certain decisions may impact their 
health. Therefore, it is essential that patients are not just instructed on how to 
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carry out their medication management tasks, but also on why certain tasks must 
be performed. For example, when instructing patients about taking their 
medications at certain times of day, providing them with rationales as to why the 
medications need to be taken as prescribed may be beneficial in fostering their 
desire and abilities to adhere to their medication regimens.  
To boost activation, patients may also benefit from having problem-solving 
strategies incorporated into the education they receive from their healthcare 
providers. For example, patients could be presented with various scenarios that 
may occur as they navigate their medication management tasks alongside their 
other responsibilities. This will create an opportunity to identify potential 
challenges patients have in their medication management as well as facilitate 
discussions that can empower them to overcome those challenges.  
Additionally, as both treatment burden and difficulty in managing 
medications were associated with medication adherence, using measures to 
assess the more burdensome and/or difficult areas in managing medications for 
patients may provide guidance on how to best facilitate individualized adherence 
to medication regimens. For example, more than half of the sample reported 
difficulty in taking medications at inconvenient times. These individuals may 
benefit from receiving assistance for incorporating strategies in their day such as 
structuring their mealtimes to coincide with their medication times or mapping out 
their daily routines to incorporate the times for their scheduled medications. 
Additionally, the patient’s daily routine could be considered when healthcare 
providers are prescribing their medication regimen, thereby reducing the level of 
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inconvenience experienced with their medications and potentially improving their 
medication adherence. Helping patients identify strategies that facilitate better 
medication management may promote a greater sense of accountability for them 
in their medication management and increase the likelihood of them achieving 
their treatment goals.  
When educating patients, healthcare providers should consider those 
characteristics that increase patients’ risk for poor disease self-management in 
relation to the CCM. This study suggests that patients who are older in age, male 
and less educated may need greater support in building capacity and reducing 
perceived burden including workload. Health literacy was low in this sample. 
Although health literacy was not found to correlate with  medication adherence, a 
clinical practice implication remains for assessing health literacy, as individuals 
who have poor health literacy may have difficulty in other aspects of disease self -
management. Additionally, participants in this study found the f inancial aspect of 
their medication workloads, particularly in the face of the COVID-19 pandemic, to 
be one of the most difficult aspects of managing their medications. As such, 
these participants could benefit from healthcare policy that provides financial 
support or reduced costs for the purchasing of prescriptions and/or supplies 
needed for management of T2D and hypertension.  
Recommendations for Future Research 
Although several significant correlations were found in this study, more 
research is needed on DSM among AAs with T2D and hypertension. All of the 
instruments in this study demonstrated good internal consistency reliability, thus, 
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future research may benefit from using the measures in studies that examine 
other DSM activities (e.g., healthy eating habits). Additionally, future studies 
could include more objective measures of capacity, and medication adherence. 
For example, in addition to assessing participants’ self-reported patient activation 
and perceived level of adherence, studies could incorporate administrative refill 
data to substantiate participants’ perceptions. Furthermore, studies may benefit 
from using the S-TOFHLA and/or the REALM as measures of health literacy to 
examine if either of these measures significantly predict medication adherence. 
The  different aspects of health literacy (e.g., reading comprehension, numeracy, 
document literacy) could also be incorporated in the regression analyses to 
examine how those specific elements of health literacy correlate to other 
independent variables and outcome measures.  
Future studies should include inquiries of waist circumferences or waist-to-
hip ratios for examining adiposity and to help determine rates of obesity more 
accurately. While cardiometabolic variables were assessed in this study, they 
were also through self-report and only the most recent reading for blood pressure 
and HbA1c. Longitudinal studies that assess trends in blood pressure and HbA1c 
to determine correlations with capacity and burden measures may provide more 
insight into the impact that DSM performance has on treatment goals. Further 
research is also needed in examining DSM capacity, patient burden, and DSM 
outcomes among AA adults with chronic comorbid conditions in various 
situations (e.g., following a hospital discharge) and settings (e.g., rehabilitation 
facility).  
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Lastly, the findings from this study suggest that there may be benefit in 
further exploration of differences in age, sex, length of time since diagnoses, 
religious practices, and social relationships among AA adults with chronic 
disease. Further exploration of these variables may provide greater insight into 
DSM performances, intervention designs, and potential outcomes for this 
population. 
Conclusions 
In this study of AA, mostly educated, younger men, self-reported glucose 
and blood pressure readings were elevated. Non-adherence to medication may 
help to explain this finding as more than half of the sample reported skipping or 
missing medications within the prior 30 days. While low levels of health literacy, 
moderate treatment burden, and moderate illness burden were found in this 
study, only patient activation significantly contributed to predicting medication 
adherence, explaining only a small percentage of variance. This finding suggests 
that while patient activation may be an effective tool for identifying AA patients at 
risk for poor medication adherence, additional concepts for DSM capacity and 
burden should be considered for this population, as the model that incorporated 
all measures only accounted for 19% of the variance in medication adherence.  
Greater illness burden was associated with lower health literacy, while 
greater treatment burden was associated with lower patient activation and higher 
perceived difficulty in managing medications. These findings imply that certain 
aspects of capacity may counteract the burdens from illness and treatment in this 
population. Paying for medications, dealing with side effects, getting refills on 
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time, managing medication schedules, and managing medication dosing were 
the most challenging aspects of medication management for this sample.  
Additionally, COVID-19 had the greatest perceived impact on getting refill 
orders, paying for medications, getting medications from the pharmacy, and 
getting supplies. These findings suggest the need for DSM support services that 
emphasize reduction of financial burdens, adequate management of side effects, 
efficient acquisition of medication refills, and minimization of disruptions from 
medication schedules. By considering the various factors that may hinder or 
promote medication adherence, strategies can be implemented to help this 
vulnerable population, particularly older, male and less educated AAs improve 
their adherence, achieve their treatment goals and ultimately, live longer and 
healthier lives.  
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Appendix A 
 
Recruitment Flyer 
 
 
 
 
 
 
VOLUNTEERS NEEDED FOR A 
STUDY OF AFRICAN AMERICANS     
          WITH TYPE 2 DIABETES AND HYPERTENSION 
 
A PhD nursing student at Georgia State 
University is working on a research study to 
learn more about skills and burdens of African 
American/Black adults with diabetes and 
hypertension. 
 
Seeking African American/Black adults who 
have had Type 2 diabetes and hypertension for 
at least 1 year. 
 
You will be asked to complete online surveys 
about how you manage your diabetes and  
                                    hypertension. You will also be asked to take                     
                                    part in a short phone call or online chat to    
                                    assess your skills. It may take a total of 45            
                                    minutes for you to complete this study.  
                                    You will receive a $25 electronic gift card for       
                                    completing this study. 
 
Interested? 
Please visit https://gsu.qualtrics.com/jfe/form/SV_bCJr1YY9mcNET2Z 
for more information 
 
If you have any questions about this study or prefer to 
receive printed copies of the surveys, please contact: 
 
        Michelle Gaddis, MSN-ED., RN-BC 
                   at 404-855-0815 
                  or mgaddis1@gsu.edu 
 
 
• Have you 
had Type 2 
diabetes and 
high blood 
pressure for 
1 year or 
longer? 
 
• Are you 
African 
American/  
Black? 
 
• Are you 18 
or older? 
 
• Do you take 
medications 
for diabetes 
and high 
blood 
pressure? 
 
 
If so, you may 
be able to 
participate in 
this study. 
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Appendix B 
 
Email/Text Message Script
 
 
 
Dear [name will be inserted here],  
My name is Michelle Gaddis and I am a PhD student at Georgia State University. I am 
writing to invite you to join a research study. The purpose of this study is to find out 
about the skills, burdens, and medication practices of African Americans with diabetes 
and hypertension. The total estimated time for you to complete this study is 45 minutes. 
Your email (or phone number) was obtained from [source will be inserted here] because 
of your potential interest in the study. 
 
You may be eligible for this study if you: 
• Are African American 
• Are 18 years or older 
• Have Type 2 diabetes and high blood pressure for 1 year or longer 
• Take at least 1 medication for diabetes and 1 medication for high blood pressure 
 
If you decide to join this study, you will: 
• Complete an online consent form  
• Complete seven short online surveys 
• Complete a 10-minute phone call or online chat to assess your skills 
• Receive a $25 electronic gift card once you have completed the study 
 
If you do not have access to complete the online surveys, please call or email Michelle 
Gaddis. It may still be possible for you to join the study. Remember, this study is 
voluntary. You can choose to be in the study or not. If you'd like to join the study, you 
can visit the following link to get started:  
https://gsu.qualtrics.com/jfe/form/SV_bCJr1YY9mcNET2Z  
 
If you have any questions about the study, please contact Michelle Gaddis:  
phone at 404-855-0815 or email mgaddis1@gsu.edu 
 
If you know of anyone else that may be interested in this study, please provide them 
with my contact information. 
 
Thank you very much.  
 
Sincerely,  
Michelle Gaddis 
Student Investigator 
Georgia State University 
Study Title: Disease Self-Management Capacity, Patient Burden, and Medication 
Adherence for African American adults with Type 2 Diabetes and Hypertension 
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Appendix C 
 
Demographic Survey 
 
 
 
 
 
  
DEMOGRAPHIC SURVEY 
ID: __________________                                              DATE: ____________ 
 
(1) Age ______________  
 
(2) Sex/Gender  
□ Female 
□ Male  
□ Other (please describe) ____  
 
(3) Race/Ethnicity (select all that apply) 
□ Black/African American 
□ Other (please describe) _________  
 
(4) Highest level of education completed 
□ Did not attend school 
□ Elementary school 
□ Middle school 
□ High school  
□ Trade school 
□ College 
 
(5) Employment status 
□ Fulltime  
□ Part-time  
□ Unemployed 
□ A homemaker 
□ Military  
□ Retired  
□ Unable to work  
 
(6) Household income 
□ < 30,000 
□ ≥ 30,000 
 
(7) Marital status 
□ Single (never married) 
□ Married 
□ Separated  
□ Widowed 
□ Divorced 
□ Domestic partnership  
 
 
(8) When did you find out that you had: 
 
          Diabetes? ___________________ 
 
          Hypertension? ________________ 
 
 
(9) Most recent HbA1c value _________  
 
(10) Most recent blood pressure _________  
 
(11) Other health issues 
 
________________________________ 
 
(12) Insurance status  
□ No insurance 
□ Private insurance  
□ Employer-sponsored insurance 
□ Medicare/Medicaid  
□ Other (please describe) ____________ 
 
(13) Do you have a primary health care  
             provider? 
□ Yes 
□ No 
 
(14) Do you have social support in doing the          
              things you need to do to manage your  
              health? (For example, a friend,   
             church member, or family member   
             who drives you to your doctor visits.) 
□ Yes 
□ No 
 
(15)  Are you able to complete 
three or more of the following activities of daily 
living on your own: eating, bathing,  
getting dressed, or toileting?  
□ Yes 
□ No 
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Appendix D 
 
Medication Workload Survey  
                  
 
ID: ___________________                               DATE: ____________ 
 
Your responses to the questions in this survey will help us learn about the work that goes 
into managing your medications.  
 
How many medications do you take for diabetes? ________________ 
How many medications do you take for high blood pressure?  ________________ 
Do you take medications for things other than diabetes or high blood pressure? (For 
example, do you take medications for cholesterol, pain, or any other health issue).   
□ Yes 
□ No 
 
How many different medications do you take for these other health issues? (Do 
not include your diabetes and hypertension medications in this count). 
_____________ 
 
Do you have to take any of your medications at separate times each day?  
□ Yes 
□ No 
How hard is it for you to take medicines at different times? [Select one response]    
 
Not hard A little hard Very hard 
□  □  □  
 
The list below includes different ways you might have to take your medications. Which of 
the following describe how you take your medicines? [Select all that apply to you] 
□ Oral (For example, pills or liquid) 
□ Topical (For example, creams or ointments) 
□ Injection (For example, you have to give yourself a shot through your skin)  
□ Pump (For example, an insulin pump)  
□ Other (please describe) ___________ 
 
How hard is it for you to take your medication in the way(s) you listed? [Select one 
response]    
 
Not hard A little hard Very hard 
□  □  □  
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Do you have to change the amount of medication you take based on blood sugar or blood 
pressure levels you check at home? (For example, you might have to check your blood sugar 
level each day and give yourself a certain amount of insulin based on your blood sugar). 
□ Yes 
□ No 
 
(By responding “yes”, the following two questions will be displayed)  
 
a. How hard is it for you to check your blood pressure and/or blood sugar levels at 
home? [Circle one response]    
 
Not hard A little hard Very hard 
□  □  □  
 
 
b. How hard is it for you to figure out the amount of medication you should take 
based on the levels you check at home? [Select one response]    
 
Not hard A little hard Very hard 
□  □  □  
 
Has your healthcare provider made changes in the last 90 days to the medications you take? 
□ Yes 
□ No 
□ Does not apply to me (Select this one if you do not have a primary healthcare 
provider) 
 
(By responding “yes”, the following question will be displayed)  
 
How hard has it been for you to deal with the changes made to your prescriptions? 
[Select one response]    
 
Not hard A little hard Very hard 
□  □  □  
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How hard is it for you to deal with the following situations?                                                                       
[Select one response for each situation]
 
 
  
How hard it for you to deal with the following situations?              
 [Select one response for each situation]   
 
 
 
 
 
 
 
 
 
 
 
 
 
  Not hard A little hard Very hard 
    
Remembering to take my medications . . . . . . . . . . . . . . . . . . □  □  □  
 
Paying for my medications . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
□  
 
□  
 
□  
 
Opening my medication containers . . . . . . . . . . . . . . . . . . . . . 
 
□  
 
□  
 
□  
 
Reading the words on the medication containers  . . . . . . . . .  
 
□  
 
□  
 
□  
 
Getting my refills on time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
□  
 
□  
 
□  
 
Taking medication at inconvenient times  . . . . . . . . . . . . . . . .  
 
□  
 
□  
 
□  
 
Understanding what my medications are for  . . . . . . . . . . . . .  
 
Dealing with the side effects from my medications. . . . . . . . . 
 
□   
  
□   
 
 
□  
 
□  
 
□  
 
□  
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Appendix E 
 
Patient Activation Measure® (PAM®) 
 
 
(Hibbard et al., 2004) 
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Appendix F 
 
Newest Vital Sign (NVS) 
 
 
 
 
(Weiss et al; 2005) 
 
  
PARTICIPANT ID: _____________________                                                 DATE: ____________ 
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Appendix G 
 
Multimorbidity Treatment Burden Questionnaire (MTBQ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Duncan et al; 2018) 
 
  
PARTICIPANT ID: _____________________                                                 DATE: ____________ 
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Appendix H 
 
Illness Intrusiveness Ratings Scale (IIRS) 
 
 
 
(Devins, 2010) 
 
  
PARTICIPANT ID: _____________________                                                 DATE: ____________ 
Illness Intrusiveness Ratings Scale 
 
PARTICIPANT ID: _____________________                                                 DATE: ____________ 
 
The following items ask about how much your illness and/or its treatment interfere with 
different aspects of your life. Please circle the one number that best describes your 
current life situation. If an item is not applicable, please circle the number one 
(1) to indicate that this aspect of your life is not affected very much. Please do not 
leave any item unanswered. Thank you. 
 
How much does your illness and/or its treatment interfere with your: 
 
1. Health 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
2. Diet (i.e., the things you eat and drink) 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
3. Work 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
4. Active recreation (e.g., sports) 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
5. Passive recreation (e.g., reading, listening to music) 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
6. Financial situation 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
7. Relationship with your spouse (girlfriend or boyfriend if not married) 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
8. Sex life 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
9. Family relationships 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
10. Other social relationships 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
11. Self-expression/self-improvement 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
12. Religious expression 
Not Very Much     1         2           3             4      5          6              7     Very Much 
 
13. Community and civic involvement 
Not Very Much     1         2           3             4      5          6              7     Very Much 
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Appendix I 
 
Extent of Adherence Survey 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PARTICIPANT ID: ___________________                      DATE: ____________ 
Please rate your agreement with the following statements.  
 
Over the past 30 days… 
1. I took all doses of my diabetes medications. Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
 
2. I took all doses of my blood pressure medications. Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
 
3. I missed or skipped at least one dose of my diabetes 
medications. 
Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
 
4. I missed or skipped at least one dose of my blood 
pressure medications. 
Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
 
5. I was not able to take all of my diabetes medications. Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
 
6. I was not able to take all of my blood pressure 
medications. 
Strongly disagree   Disagree    Neutral     Agree    Strongly agree 
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(Voils et al., 2012) 
 
 
  
Reasons for Nonadherence  
Situations come up that make it difficult for people to take their diabetes and blood pressure medications as prescribed by their 
doctors. Below is a list of those situations. We want to know how much these situations contributed to you missing a dose of 
your medication. Only one of these situations may apply to you, or many may apply to you. 
In the past 7 days, how much did each situation contribute to you missing a dose of your diabetes or blood pressure medication? 
  Not at all A little A lot 
1. I was busy o  o  o  
2. They caused some side effects  o  o  o  
3. They cost a lot of money  o  o  o  
4. I felt I did not need them o  o  o  
5. I was supposed to take them more than once a day o  o  o  
6. I ran out of medication  o  o  o  
7. My blood pressure or blood sugar was too low  o  o  o  
8. I was feeling too ill to take them o  o  o  
 
Were there other reasons why you missed taking your medications? 
□ Yes 
□ No 
If you selected “yes” in question #8, please use the space below to list other reasons for why you did not take your diabetes or 
blood pressure medications.  
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Appendix J 
 
COVID-19 Impact Survey 
 
 
 
 
